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ABSTRACT 
The general objective of this dissertation was to investigate physical function in 
osteoarthritis (OA) and total knee replacement (TKA) patients. First, a validation study was 
performed to evaluate the validity of the Continuous Scale Physical Functional Performance 
(CS-PFP10) test in knee OA awaiting TKA. The CS-PFP10 scores were compared to the 
Western Ontario and McMaster Universities OA Index (WOMAC), The Knee Societys Clinical 
Rating System (KSS), and the Short Form 36-item health survey (SF-36) physical function 
scores. It was hypothesized that at least moderate associations between the CS-PFP10 test 
scores and the WOMAC, KSS, and SF-36 scores in TKA candidates exist. The results of this 
study indicated moderate to strong associations between the CS-PFP10 and other physical 
function scores (r=.474 to .598, p<.001) showing that the CS-PFP10 is a valid tool for 
measuring physical function in OA/TKA patients.  
 The second study was a 12-week prospective study investigating the return of physical 
function in TKA patients following surgery. We also examined the sensitivity of the CS-PFP10 
test to change in TKA patients. The hypotheses of this investigation included that the CS-PFP10 
would be sensitive to functional changes in TKA patients and that the magnitude of effect sizes 
during the initial recovery period following surgery (between 3 and 6 weeks post-op) would be 
greatest for the CS-PFP10 and the KSS. Finally, we hypothesized that improvements in 
objective measures of function would not be affected by dispositional optimism, but the 
subjective measures would be. 
Consistent with our hypotheses, the results demonstrated a functional incline over the time 
course of the study. The effect sizes of the follow-up data suggest that the CS-PFP10 is sensitive 
in detecting change in function over time, even in a small group of patients. Unexpectedly, the 
CS-PFP10 indicated an initial drop in physical function immediately after surgery (3 weeks 
  x
post), while the other tests did not. These findings indicate that there are differences in 
perceived and performance-based physical function and could be an indication of the CS-PFP10 
being a more sensitive measure of function when compared to the other instruments. 
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CHAPTER 1 
INTRODUCTION 
 
Osteoarthritis (OA) is a leading cause of disability and the most common form of arthritis in 
older adults3, 4. Specifically, knee OA is one of the five leading causes of physical disability 
among men and women 60 years and older and accounts for more functional limitations than 
any other disease in older adults5, 6. By comparison, the disability risk associated with OA is 
comparable in magnitude to the disability resulting from cardiovascular disease7, 8. The process 
of disablement in OA patients involves pain, loss of mobility in joints, muscle weakness and 
atrophy, as well as functional limitations in activities of daily living (ADLs)9, 10.  
Total knee arthroplasty (TKA) is effective in reducing joint pain, improving knee function, 
and quality of life in knee osteoarthritis (OA) patients11. Functional improvement following 
TKA is commonly measured using the Western Ontario and McMaster Universities 
Osteoarthritis index (WOMAC)12, 13, the Knee Society Clinical Rating System (KSS)14, and the 
Short Form Health Survey (SF-36)15. The WOMAC and the SF-36 are survey instruments that 
rely on patient self-reported information and they are therefore subjective measures of physical 
function. Some known limitations of self-report assessment tools are, however,  that they may 
be imprecise, lack sensitivity to change, and may be subject to errors in judgment or memory, 
the ability and willingness to answer questions correctly, and discrepancies between perception 
and actual ability16-19. Self-report measures may also be influenced by factors other than the 
physical functional capacity of the lower extremity including depression and fatigue20.  
Consequently, there is considerable interest in the development of universally applicable 
objective measures of physical function that will allow scientists and clinicians to measure 
functional outcomes in various patient groups with greater specificity and sensitivity20, 21. 
Moreover, standardizing the approach to measure clinical outcomes will offer investigators the 
advantage of making comparisons across studies. The KSS may offer some advantage in this 
  2
regard. While this instrument incorporates certain self-reported outcomes, it also includes 
objective measures of stability, range of motion, and knee alignment in the overall assessment 
of the knee. However, one could argue that these are measures of impairment rather than 
functional ability. Regardless, it is important to continue to identify and refine quantifiable 
measures of function that reflect the ability of the person to execute basic and instrumental 
ADLs in TKA patients so that clinicians and scientists can evaluate treatment outcomes with 
greater sensitivity.  
There are many advantages to performance-based tests.  In addition to providing objective 
measures of function, they  provide important information about future disability and mortality, 
they are thought to be a meaningful reflection of the conduct of similar tasks usually performed 
at home, and they appear to be better suited for between-subject comparisons than self-report 
because the basis of comparison is the same22. Another advantage of performance-based tests is 
that the information obtained may provide an opportunity for individuals to learn that their 
ability to perform ADLs may be different from what they perceive16.  In addition, outcomes of 
interventions measured by subjective measures have been linked to dispositional optimism23, 24 
indicating that participants responses may be influenced by an individuals tendency to 
evaluate all situations as positive. Therefore, self-reported functional measures may not reflect 
accurate changes in function, which further emphasizes the importance of using objective 
outcomes instruments in intervention studies.  
The Continuous-Scale Physical Functional Performance 10-item Test (CS-PFP-10) is an 
objective measure of physical function16, 25. This test requires participants to perform basic and 
instrumental ADLs in a standardized testing environment. This test provides information on the 
patientsoverall physical function, as well as several fitness domains including strength, 
endurance, and balance and coordination. Because the CS-PFP10 includes items that are 
  3
performance-based, it is not subject to problems inherent in self-report measures such as the SF-
36 and WOMAC.  
Because of the rise in patients needing TKA, a larger number of near-end stage OA patients 
will have involvement of both knee joints and require replacement of both joints to restore 
physical function. The current literature suggests that complications following bilateral TKA are 
no greater than those associated with unilateral TKA26-29. However, functional disability caused 
by severe OA in both knees and the improvement in physical function as a result of bi-lateral 
TKA has not been widely studied30-32. While no known studies objectively measure physical 
function following unilateral or bilateral TKA, there are a few studies that objectively examine 
the physical functional recovery following the two surgeries using various instruments27, 33, 34. 
To objectively quantify and measure physical function, or return to function in unilateral and 
bilateral TKA, investigators should utilize validated and reliable measures of function.  
1.1 Purpose of the Dissertation   
The general objective of this dissertation was to examine physical function in unilateral and 
bilateral TKA patients. Two studies were conducted to achieve this objective. The following 
section provides a brief summary of each study.  
First, a validation study (Chapter 3) was conducted to evaluate the validity of the CS-PFP10 
in unilateral and bilateral TKA patients by comparing the CS-PFP10 to the WOMAC, KSS, and 
the SF-36. The main purpose of this study was to determine whether the CS-PFP10 test is useful 
in measuring physical functional performance in the TKA patient population.  
The second study was a 12-week prospective study (Chapter 4) conducted to examine the 
return of physical function and the sensitivity to change of the CS-PFP10 test  in unilateral and 
bilateral TKA patients from baseline (pre-surgery) to follow-up (3 wks, 6 wks, and 12 wks). 
Because the use of subjective measures in intervention studies may be biased by dispositional 
optimism of the patients and controlling for optimism may expose greater differences in 
  4
subjective and objective instruments, dispositional optimism was used as a covariate in the 
analyses.   
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CHAPTER 2.   
LITERATURE REVIEW 
 
2.1 Epidemiology of Osteoarthritis 
 
2.1.1 Understanding Osteoarthritis  
 
As one of the most common chronic diseases, knee osteoarthritis (OA) causes disability in a 
large proportion of older adults negatively affecting a large percentage of the population3, 4. 
Because knee OA is so common, it is not always regarded as a serious disease9. Knee OA 
affects the patients ability to perform activities of daily living (ADLs) more than any other 
condition in the world5. These impairments contribute to functional limitations in basic and 
instrumental ADLs5, 6, 9, 10. Consequently, OA has considerable effects on labor force 
participation of working-age Americans being responsible for significant work related losses 
and consequent socioeconomic burden 9, 35, 36. It is estimated that musculoskeletal conditions 
such as OA cost the U.S. economy more than $86 billion each year in lost wages and 
production, and direct expenses29. According to Arthritis Foundations  estimates, arthritis and 
chronic joint problems cost the economy up to $124.8 billion each year including $82.2 billion 
on lost productivity and $42.6 billion in direct medical expenses37 The financial losses that 
accumulate to an individual during the process of disablement also have a significant impact on 
social and emotional well-being35,36, 38. Osteoarthritis patients often struggle with loss of ability 
and feelings of helplessness and depression. As a consequence, they may be unable to fulfill 
social roles successfully, including interpersonal relationships, resulting in limitations in social 
activities9,10. This review will address functional loss and quality of life issues in greater detail 
in section 3 of this chapter. 
2.1.2 Etiology and Diagnosis of Osteoarthritis 
Although the causes of OA are not entirely understood, it is known that both biomechanical 
stresses and biochemical factors are important in the pathogenesis of OA. The American 
  6
College of Rheumatology defines OA as a "heterogeneous group of conditions that leads to joint 
symptoms and signs which are associated with defective integrity of articular cartilage, in 
addition to related changes in the underlying bone at the joint margins39. Evidence implicates 
the role of systemic factors such as genetics, diet, estrogen use, and bone density; and local 
biomechanical factors such as muscle weakness, obesity, and joint laxity40, 41. The disability 
resulting from OA is primarily due to pain, which is most often caused generally by 
inflammation and/or joint irregularity. 
Osteoarthritis has been studied and identified in ancient and modern human and animals42. 
While the exact etiology of OA is not well understood, there is evidence that the first description 
of the disease dates back to early man 43. According to some experts, the gross morphologic 
changes within the joints of OA patients were described over 200 years ago42. Until the 1980s, 
OA was considered to be primarily a degenerative disorder and a result of natural age-related 
wear-and-tear on joints.  It was also believed that once OA becomes clinically symptomatic, 
the progression of the disease would be inevitable42. Today, clinicians generally view OA as a 
common and slowly progressing disorder that occurs later in life and mainly affects weight-
bearing joints and peripheral and axial articulations. It is clinically characterized by pain, 
deformity, functional limitations, and slowly progressive disability42.  However, recent evidence 
suggests that OA is not simply a passive, degenerative disorder for which little can be done, but 
rather that it is a metabolically active disease process of the joint, and that the disease process 
can be either hindered or accelerated by mechanical and/or biochemical factors42.   
Regardless of the specific etiology, the pathophysiology of OA involves mechanical, 
cellular, and biochemical processes that lead to changes in the properties of the articular 
cartilage together with changes in subchondral bone and mild intra-articular inflammation39. In 
the osteoarthritic joint, the catabolic reactions exceed cartilage synthesis leading to degenerative 
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changes in the joint43. In healthy cartilage, remodeling of the tissue occurs as the chondrocytes 
restore macromolecules lost through degradation. In the osteoarthritic joint, this remodeling 
process is interrupted leading to abnormal repair response and degenerative changes. The 
histologic changes include focal, erosive lesions of the cartilage surface, and increases in the 
rate of synthesis of collagen and proteoglycan. As a result, the subchondral bone thickens and 
the bone is remodeled42. As the disease progresses, the abnormal repair process causes the 
formation of osteophytes and subchondral cysts43. Eventually, all tissues in and around the joint 
thicken and hypertrophy causing increasing deformity in the joint42. Many of the radiographic 
and clinical characteristics of the disease that exist are due to attempts by the damaged joint to 
repair itself44.   
Therefore, OA is now characterized by tissue repair in addition to the characteristic tissue 
destruction that causes pain and disability. However, the process of the repair is still unknown. 
Some researchers suggest that the process of OA can be interrupted, or even reversed42. The 
evidence, both experimental and clinical, indicates a partial reversal of severe osteoarthritis, 
suggested by radiographic images revealing the reappearance of joint spaces over time. The 
mechanism for the reversal and the spontaneous recovery of joint space is unknown, but it is 
proposed that the rate of synthesis exceeds the rate of enzymatic degradation causing the 
increase in new cartilage42. Thus, the belief that OA is an inevitable result of "wear and tear" of 
joints over time is becoming less accepted and is being replaced by this new evidence.  
In addition, there are several notable and unique differences between normal aging joints 
and osteoarthritic joints that support these new findings42. The aging joint does not reflect the 
biological changes in the cell that result in an osteoarthritic joint including evident physical, 
chemical, synthetic, and degradative changes. The water content in the cartilage of a joint, 
affected by OA, increases early, while the water content of cartilage in the aging joint does not 
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change significantly. In addition, a normal aging joint does not represent the subchondral bone 
changes that are associated with an osteoarthritic joint. Furthermore, regular, moderate use of 
normal joints can help maintain overall health, muscle strength, and range of motion and does 
not increase the risk for OA as previously assumed45. 
There is also evidence suggesting that due to variation in risk factors and outcomes, OA of 
different joints needs to be regarded as distinct disorders46. Osteoarthritis is most commonly 
found in the hip and knee joints, as well as hands and spine43. It does not usually affect 
shoulders, elbows, or wrists. Historically, there is also evidence that knee OA appears to be a 
more recent phenomenon while hip and spinal OA were common among early man44. 
Previously it was believed that OA involved only the joint surface. According to recent 
research, OA is a disorder of the whole joint organ, including the synovium, capsule, the bone 
beneath the cartilage, and the cartilage. The rate of disease progression varies from patient to 
patient, even when the patients are similar demographically44. Interestingly, OA at the hip joint 
shows a later manifestation than does OA of the knee47.  
Diagnosis of OA is usually made by obtaining a detailed history and physical examination 
by a physician. The history includes questions regarding the patients symptoms and how long 
they have existed. The physician may also examine the patients reflexes and general health, 
including muscular strength and function. Common symptoms of OA include patient reported 
pain and joint stiffness of one or only a few joints along with some functional limitation or 
disability43. The pain of OA usually appears gradually over a period of years. Pain typically 
worsens with the use of the osteoarthritic joint and is alleviated with rest. Other clinical 
characteristics of OA include joint instability, bony enlargement at affected joints, limited range 
of motion, crepitus, and malalignment43. As the disease progresses, crevices and bone spurs 
(osteophytes) cause increased pain and decreased mobility. The physical changes within the 
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joint are observed through radiographs. The radiographic signs of primary OA include joint 
space loss, osteophyte formation, cyst formation and subcholdral sclerosis. In early OA 
however, minimal non-uniform joint space narrowing may be the only radiographic finding48. In 
contrast, many patients show radiographic OA of the knee, but report few symptoms49-51. It is 
still unknown why individual patients with similar conditions exhibit differing levels of pain and 
disablement50, 52. From a clinical perspective, however, the most convincing definition of OA is 
one that combines the pathology of OA observed through radiographs with patient reported 
symptoms of pain.  
2.1.3 Classification of Osteoarthritis 
The term osteoarthritis refers to a large and diverse spectrum of idiopathic joint disorders.  
Most commonly OA can be classified based on etiologic factors (from a known cause).  The 
etiologic classification of OA includes two groups, primary and secondary OA, each exhibiting 
different characteristic patterns of onset and risk factors.  
2.1.3.1 Primary Osteoarthritis. Primary OA is a process in which articular deterioration 
occurs in the absence of any other apparent underlying abnormality (unknown cause). Primary 
OA is age related and associated with repetitive and/or high mechanical stress on a normal joint. 
It is the most common form of OA and is usually observed in weight-bearing joints that have 
undergone abnormal stresses (e.g., from obesity or overuse)53, 54. The symptoms of OA are 
consequences of these abnormal stresses on the weight bearing joints and become more severe 
as the individual ages. Symptoms of OA can also result from normal stresses on weakened 
joints55. Primary OA is present most commonly in knees and hips, but it is also found in the 
spine, the big toe, and finger joints. Some medical experts believe that primary OA does not 
exist at all, and that the mechanical deviation in the osteoarthritic joint is the cause of some 
infantile and childhood disorders that were not observed at the time40.  
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 2.1.3.2 Secondary Osteoarthritis. The term secondary OA is used when direct causes of 
the disorder are known42. Conditions that can cause secondary OA include obesity, trauma, 
abnormal joints at birth (congenital abnormalities), surgery to the joint structures, inflammatory, 
metabolic, developmental, or connective tissue diseases54. Secondary OA results from an 
abnormal application of force across a joint with normal articular cartilage matrix or an ordinary 
concentration of force across an abnormal articulation51.  Table 2.1 summarizes the causes of 
secondary osteoarthritis1, 2, 43.   
Distinguishing primary and secondary OA is becoming more difficult due to ambiguous 
definitions and lack of uniformity in characteristics of OA. However, one of the typical 
presentations of secondary OA is that it is more likely to be diagnosed at an earlier age than 
primary OA. Regardless of whether the OA is diagnosed as primary or secondary, the disease 
impact and treatments are similar, but it is important to note that secondary OA may be an initial 
clue to potentially dangerous and treatable systemic diseases if diagnosed early55.   
2.1.4 Prevalence of Osteoarthritis   
The prevalence of OA is difficult to estimate due to great variation in current definitions and 
assessment criteria. Universal criteria for assessing the prevalence and impact of OA are 
currently lacking. It has been reported that the prevalence of OA increases with increasing age56-
59. Nonetheless, the NIH estimates that 21 million adult Americans suffer from OA7.  
Furthermore, it is estimated that the prevalence of OA in the United States in people age 60 
years and older is approximately four times that of a person age 20 years and older3. Almost 
every person over the age of 65 shows radiographic signs of OA in at least one joint47. However, 
55% of individuals age 65 and older report having chronic joint symptoms and arthritis58, and 
47.8% of people 65 and older (15.7 million) report doctor-diagnosed arthritis60, 61. By 
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comparison, 7.9% of people aged 1844 (8.7 million) versus 28.8% of people aged 4564 (18.5 
million) reported doctor-diagnosed arthritis60, 61.  
Due to the increasing number of older adults in many countries, the prevalence of arthritis is 
expected to rise. In the U.S., it is estimated that the prevalence of arthritis will rise from 43 
million in 1997 to 60 million by 20203, 57 and 67 million by 20303, 7, 57. After the age of 45, OA 
affects more women than men62. These estimates indicate a growing public health burden. 
Because of this growing epidemic, it is important to understand and monitor the impact of 
arthritis on health outcomes. However, it is difficult to quantify the actual cost and burden of 
OA and its impact on physical function, activities of daily life, and psychosocial factors.   
For the most part, data on the prevalence of knee OA is based on patient self-reports. This is 
somewhat problematic in that there is often no correlation between symptoms and clinical signs 
of knee OA and the presence of radiographic signs of OA63. Thus, it is difficult to ascertain a 
truly accurate estimation of the numbers of older adults with knee OA. Nonetheless, it is 
estimated that over 10 million Americans, approximately 6% of the adult population, suffer 
from knee OA that causes severe pain and functional limitation. It has also been reported that 
knee OA can be identified in 35% of people as early as age 3042. It is important to note that the 
prevalence of knee OA increases with age with a sharp increase beginning at about 55 years of 
age9, 42, 57, 60.   
2.1.5 Demographics of Osteoarthritis 
Two-thirds to three-fourths of people that suffer from knee OA are women9, 44, 58. According 
to self-reported measures of prevalence of OA from the Framingham OA study, 88% of the 
knee OA patients are Caucasian, 9% African American, and 3% reported other. This indicates 
prevalence rates of  2.7% among the Caucasian population, 2.1% among African-Americans, 
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and 1% of "other racial groups50. The Johnston County OA Project is an on-going, community-
based, longitudinal study including 3200 rural white and black residents aged 45 and older. The 
project was designed to determine the prevalence, incidence, and risk factors associated with the 
occurrence and progression of hip and knee osteoarthritis (OA). Findings from phases I and II of 
this study (completed in 1991-2005) demonstrated a greater rate of OA among African 
Americans than previously thought49, 64.  
2.1.6 Osteoarthritis Risk Factors 
2.1.6.1 Primary Risk Factors. The major risk factors for primary OA development and 
progression differ across populations, but generally include aging, obesity, genetic 
predisposition, and gender65. All age groups are affected by arthritis, including the working-age 
group. However, it is generally accepted that age of 50 and older is a primary risk factor for 
OA43, and approximately 70% of people over the age of 65 show some degree of osteoarthritis 
upon x-ray examination. Felson et al. (1987) reported an increase in knee OA with each 10-year 
increment in age in subjects 25-74 years of age59. This age associated increase was significant 
for both radiographic and symptomatic indicators of the disease58. The radiographic evidence of 
OA was detected in 27% of the Framingham OA study participants aged 65-69 and increased to 
51% in those aged 85 and older58. The etiology of the age-related increase in OA rates is 
unclear. Research shows that the ability of cartilage to repair itself decreases as the person ages 
possibly making the aging cartilage more susceptible to damage resulting in OA59. The age-
related decrease in the ability of the cartilage to repair itself can be attributed to decreased 
chondrocyte function, changes in the matrix composition, and decreased responsiveness to 
stimuli43. Interestingly, the age-associated increase in OA prevalence does not seem to be as 
profound in men as it is in women58. Lastly, neuromuscular changes that occur with aging, may 
predispose the joint to damage, resulting in consequent OA66.      
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With the exception of age, obesity is the most significant risk factor for knee osteoarthritis. 
Thus, maintaining appropriate body weight is considered to be the single most important factor 
in the prevention of OA in weight-bearing joints43. Obesity leads to OA by increasing the 
mechanical stress on the cartilage. Generally, the greater ones body weight, the greater the 
pressure on weight bearing joints59, 67. It has been reported that subjects who lose weight are less 
likely to develop symptoms and show radiographic signs of progression of OA67. However, 
estimating prevalence across populations is difficult because definitions for obesity and knee 
OA vary among investigators. Data gathered from the National Health and Nutrition 
Examination Survey (HANES I) indicated that obese women had almost 4 times the risk of knee 
OA when compared with non-obese women. For obese men, the risk was nearly 5 times 
greater59, 67. The Framingham study showed that overweight individuals, who were in their 
thirties and did not have knee OA, were at greater risk of later developing the disease than 
individuals that were not overweight67. Additional studies have since confirmed that being 
overweight significantly increases the risk of developing knee OA67, 68. It is estimated that 
persons in the highest quintile of body weight have up to 10 times the risk of knee OA than 
those in the lowest quintile69.  
Interestingly, however, researchers found surprising results when the Framingham 
Osteoarthritis Study58 was replicated with elderly patients in China70. Because of the strong 
correlation between weight and OA found in the US, the investigators expected to find a lower 
rate of OA in the Chinese population, which tends to have lower rates of obesity67. However, the 
findings showed a greater incidence of OA among Chinese women (42.8%) than in the 
Framingham study (34%), and no difference in the prevalence of OA among men 
(approximately 21.5% across both studies). These results have raised additional questions 
regarding the role of obesity in the onset of OA. However, heavy physical activity in the studied 
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population was significant. Over one-third of the Beijing OA study participants, both men and 
women, reported that their jobs involved moderate to heavy labor70. This may suggest that the 
role of heavy physical activity may be at least as significant in contributing to the onset of OA 
as obesity70. The fact that the differences between US men and the Chinese men were not as 
large as those found in women suggests that heavy physical activity by itself is not a sufficient 
explanation for the high prevalence of OA in the Chinese population. Genetic differences were 
also proposed to be a possible explanation to these differences across the two studies. There 
might also be lack of uniformity in diagnosing OA, although radiographic findings were the 
primary diagnostic tool in both studies58, 70.   
Genetic predisposition is now accepted as a primary risk factor for OA. The current belief is 
that some gene mutations may contribute to predisposing individuals to developing OA. 
Evidence shows that a genetic alteration in a type of collagen can lead to OA71, 72. Collagens are 
structural proteins that provide structural strength to connective tissue, such as skin, bone and 
cartilage. Fertala et al. (1997, 2001) found that the altered version of collagen does not properly 
fit together with another type of collagen necessary to form the structure of cartilage, resulting 
in the development of OA. The critical interaction between collagen II and collagen IX is 
altered as a result of this particular mutation and it can significantly contribute to the 
progression of OA71-73. 
Another primary risk factor for OA is gender. Females tend to have higher rates of OA than 
males for all age groups58. It has also been reported that females have higher rates of activity 
limitations for each age group57. Women over the age of 50 are more likely to develop OA than 
men58, 74, 75. Estrogen may play a role in the slightly higher rate of OA in women, while the 
prognostic factors for men and women appear to be somewhat different47, 76. High bone density 
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may be a risk factor for developing knee OA whereas low bone density is a risk factor for a 
more rapid progression of the disease45. 
2.1.6.2 Secondary Risk Factors. Secondary risk factors for knee OA include major trauma 
(e.g., ligament damage, fracture), which can be a result of a chronic or acute injury to a joint. 
Acute injury includes sports injuries to the knee that can lead to the development of OA of the 
joint. Repetitive overuse (e.g., occupational, recreational, athletic activity) also predisposes a 
joint to OA. Repetitive stress injuries are commonly related to certain occupations such as 
assembly line work, performing arts, mining, and carpet or floor laying. These chronic injuries 
result from any activity that involves kneeling or squatting, walking more than two miles per 
day, or lifting at least 25 kg regularly77, 78. Other secondary risk factors include metabolic or 
endocrine disorders (e.g., diabetes, hypothyroidism, Wilson's disease), repeated episodes of gout 
or septic arthritis, and some other metabolic disorders and other congenital conditions.  
2.1.6.3 Additional Risk Factors. There are other potential risk factors that are suspected to 
increase the risk of OA or the progression of the disease. These include low intake of vitamins C 
and D, poor posture or bone alignment caused by developmental abnormalities or injury, poor 
aerobic fitness and muscle strength, and psychosocial factors. The psychosocial factors may 
include low personal self-efficacy and depression. The developmental abnormalities causing 
bone alignment include varus malalignment (knock knees). Our present understanding of the 
association between these factors and OA is limited at this time, and more research is 
warranted42. 
2.2 Treatment Strategies for Osteoarthritis 
Treatment of OA should be individualized based on the patients co-morbidities, needs and 
expectations, and the final treatment plan should be a cooperative decision between the patient 
and physician43, 79. The goals of any OA treatment should include pain control, increased joint 
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function, and general improvement in symptoms and quality of life79, 80. Long-term goals for 
treatment of OA should include achievement/maintenance of normal body weight and a healthy 
lifestyle. Thus, a wide variety of treatment alternatives are offered for OA of the knee. 
Treatments can be generally categorized to1) non-pharmacologic (i.e. health and behavior 
modifications), 2) pharmacologic (drug therapy and intra-articular injections), and 3) surgery 
(arhoroscopy, osteotomy, and total knee replacement)81, 82. Only a small fraction of patients with 
OA will ultimately require surgery to treat their diseased knees. Some experimental and 
alternative treatments such as acupuncture and magnetic therapy have also been tried; however, 
there is no scientific evidence to support these treatments at this time.  
Several treatment algorithms or management plans for treating OA have been developed by 
various authors. Manek detailed a treatment algorithm for medical management of OA in which 
the 1) non-pharmacological treatment and pain medicine is prescribed first, 2) the second 
treatment option includes topical application of pain medicine, and then 3) aspiration of the joint 
and intra-articular injection of pharmacologic agents79, 83. If these steps are not successful in 
controlling pain and/or other symptoms, the treatment algorithm recommends step 4) a 
prescription of non-steroidal anti-inflammatory drugs (NSAIDs). If these approaches are not 
successful, then surgery can be considered as a final option in the treatment of OA83. Most of 
the other treatment algorithms suggest similar treatment approaches and always include the 
three categories of treatments detailed above81-83. Examples of the major treatment algorithms 
include the American Academy of Orthopaedic Surgeons (AAOS), European League Against 
Rheumatism (EULAR), and the Manek algorithm. The different treatment approaches are 
discussed in more detail in the following sections. 
Zhang critiqued the quality of the EULAR recommendations for the management of hip and 
knee osteoarthritis (OA) and compared them with other guidelines and recommendations84. He 
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found the EULAR recommendations to be among the best for overall quality. Zhang mentioned 
that the principal strength is the EULAR recommendations attempt to fill the gap between 
guidelines based solely on either research evidence or expert opinion84. 
2.2.1 Non-pharmacologic Management of Osteoarthritis  
 Non-pharmacological therapies are considered very important in the overall management of 
OA85. Non-pharmacologic management of OA includes patient education, exercise and physical 
therapy, weight loss, assistive devices such as knee braces, and regularly scheduled rest periods 
to get relief from stress on the joints. Outcome goals of non-pharmacologic treatment of OA 
include reduced pain, improved functionality and improved self-efficacy. 
2.2.1.1 Patient Education. Patient education should be introduced first and it should focus 
on understanding of the disease, treatment options, and assistance in developing individualized 
exercise and cognitive pain management programs42. The aim is to provide patients with an 
understanding of the disease process, its prognosis and provide a foundation for managing their 
condition, thus improving OA related self-efficacy.  
Self-efficacy is the belief one has that personal action or behavior change can affect 
outcome.  More specifically, arthritis-self-efficacy is the patients perception of their ability and 
capacity to manage the condition86. Because of the challenges OA can present to a patient, self-
efficacy is an important aspect that should be taken into consideration in the management of the 
disease.  According to 12 years of research conducted by Dr. Kate Lorig of Stanford 
University87-89, health outcomes for patients with chronic arthritis are affected by the patients 
perception of self-efficacy. The patients in these studies participated in the 6-week Stanford 
Self-Management Course, also called the Arthritis Self-Management Program (ASMP). The 6-
week course included weekly 2-hour sessions, which were guided by two trained instructors 
following a detailed protocol90.The ASMP is a community-oriented program in which patients 
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receive education and learn skills for self-management of the negative effects of arthritis. The 
course helps OA patients learn and practice skills needed to build a self-management program 
for the disease and gain the confidence to carry it out90. The program includes information on 
exercise, pain relief, doctor-patient communication, and how to protect the OA joint. Most 
importantly, the program is designed to improve ones self-efficacy in OA management.  
The investigators discovered that following an implementation of the ASMP self-
management program, patients experienced improved behavior, self-efficacy, and health status 
of which some were retained for up to 4 years with no further reinforcement. Thus, patient 
education was determined to be effective in improving pain levels and improving health related 
quality of life (HRQL) in OA patients91. The study participants reported a 20% decrease in pain, 
and a 40% decrease in physician visits following the implementation of the ASMP90. However, 
health status changes appeared to be more closely related to self-efficacy than to behavior 
change87, 88, 91, 92. Results from a more recent study indicate that a self management program for 
arthritis reduces anxiety levels and improves participants' perceived self efficacy to manage 
symptoms, but has no significant effect on pain, physical functioning, or contact with primary 
care93.  
Other investigators emphasize the importance of educational programs that teach OA 
patients skills to improve self-efficacy, offer social support, and provide skills in long-term 
monitoring of progress. One group of investigators assessed the efficacy of a self-management 
program in a primary healthcare setting in middle-aged patients with OA. The study included 
273 OA patients between the ages of 40 to 60 with a 21-month follow-up. OA self-management 
techniques were taught as an intervention and compared to the traditional care control group. 
The main outcome measures included self-reported pain, other significant complaints, and 
functional limitations. The intervention group improved significantly on a visual analog scale 
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(VAS) for knee pain (score 0.67; SD 2.10) and the WOMAC (score 2.46; SD 9.49), while the 
control group showed stable VAS knee pain (0.01; SD 2.00) and deterioration on WOMAC (-
0.53; SD 9.47) at 3-months. There were further improvements in pain and function in the 
intervention group (VAS pain knee: p values from 0.023 at 3 mo to 0.004 at 21 mo; WOMAC: p 
values from 0.030 to 0.022) at 21-month follow-up. The researchers concluded that the self-
management program was effective in reducing knee pain and self-reported function in OA 
patients94. 
When managing OA of the knee with self-management programs, the severity level of OA 
should be mild to moderate and the main goal is to manage the symptoms. With more severe 
arthritis symptoms, more aggressive treatment options must be implemented. 
2.2.1.2 Physical Therapy and Exercise. Physical activity (PA) helps reduce risk factors for 
several chronic diseases that are common among older adults, thus it is recommended for all 
people95. PA also promotes functional independence and improves physical performance and 
psychological health in older adults96-99. Aging with OA often results in chronic pain, adoption 
of a sedentary lifestyle, and functional dependency100, 101. Exercise may be the most effective 
and inexpensive intervention available for OA management83. Likewise, therapeutic exercise 
applied in the management of OA can decrease pain, improve muscle strength, joint range of 
motion, endurance and aerobic capacity85. Thus, recent guidelines have recommended the 
inclusion of exercise in management of OA of the knee81, 102.  
Inactivity due to pain leads to muscle atrophy around the osteoarthritic joint and can lead to 
consequent joint instability. The goal of exercise as a treatment option in OA is to reduce pain 
and disability by strengthening muscle, improving joint stability, increasing the range of 
movement, and improving aerobic fitness100. Although exercise does not appear to reverse or 
retard the pathological process of OA, there is enough evidence to show that exercise does not 
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exacerbate or accelerate the disease progress or pain either100, 103. In spite of the evidence to the 
contrary, reports that suggest exercise may be a cause of OA or exacerbate OA symptoms still 
exist. This may create a barrier in appropriate management of OA and discourage physicians 
from recommending exercise as a OA management modality103-106. Further, lack of standardized 
management protocols and outcome measures may also have contributed to poor exercise 
implementation in OA patients107. According to a recent report by Felson et al.95, there are two 
schools of thought regarding exercise and OA. One view is that frequent weight-bearing 
exercise causes cartilage to thicken, thereby having preventative benefits of knee OA. Another 
view is that the repetitive stress associated with PA may contribute to the wear and tear 
element of knee OA95. Felson et al. addressed this controversy by describing the findings from 
the Framingham study in more detail. The effects of recreational PA on the development of 
knee OA in 1,279 subjects were examined. Felson reported that neither recreational activities 
such as walking and jogging, nor high levels of activity were associated with the development 
of OA. He concluded that the risk of developing OA was neither increased nor decreased by 
walking for exercise in middle-aged and older adults without knee OA95. Similarly, those that 
exercised more vigorously had no greater risk of developing OA than those who did not 
exercise95. Other investigators have also concluded that a moderate recreational exercise is 
associated with a decreased risk of knee OA108. 
Thus, it is imperative that practitioners continue to explore the efficacy of exercise as a 
treatment strategy, and encourage OA patients to remain active at a level that will optimize 
function and HRQoL. Physicians can be reassured by the results from the Framingham study 
that moderate to high intensity PA will not result in increasing the patients risk of developing 
painful OA95. Rather, it will result in many additional health benefits outside the scope of OA. 
As a conclusion, Dr. Felson encourages all middle-aged and older adults to improve their health 
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by following the Centers for Disease Control and Prevention recommendations to undertake 30 
minutes of PA of at least moderate intensity most days of the week.95, 109  
Prior to prescribing exercise or PA, however, the patient care team should consider many 
factors such as the severity of the disease and the location or site of the affected joints. For 
example, patients with mild to moderate knee OA are apt to have positive experiences by 
incorporating exercise into their therapeutic regime. Further, OA at different sites requires 
different approaches as range-of-motion (ROM) exercises may exacerbate pain in OA of the 
hip, and extension exercises can worsen the pain in patellofemoral OA110. Thus, an individual 
exercise program should be designed by a physical or occupational therapist in consultation with 
the treating physician. It should be based on the individuals ROM, muscular strength, 
endurance, pain, aerobic capacity, physical function, and need of assistive devices83. The main 
outcome goals of this treatment strategy should be improved function, flexibility, muscle 
strength, cardiovascular fitness, and reduced pain.   
Other benefits of exercise may include increased self-esteem, weight reduction, and overall 
improvement in general health of the OA patient. Exercise may also relieve fatigue associated 
with arthritic conditions. Although indirect, more relevant benefits of exercise in OA patients in 
terms of HRQL may include improved sleep and an overall sense of well-being111.   
Three categories or modes of exercise therapy include 1) ROM and flexibility training, 2) 
muscle conditioning/strength training, and 3) cardiovascular training83. At this time there is not 
sufficient evidence to conclude that one program is better than another or if a combination of 
different modes of exercise is best in terms of OA management. All exercise programs, as well 
as combination programs are effective in managing OA96, 112, 113. According to Van Baar, who 
conducted a systematic review of clinical trials applying exercise as treatment for OA, short-
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term exercise programs show a small to moderate reduction of pain and disability regardless of 
the mode employed97. 
2.2.1.2.1 Range of Motion and Flexibility Training. Flexibility or ROM exercises are 
stretching and functional exercises designed to preserve or increase joint mobility and decrease 
stiffness101. According to the American College of Sports Medicine (ACSM), a flexibility and 
ROM exercise program can be defined as a planned, deliberate, and regular program of 
exercises intended to progressively increase the usable range of motion of a joints or set of 
joints.101.  
The ACSM recommends a general static stretching program to be performed at least 3, but 
ideally 5-7 days per week114. The American Geriatric Society (AGS) has published an exercise 
prescription for OA patients based on the general recommendations of ACSM103. These 
recommendations indicate that stretching and ROM exercises should be performed daily in the 
OA population during the time of day when pain and stiffness are minimal. Initially, the 
flexibility program should include static stretching exercises (one stretch per muscle group) and 
held for 5-15 seconds each. The recommendations for a general static stretching program should 
include 4-10 repetitions per stretch and involve all major muscle and tendon groups101. The goal 
of the stretching program should be to reach full or normal range of motion and to hold the 
stretches for 20-30 seconds.  
ACSM has also set specific guidelines for OA patients to include passive stretching 
(defined as movement through the range of motion by means other than muscle contraction) for 
acutely inflamed joints progressing to active stretching (defined as movement through the range 
of motion produced by muscle contraction) for joints less inflamed.115 According to these 
guidelines, passive stretching should be performed one to two times per day starting with one 
set of 5 to 7 repetitions and eventually increasing to several sets of 10 repetitions. Over-
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stretching unstable joints should be avoided and the application of any medial/lateral forces is 
not recommended. According to these specific stretching guidelines for OA patients, by ACSM, 
stretching is recommended even on days when patients experience many symptoms of 
osteoarthritis 115. 
The function of the soft tissue surrounding a joint, including ligaments, synovial and 
connective tissue (such as the joint capsule), is to function together to protect the joint from 
stress. The stiffness, pain, and swelling associated with OA often significantly reduce the range 
of motion of the arthritic joint. Patients with OA of the knee commonly experience loss of full 
knee extension or flexion contracture. Flexion contracture is the inability to fully extend the 
leg either actively or passively. This condition is usually caused by a mechanical block, such as 
retained osteophyte, scarring of the posterior capsule or posterior structures, or extremely tight 
hamstrings. A flexion contracture significantly increases the difficulty in walking and other 
ADLs116. This lack of normal ROM makes it very difficult for patients to move their joints more 
than a little making even the simplest tasks very challenging117. 
Because of the aforementioned reasons, flexibility exercises should be a key component of 
an exercise program for OA patients and should be recommended by all caregivers of OA 
patients.  The need for hamstring, calf, and posterior knee capsule stretching is significant in 
prevention of flexion contractures of the knee joint. If knee extension is not maintained, then 
quadriceps muscle strength is compromised resulting in more significant atrophy of the knee 
extensors and worsening of the flexion contractures118. However, the scientific evidence for 
ROM and flexibility training is inconclusive and should be further investigated99. Nevertheless, 
most clinicians and researchers agree that the implementation of a ROM and stretching program 
in OA is beneficial and recommended97, 103, 113, 119-121.   
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2.2.1.2.2 Muscle Conditioning/Strength Training. Sarcopenia, or muscle loss, is an 
important independent predictor of disability and it is linked to poor balance, gait speed, falls, 
and fractures122-124. Strength peaks in the mid-twenties and declines thereafter. After the age of 
50, muscle strength declines by 15% per decade and by 30% per decade after the age of 70 in 
older adults125. The decline is steep after 65 years of age, though few longitudinal studies exist 
on this topic122, 124, 126-129. Forty-five percent of people 65 years and older, and 65% of people 75 
years and older can not lift a 10-lb weight125. In OA patients, weakness of the musculature is 
more common. Moreover, research suggests that muscle weakness is a significant risk factor for 
OA130-132 and that strengthening exercises are effective for management of OA97, 133.               
ACSM emphasizes strength training as an important element of an exercise program for 
those with OA. It can lead to decreased impairment, improved function, and better protected 
joints. In addition, ACSM points out that other physiologic variables including neuromuscular 
control involves muscle mass, contractile velocity, force production, muscular endurance, and 
motor skills are often compromised due to muscle inactivity associated with osteoarthritis, 
which further accentuates the importance of strength training115. 
Quadriceps weakness is common, especially in knee OA, and it is often a consequence of 
pain-related inactivity. ACSM states that 1) osteoarthritis tends to cause less activity and result 
in lower levels of cardiovascular and musculoskeletal fitness in comparison to unaffected peers; 
2) pain, joint stiffness, biomechanical inadequacy, and gait irregularities can increase the 
metabolic cost of physical activity by as much as 50%; 3) joint range of motion may be 
restricted due to stiff, swollen, painful joints and joints may exhibit bony changes, fibrosis 
(formation of fibrous tissue), and ankylosis (stiffening or fixation of a joint); 4) inability to 
perform quick, repetitive movements affects exercise; 5) location and severity of joint 
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osteoarthritis determines exercise modes for exercise testing; and 6) poorly conditioned and 
insufficiently supported joints display a high risk for injury115. 
Hence, strength training/muscle conditioning improves the strength of the muscles 
surrounding the osteoarthritic joint reducing instability, improving function, and resisting 
further damage. Given that the quadriceps muscle group functions is a primary shock absorber 
during normal walking activities, the force can be better absorbed if the quadriceps and the 
surrounding musculature are strong. Furthermore, weakened quadriceps muscles in patients with 
OA of the knee can result in further flexion contracture, loss of mobility and function of the 
knee resulting in decline in general health118. Evidence also indicates that quadriceps 
strengthening is effective in reducing the number of falls134. Thus, the objectives of the strength 
exercise program for knee OA patients should include prevention of soft-tissue contractures and 
falls in addition to improved overall symptom management103.  
Clinically relevant muscle groups to be strengthened for OA patients include hip extensors, 
knee extensors, ankle plantar- and dorsiflexors, biceps, triceps, muscles of the shoulders, back 
extensors, and abdominal muscles99. Initially, sedentary patients should employ low intensity 
strength training and gradually advance intensity as strength improves99. Pain will be an 
important factor to consider in designing an appropriate strength-training program for the OA 
patient. If whole body movement is not possible initially, the patient should start with isolated 
exercises for upper or lower extremities135. Isometric muscle conditioning exercises may be 
ideal and they are often recommended for those patients improving strength while minimizing 
pain during training83. The ACSM advocates utilizing isometric or isotonic exercises when 
designing a program for OA patients115. Isometric exercises are particularly useful when painful 
joints limit movement. The ACSM recommendations include maximal contractions held for 3 
to 6 seconds with a 20-second rest in between sets, performed three times per week. This type 
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of strengthening program increases muscular strength without damaging the osteoarthritic joints. 
Isotonic exercises should begin with few repetitions, low resistance, and limited range of motion 
and gradually increase in number of repetitions and ROM as exercise tolerance 
increases115.These guidelines  also recommend to set the percentage of maximal voluntary 
contraction (MVC) according to pain tolerance, to begin with two to three repetitions and 
progress to 10 to 12 repetitions, and to perform strength training two to three days per 
week115. 
Research indicates that isometric and dynamic resistance training are effective in medical 
management of OA136. Resistance training helps build or maintain muscle tone, which is 
necessary for joint stability. Topp et al. conducted a study in which both isometric and dynamic 
resistance training protocols were implemented. The program consisted of resistance training 3 
times weekly for 16 weeks. The dynamic exercise group performed strength exercises across a 
functional range of motion and the isometric group performed them at isolated joint angles. 
Functional tasks such as stair climb and knee pain were assessed as outcomes. The investigators 
found that both types of strength training programs have positive effects on knee pain and 
function in OA patients. Patients had less pain while moving their knees and they were able to 
perform motor tasks faster after the completion of the 16-week program. The improvements 
were not significantly different in the two training groups as a result of their respective 
therapies, indicating that both types of strength training methods are effective in reducing knee 
pain and improving function in OA patients136. Thus, exercise selection should be based on 
tolerance of different exercise types because both types of programs seem equally effective.  
The results from the smaller training studies are supported by some large scale randomized 
trials. The Fitness Arthritis and Seniors Trial (FAST) study is considered a landmark study of 
the effects of exercise in the treatment of OA. This large randomized multi-center study 
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examined pain and disability, as well as radiographic information over an 18 month period in 
OA patients96. The researchers implemented 3 months of supervised exercise, either 
strengthening or aerobic, followed by a 12-month home program. The FAST demonstrated that 
both strengthening and aerobic exercise have a positive impact on the symptoms of OA patients 
and that no specific form of exercise was superior in management of OA96. Patients who 
engaged in either resistance or aerobic exercise achieved better OA-related pain control and 
functional outcomes compared to those who only attended an educational program. With both 
exercise groups demonstrating improvements in well-being and reduced OA symptoms, this 
study confirms the effectiveness of strength training in OA patients, helping us understand the 
importance of maintaining muscular strength in this population96. A notable limitation of this 
study was that the patients continued to take various arthritis medications while in the study, 
presenting a possible confound in the results. However, due to the nature of OA, it might be an 
impossible task to recruit an adequate sample of OA patients that would not be currently using 
any medications.    
Van Baar et al. implemented a 12-week exercise program in OA patients with supervised 
individual treatment, including strengthening exercises, ROM exercises, and functional 
training98.The study enrolled 201 patients with OA of the hip or knee who were selected to 
follow a 12-week exercise program97. Follow-up visits were conducted at 24 and 36 weeks. The 
main outcome measures were self-reported pain, NSAID use, and observed disability. At 24 
weeks follow-up, the investigators discovered that exercise treatment was associated with a 
small to moderate effect on pain during the past week. At 36 weeks there were no differences 
found between the exercise and control groups indicating a slow decline in the beneficial effects 
of exercise treatment in OA patients. The patients in the exercise group and control group 
presented similar clinical status at the last follow-up137. These results are in line with earlier 
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studies that also reported some decline in the post-treatment effects of exercise in OA 
patients107. In contrast, some studies report sustained effects of exercise up to one year after the 
program implementation138, 139. Thus, it remains unclear how long the beneficial effects of 
exercise program are maintained, and more research in this area is needed.    
These landmark studies are supported by a host of other work that appears in the literature 
regarding the effectiveness of strength training in the management of OA. De Jong, Hopman-
Rock, and colleagues implemented a 6-week program in OA patients140, 141.  The program 
consisted of health education and instructed physical exercises performed once a week for a 
total of 2 hours (1 hour of education and 1 hour of exercise)141. The intensity of the exercise 
regimen was defined as moderate and the health education model implemented was based on 
cognitive behavioral and social learning theories.141 No further information regarding exercise 
selection or training volume was provided. Outcome variables included pain, quality of life, 
activity restrictions, OA knowledge, self-efficacy, body mass index (BMI), and mobility 
measures. The investigators reported significant improvement in pain, quality of life and 
strength. Furthermore, other variables were also reported to improve including knowledge, self-
efficacy, BMI, and physically active lifestyle. The authors concluded that the intervention was 
reasonably effective; however, more attention should be directed to designing interventions with 
proactive follow-up visits. 
Quilty et al. also demonstrated improvement in pain, disability, and strength with a 10-week 
quadriceps strengthening program. This program consisted of education and quadriceps and 
functional exercises in nine 30-minute sessions over 10 weeks. The investigators also utilized 
patellar taping for increased joint stability and advised patients to continue the exercises after 
the completion of the program142. Outcome measures included pain in the worse knee measured 
by 100 mm visual analog scale, disability measured by the WOMAC, and quadriceps strength 
  30
expressed as maximum voluntary contraction. The authors reported that the program produced 
small improvements in knee pain scores and quadriceps muscle strength at 10 weeks following 
the end of the treatment period. At the 12-month follow-up, these improvements had diminished 
with no significant differences found between the intervention group and controls142. 
Schilke et al. implemented an 8-week isokinetic muscle-strength-training program in 20 
knee OA patients and examined its effect on the patients functional health status143. The 
patients were randomly assigned to either an experimental (n=10) or control (n=10) group. The 
8-week training program consisted of six sets of five maximal contractions on 3 days of the 
week. Outcomes were measured before and after implementation of the training program and 
included extension and flexion strength, the 50-foot walk time, ROM of the knee joint, the 
Osteoarthritis Screening Index (OASI), and the Arthritis Impact Measurement Scale (AIMS). 
Investigators found a significant increase in joint mobility and strength, and a significant 
decrease in pain and stiffness. The results of OASI and AIMS also showed a significant decline 
in arthritis activity in the exercise training group143.  
In addition to the benefits noted during supervised clinical trials, there is also evidence 
suggesting that a simple, unsupervised, home-based exercise program can reduce knee pain and 
disability, with its effects sustaining over two years144.  
In one study, 786 men and women were recruited and randomized to four groups to receive 
home-based exercise therapy, monthly telephone contact, exercise plus telephone contact, or no 
intervention over a two-year period. The outcomes of the study included self-reported knee pain, 
physical function, and stiffness using the WOMAC osteoarthritis index, and self-reported 
physical function utilizing the SF-36 questionnaire. Psychological outlook and isometric muscle 
strength were also measured. Significant reductions in knee pain were observed at 6, 12, 18, and 
24 months for the exercise groups and compared with the non-exercise groups. There was no 
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improvement observed in patients who only received a telephone contact, which suggests that 
improvements in pain are not merely due to psychosocial effects144, 145.  
OReilly and colleagues also implemented a home-based quadriceps strengthening program 
in OA patients146. They recruited 191 OA patients between the ages of 40 and 80 and randomly 
selected them to either an exercise group (n=113) or no intervention group (n = 78). The 
exercise group was instructed to perform strengthening exercises daily for six months. The 
outcomes measured included knee pain and physical function using the WOMAC and visual 
analogue scales (VAS) for pain on stairs and walking. The researchers found that the WOMAC 
pain scores improved (were lowered) by 22.5% in the exercise group and by 6.2% in the control 
group. Physical function scores improved by 17.4% in the exercise group, indicating improved 
self-reported physical function, and they were unchanged in controls (p < 0.05). The researchers 
concluded that a simple home exercise program of quadriceps strengthening can significantly 
improve self-reported knee pain and function146, 147. 
Further evidence of a home-based strength program effectiveness is offered by Petrella et 
al.107, 148, who implemented an 8-week home-based resistance-training program that included 
ROM exercises and NSAIDs in patients with unilateral OA of the knee. This program consisted 
of a brief 10-minute exercise period with a series of three exercises using common household 
items. Compliance rate of this program was excellent (96%). Pain and physical functioning 
increased significantly from baseline measures. Furthermore, Thomas and colleagues also 
implemented a home-based strengthening and ROM program and followed the patients for 2-
years144 that included 786 men and women aged >/=45 years with self reported knee pain. 
Participants were randomly selected to one of four groups and received exercise therapy, 
monthly telephone contact, exercise therapy plus telephone contact, or no intervention. 
Outcomes included self- reported knee pain, physical function, and stiffness using the WOMAC 
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and they were measured at two years. General physical function and psychological outlook were 
also obtained using the SF-36 questionnaire and the hospital anxiety and depression scale, 
respectively. Isometric muscle strength was also measured and represented the only objective 
measure obtained in this study.  
 The evidence in support of home programs is important insofar as home-based programs 
may impose less of a burden on the care provider and they may remove barriers associated with 
travel and scheduling that are frequently reported as a source of difficulty in compliance to 
supervised programs148.    
2.2.1.2.3 Cardiovascular Training. Cardiovascular training is fundamental for controlling 
weight and improving general health. This underlines the need for aerobic conditioning in those 
with OA. The AGS recommends that people with arthritis initiate aerobic activity exercise with 
a duration and frequency of 15 to 20 minutes at least three times a week, respectively, and then 
gradually increase duration and frequency to 30 minutes daily. In addition, it is recommended 
that all exercise sessions include at least 5 to 10 minutes of warm-up plus 5 to 10 minutes of 
cool-down.  
ACSMs recommendations for aerobic exercise programming for OA patients include 
performing large muscle activities at 60% to 80% of peak heart rate or 40% to 60% of 
maximum oxygen uptake (VO2 max) or an rate of perceived exertion (RPE) level between 11 
and 16. The ACSM recommends a frequency and duration of exercise sessions of three to five 
days per week for 5-minute sessions, building up to 30-minute sessions115. OA patients are 
encouraged to select low-impact activities that reduce the load on joints (e.g., swimming, 
biking, rowing) initially using low intensity and low duration. If necessary, OA patients can 
perform cardiovascular exercise in various sessions throughout the day while building better 
tolerance. The ACSM suggests setting time goals rather than distance goals and to use various 
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forms of aerobic exercise (i.e., weight-bearing, partial weight-bearing, and non-weight-bearing). 
It is also advised that patients with OA of the knee or hip avoid stair-climbing, jogging, and 
running and that they select shoes and insoles that maximize shock absorption.  
Studies show that aerobic conditioning reduces pain and improves function in OA patients 
96, 149, 150. The FAST study showed that both strength and cardiovascular exercise are 
recommendable in OA patients135. With its comprehensive research model the FAST 
demonstrated that aerobic exercise has a desirable effect in OA patients with improvements in 
well-being and OA symptoms96. A recent report of the FAST trial in 2006 by Mangani confirms 
that OA patients that have additional co-morbidities benefit from aerobic training151. The 
investigators found that aerobic exercise improves physical function and knee pain 
independently regardless of the presence of co-morbidity. Co-morbidity was defined as the 
presence of OA and ≥2 clinical conditions. The investigators concluded that OA patients with 
co-morbidities should perform aerobic exercises to preserve physical function. In addition, the 
pain and disability scores were improved by the aerobic exercise intervention in OA patients 
with additional co-morbidities. 
Messier et al. implemented an aerobic exercise program in 252 OA patients. The program 
included 3 months of supervised exercise followed by 12-months of home-based exercise 
performed three times a week152. The exercise program consisted of aerobic exercise 3 days per 
week for 30 minutes combined with 15 minutes of resistance training. These investigators 
compared aerobic training (exercise group) to groups that received a combination of exercise 
and diet (combination group), diet alone (diet group), or health-education only (healthy lifestyle 
group). Outcome measures included physical function, weight, distance walked in 6 minutes, 
stair-climbing, knee pain, and knee radiographs and they were obtained at baseline and at six 
and 18 months after the beginning of the intervention. At the 18-month-follow-up, the 
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participants in the combination treatment group reported 24% increase in physical function. 
Further improvement was recorded in walking distance and stair-climb, along with a 30% 
decrease in knee pain. The diet group reported 18% improvement in self-reported function, the 
control group 13%, and the exercise group 12%. Further, the exercise group improved in six-
minute walk distance (p < .05). There were no differences observed between the groups in 
radiographic changes in joint space width. Messier et al. reported that combination treatment 
was the only intervention out of the four interventions that was significantly superior to the 
control group. He suggested that the combination of diet plus exercise as a treatment for OA is a 
good idea because it produces consistently better and clinically relevant improvements in 
physical function.   
Bautch et al.150 implemented a 12-week walking program among a group of OA patients to 
determine the effects of low intensity aerobic training on OA of the knee. The participants 
walked three times per week with progressive increments in walking distance each week150. 
Synovial fluid keratan sulfate (KS) and hydroxyproline were measured as markers of cartilage 
degradation150. Health status was measured by the Arthritis Impact Measurement Scale (AIMS) 
and pain was measured by a visual analog scale before and after the intervention. The exercise 
group (n = 15) performed low intensity exercise three times a week and attended a weekly 
educational program for 12-weeks. The minimal treatment group (n = 15) received only the 
education program. The exercise group demonstrated reduced pain, and the group that received 
minimal treatment showed improvement on the AIMS. The analysis of the synovial fluid 
obtained in 11 subjects before and after the intervention showed no change in the levels of KS 
and hydroxyproline. Other trials have also examined walking as a mode of cardiovascular 
exercise in the treatment of OA and generally indicate that walking programs have a beneficial 
effect on OA related pain, walking performance, and physical function 96, 98,148.  
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Brosseau153 and colleagues conducted a review of the literature to investigate whether the 
intensity of exercise has an effect on pain reduction in OA patients. Only three studies regarding 
different intensities of exercise in the OA population were identified. Out of the three studies, 
only one study by Mangione et al.145 met the criteria used by investigators. The other two 
studies were excluded from the review because of missing data or large dropout rates 153. In this 
study, 39 adults with OA of the knee were assigned to low-intensity (40% of heart rate reserve) 
or high-intensity (70% of heart rate reserve) stationary cycling. The program consisted of three 
sessions of stationary cycling per week for the duration of 10 weeks. The outcome 
measurements utilized included the AIMS2 for overall pain, chair rise, 6-minute walk, and 
graded exercise treadmill test. Acute pain was obtained daily with a visual analog scale and the 
WOMAC. Participants in both groups significantly improved in chair rise time, the 6-minute 
walk test, the range of walking speeds, the amount of overall pain relief, and in aerobic capacity. 
Further, according to the daily pain reports, cycling did not increase acute pain in either group. 
Researchers found that the improvements in pain and aerobic capacity were similar in both 
study groups145, 153. 
In conclusion, meta-analyses, individual studies, and professional opinion support exercise 
as an important and beneficial factor in OA management20, 28, 56, 73, 116, 135, 136, 139, 142, 146, 151, 158, 171, 
186, 187, 190-199. All three types of exercise interventions seem to be effective and evidence 
confirms that the positive effects of exercise include reduced pain and self-reported disability,  
and improved overall well-being in OA patients119. Because pain and disability are among the 
most common symptoms of OA, exercise treatment is indicated in this population97. Further, no 
specific form of exercise has been superior in management of OA than others96. The particular 
form of exercise is less important than the fact that exercise has occurred in treatment of OA 
symptoms135. However, the benefits of exercise appear to be additive when exercise is delivered 
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with other interventions such as weight loss119 Some researchers also suggest that supervised 
exercise sessions are superior to home exercises for pain reduction in OA patients119. However, 
with regards to reducing the number of falls, quadriceps strengthening has been emphasized as 
extremely important134, 154.  
Finally, any additional activity beyond the current level will be beneficial for most patients 
with OA. Patients are more likely to do activities they consider enjoyable. Social dancing, for 
example, is a good alternative when prescribing exercise for OA patients99. It is a good idea to 
consult with the patients regarding the type of exercise as they may often be helpful in designing 
their own exercise programs. Physicians should promote exercise in the management of OA of 
the knee155. The challenge will be to find the appropriate strategies to maximize exercise 
compliance and optimal treatment combinations119.  
Some limitations of the previous studies include the lack of differentiations among active 
and passive ROM exercises and the inconsistency in outcome instruments and measurement. 
Further, there are only a limited amount of controlled studies with adequate sample size to 
supply sufficient validity and adequate power to support outcome differences156,133,57, 97, 102, 107, 
148, 157. According to Petrellas review, only two trials had sufficient power and they indicated 
that exercise had small effects on disability96, 98, 107. However, most clinicians and professionals 
would not argue against the proposed benefits of exercise training on OA and would be 
supportive of any exercise. 
2.2.1.2.4 Exercise Compliance of Osteoarthritis Patients. Prescription of aerobic and 
strengthening exercise has potential benefits in the management of OA and they should be 
included as essential parts of any OA management program133. However, patient compliance is 
another significant factor that affects the success of exercise as a treatment strategy for OA. 
Marks recently published a review of literature of factors that may influence exercise 
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compliance among people with OA158. Results of this review revealed several determinants of 
exercise adherence; however, it was also stated that these determinants have not been 
thoroughly investigated in OA patients. Nonetheless, Marks suggests that poor adherence is the 
most compelling explanation for the declining impact of the benefits of exercise over time. 
Marks concluded that programs that focus on OA patients self-efficacy are necessary to 
improve exercise adherence and better management of the disease among people with OA. A 
Finnish study also found that health promotion was the single most often cited reason for 
continued adherence in exercise program in seniors159, 160. In this study, self-reported data 
regarding exercise related advice received was collected among 611 non-institutional older 
adults aged 65-84 years. The participants were asked whether they had received exercise 
counseling. Of all the subjects, 58% of them recalled receiving advice to exercise. Those 
participants who recalled having received advice, participated in supervised exercise classes 5-6 
times more frequently than those who did not recall being advised. The investigators concluded 
that initiating new physical activities in old age is strongly associated with social support and 
encouragement to exercise by health care professionals. This further confirms that health care 
providers should be encouraged to promote exercise among older patients159, 160. Additionally, 
according to Nied and Franklin99, a long-term exercise program is most likely to be adhered to if 
barriers to activity are identified and overcome, and specific goals are set. Nied also emphasizes 
that family support and positive reinforcement are important factors for adherence99. Although 
counseling patients about the importance of exercise can be time consuming for family 
physicians, it is highly effective and should be encouraged99.  
2.2.1.3 Hydrotherapy. Hydrotherapy or water therapy consists of exercises performed in a 
pool decreasing the weight bearing on the joints, thus reducing the pain associated with exercise 
training. OA patients may benefit most from aerobic and weight training when the weight-
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bearing on the joints is reduced and rotational joint stresses are minimized135. Aquatic exercise 
is often recommended for the management of OA, however, only a few studies have examined 
the effects of water exercise on OA patients161. Wang conducted a randomized controlled study 
with 38 participants to study the effects of aquatic exercise on self-reported physical function 
and pain in adults with OA of the hip or knee. Patients were randomly assigned to a 12-week 
water-exercise program or a non-exercise control group. Data were collected at baseline, at 6 
weeks, and at 12 weeks following implementation of the program. The study outcomes included 
a goniometer assessment of ROM, a handheld dynamometer assessment of strength, and the 6-
minute walk test. The multidimensional Health Assessment Questionnaire162, 163 (HAQ) was 
utilized to obtain self-reported function and a visual analogue scale was used for the assessment 
of pain. The investigators observed improved knee and hip flexibility and strength, and 
enhanced aerobic fitness following the program. Interestingly, although the objective function 
and physical fitness scores improved, the aquatic exercise did not have a significant effect on 
self-reported physical functioning and pain. Nonetheless, the results of the study suggest that 
water-exercise has beneficial short-term effects on physical fitness (flexibility, strength and 
aerobic fitness) in adults with OA of the hip or knee161. The lack of improvement in self-
reported function may be because of a lack of sensitivity of the instrument used for measuring 
physical function.   
 In contrast to Wang et al, Cochrane et al. observed improvements in objective and 
subjective measures of function and well being in 106 older-adult OA patients following 1 year 
of water-exercise with a subsequent 6-month follow-up.125.  The outcome measures included a 
physical function assessment and pain score using the WOMAC, and quality of life. The 
researchers confirmed the short-term effectiveness of water with effect sizes ranging from 0.44 
[95% confidence interval (CI) 0.03 to 0.85] on WOMAC pain to 0.76 (95% CI 0.33 to 1.17) on 
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WOMAC physical function. Water exercise therapy remained effective at the 1-year follow-up, 
but the overall effect size was small. The effects were non-significant at 18 months. The 
researchers concluded that exercise-therapy for OA of the knee results in a significant reduction 
in pain and improvement in physical function, however, these effects did not persist after the 
completion of the exercise.  
2.2.1.4 Thermal Modalities. Heat and cold treatments are known to improve joint function 
and reduce joint pain, stiffness, and swelling often associated with OA85, 164-166.Cold can lessen 
pain in a sore joint by numbing the local tissues and by decreasing swelling. Applying ice packs 
or heating pads, as well as deep heat provided by ultrasound and hot packs, can help relieve 
local pain. Heat also relaxes muscle spasms around inflamed joints. Heating joints and muscles 
with a warm bath or shower before exercising may help the OA patient exercise more easily. In 
general, locally applied heat increases and locally applied cold decreases the temperature of the 
skin, superficial and deeper tissues, and joint cavity. Therapeutic heat and cold are widely used, 
although the effects and benefits have not been fully established85. Brosseau et al. examined the 
effect of heat and cold therapy in 179 OA patients on pain, swelling, ROM, and function165. Ice 
therapy, which included 20 minutes of ice massage applied 5 times per week for 3 weeks, was 
found to have a beneficial effect on ROM, function, and knee strength with decreased swelling. 
Quadriceps strength was improved by 29%. Applying ice therapy did not have a significant 
effect on pain when compared to the control group. Furthermore, hot packs did not reduce 
swelling. Other researchers recognize the efficacy of thermotherapy in OA management, but 
they also recognize that although it is widely used, the evidence is somewhat limited166. 
However, the main treatment goals of thermal therapy is to control pain, improve function, and 
reduce disability166. 
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2.2.1.5 Weight Loss. Obesity is a known risk factor for the development of OA, and it is 
also associated with radiographic progression of the disease and disability74. It has been 
identified as probably the most important and modifiable risk factor associated with the 
development and progression of OA167. The two diseases share similar pathogenic factors, while 
the development of one of the diseases increases the risk of the other, leading to the onset of a 
vicious cycle168-172. Weight loss is a recommended treatment strategy in OA patients at all 
stages. Weight reduction is of proven benefit in obese patients with OA of the knee85. 
Research suggests that overweight young adults are likely to develop OA of the knee as they 
age65, 67, 173; therefore, it is important to shift the focus to the prevention of OA.  Obesity is a 
significant risk factor for the development of the disease because it explains a major role in the 
occurrence of knee OA174. Thus, weight control benefits all patients by decreasing the stress on 
weight bearing knee joints. When people walk, three to six times the body weight is transmitted 
across the knee joint; any excess weight should be multiplied by this factor to estimate the 
excess force across the knee joint of overweight people110. Weight-loss in OA patients results in 
improvement in symptoms and reduced joint pain, thus potentially increasing physical function 
and quality of life. Further, weight-loss can increase self-esteem and reduce the risk of 
psychological suffering and depression that can affect overweight individuals. Weight loss 
methods should be coupled with a regimen of more physical activity. A recommended goal is a 
total of 30 minutes of daily exercise114. 
 Messier et al. conducted a study in which a diet intervention, based on a concept of 
accomplishing and maintaining a 5% weight loss during the study period, was implemented. 
Patients met with health educators weekly for 16 weeks and then biweekly to monthly 
thereafter167. The investigators found that only a modest reduction in weight, about 5% over 18 
months, resulted in an average improvement of 18% in physical function167. 
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The Framingham study demonstrated that modest weight loss can reduce the risk of 
developing symptomatic knee OA in women175. In this study, weight loss was associated with a 
significantly lower risk of knee OA in women with a baseline BMI greater than or equal to 25. 
The investigators discovered that for every 11 lbs of lost weight, which equals approximately 2 
BMI units, the risk of knee OA was reduced by more than 50%. Conversely, they also found 
that gaining weight is associated with a greater risk of developing knee OA later on with odds 
ratio of 1.28 for a 2 BMI-unit weight gain. The authors concluded that if elderly obese older 
adults (i.e., BMI greater than 30) accomplished a weight loss that moved them into the 
overweight category (BMI 26-29.9), and if the older adults that were categorized as overweight 
lost enough weight that moved them into the normal weight category (BMI less than 26), knee 
OA would decrease by 21.5% in men and by 33% in women. Thus, weight loss potentially 
offers an important modifiable factor in the behavioral treatment of knee OA58, 67.  
Some studies report a relationship between decreased body fat and profound improvement in 
symptoms and walking capacity following the implementation of an exercise program in OA 
patients176-178. These improvements in symptoms were due to a modest weight loss of less than 
5kg. Further, other studies have reported substantial decreases in the need for pain medication 
with an implementation of an exercise program in an OA population. Miller et al. conducted a 
6-month study in 87 obese (BMI > or = 30.0 kg/m2) adults with OA179. Physical function and 
body composition were measured following an implementation of an intensive weight loss 
program. Participants in the weight loss group were prescribed a 1000 kcal/d energy deficit diet 
along with exercise training 3 d/wk. The control group only received health information. 
Physical function was measured utilizing the WOMAC, 6-minute walking distance, and a timed 
stair climb. The researchers found that an intensive weight loss intervention resulted in positive 
changes in physical function. Furthermore, this study provides evidence of a dose-response 
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relationship insofar as the magnitude of weight lost was positively associated with the 
magnitude of improvement in function179. 
A similar study conducted by Christensen et al in 2007 showed that disability due to knee 
OA could be significantly improved with modest weight loss of over 5.1% or weight loss at a 
rate of more than 0.24% per week172. An earlier study by Christensen revealed that those 
patients who followed a low-energy diet and who had weekly dietary sessions were able to elicit 
an 11.1% reduction in weight, which further led to a 28% increase in function as measured by 
the WOMAC OA index170, 171.   
Weight loss can be achieved with regular sessions with a dietitian who can provide 
instruction on reducing caloric intake, using food diaries, and cognitive-behavioral modification 
to change dietary habits177. Weight loss is an important and modifiable risk factor in 
management of OA and needs to be further implemented in OA patients.  
2.2.1.6 Knee Bracing/Mechanical Aids. Knee braces, walking aids, crutches, shoe insoles, 
and patellar taping are useful tools in some OA patients85. External knee braces in the treatment 
of knee OA have been designed specifically to help with stability and function. Outcomes that 
are typically addressed with knee bracing include improvement in pain and other symptoms, and 
improved function. One particular style of brace often utilized is an unloader brace that shifts 
the load from the involved area of knee reducing the stress on the osteoarthritic areas. Another 
type of brace often used is a support brace that supports the full load of the knee. Some 
adverse events may include the likelihood that patients will rely too greatly on the brace and 
force themselves past their functional limits causing damage to the knee.  
Valgus bracing is designed to remove the load on the medial compartment and mechanically 
unload the arthritic compartment of the knee. They are clinically effective by reducing pain, 
improving function, and reducing the use of NSAIDs and analgesics. This type of bracing also 
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allows for greater activity levels in the younger patient for whom surgical procedures are not 
recommended. The brace improves the symmetry parameters of stance and the swing stage of 
gait immediately and consistently180. Limitations of the current literature on knee bracing 
include that the perfect candidates for these bracing options continue to be unidentified. Of the 
few research studies conducted, bracing has been examined in those with concomitant use of 
NSAIDs or analgesics, so it is quite complex to evaluate the benefits of bracing alone181, 182.   
Although there is not enough evidence available from well-designed research studies to 
support the efficacy of walking sticks for OA, clinicians agree that they should be widely 
recommended110. According to Grainger, OA patients should also be encouraged to wear shock-
absorbing shoes with good mediolateral and arch support and calcaneal cushion110. Lateral heel 
wedges may also help reduce pain related to OA of the medial tibiofemoral compartment and 
patellar tapping can provide relief in patellofemoral OA110. 
2.2.2 Pharmacologic Management of Osteoarthritis   
Most people with OA are prescribed some type of medication to control pain and 
inflammation associated with the disease117. Pharmacological management of OA should be 
considered in addition to the non-pharmacological treatment, not as the sole therapy 83, 102. The 
American College of Rheumatology (ACR) states that pharmacologic management of OA is 
most successful when combined with other strategies102. The pharmacologic therapy protocol 
should be designed for each patient individually after careful consideration of any co-morbid 
conditions, possible side effects, symptom severity, and patient preferences. Initial 
pharmacological treatment for OA should include the use of the safest and most benign 
medication to alleviate pain83.  
2.2.2.1 Analgesics. Analgesics are drugs that alleviate pain, but that do not help with 
swelling or inflammation117. It is now recognized that pain in OA is not necessarily a result of 
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inflammation and therefore simple anelgesics are recommended83. The most commonly 
recommended and often the first choice oral analgesic for OA pain is acetaminophen, which is 
also called paracetamol82, 102,117. It is used for managing symptomatic OA with mild to moderate 
pain and it is recommended by the ACR117, 183. Acetaminophen is one of the safest analgesics 
and it has fewer side effects than most NSAIDs110, 117. However, pain relief achieved with 
acetaminophen is often comparable with the relief achieved with a NSAID in patients with 
mild-to-moderate OA pain184-186. A few reported side effects of acetaminophen include that it 
may prolong the half-life of certain drugs and it should be used with caution in certain high-risk 
patients, such as those with liver disease and/or high alcohol consumption. Examples of over the 
counter (OTC) acetaminophen include Tylenol, Excedrin, and Panadol. Acetaminophen is taken 
in doses from 325 to 1000 mg, every 4-6 hours, with no more that 4000 mg per day82, 83, 102, 110. 
For more severe pain, the physician may prescribe a stronger analgesic such as propoxyphene 
hydrochloride, acetaminophen with codeine, or tramadol. These drugs carry the risk of 
dependence so they should only be prescribed for short periods of time83.    
2.2.2.2 Non Steroidal Anti-inflammatory Drugs. Non-steroidal Anti-inflammatory Drugs 
(NSAIDs) are a large group of medications that help reduce swelling, inflammation, and joint 
pain117. For patients with OA of the knee, who experience moderate-to-severe pain, the ACR 
recommends NSAIDs as an alternative drug therapy to acetaminophen102, 117. NSAIDs work by 
preventing the production of prostaglandins, which are involved in inflammation. Aspirin and 
ibuprofen are the most common NSAIDs. Examples of aspirin are Bayer and Exedrin, and 
examples of ibuprofen include Advil and Motrin. Other examples of OTC NSAIDs are 
ketoprofen, naproxen, and naproxen sodium. Meloxicam (Mobic) is a NSAID that is available 
by prescription only. The NSAIDs are often more effective in relieving moderate-to-severe pain 
than acetaminophen, but they also present an increased risk of some adverse upper 
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gastrointestinal events including irritation that can lead to bleeding and ulcers110, 117, 187. 
Therefore, NSAIDs should be prescribed only for patients who do not achieve sufficient pain 
relief with acetaminophen.  
A newer drug called COX-2 inhibitors (short for cyclo-oxygenase-2 specific inhibitors) or 
Coxibs are as effective as traditional NSAIDs in relieving pain and inflammation, but they 
have a better gastrointestinal (GI) side-effect profile. There are two types of enzymes involved 
in prostaglandin production: COX-1 and COX-2. COX -1 produces prostaglandins that help in 
protecting the digestive system from its corrosive acid. COX-2 facilitates the production of 
prostaglandins, which are involved in the process of inflammation. The mechanism by which 
traditional NSAIDs work is by inhibiting both COX-1 and COX-2. This decreases 
inflammation, but it can also cause GI problems. COX-2 inhibitor drugs only stop production of 
the type of prostaglandin involved in inflammation (erostaglandins), but not those that protect 
the GI system. In theory, because of this mechanism, COX-2 inhibitors should be safer when 
compared to traditional NSAIDs117. However, the COX-2 inhibitors carry other risks including 
heart attack, stroke, blood clots, or skin reactions. Currently, celecoxib (Celebrex) is the only 
COX-2 inhibitor on the market117. Both NSAIDs and COX-2 inhibitors may acutely cause 
hypertension, deterioration in renal function, and fluid retention110. Furthermore, cardiovascular 
risk factors should also be taking into consideration before prescribing a NSAID or COX-2 
inhibitor. Thus, COX-2 inhibitors are often recommended for patients that have any GI risk 
factors187. All NSAIDs have similar efficacy, so those with the lowest risk profile for upper-GI 
hemorrhage, such as ibuprofen, are recommended102, 117.  
2.2.2.3 Glucosamine Sulfate and Chondroitin Sulfate. Glucosamine sulfate (GS), an 
amino sugar, and chondroitin sulfate (CS), a carbohydrate, are  both derivatives of 
glycosaminoglycans found in articular cartilage188. The combination of glucosamine-chondroitin 
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is a popular supplement, commonly orally ingested, and available without prescription. In recent 
years, glucosamine and chondroitin have been widely used as a treatment for OA. 
Glucosamineis believed to promote the formation and repair of cartilage and chondroitin is 
thought to promote water retention and elasticity of cartilage, and to slow down the cartilage 
break down. Both compounds are naturally manufactured by the body, but are also sold as 
supplements produced from animal tissues189. In simple terms, theoretically GS stimulates the 
formation of cartilage, and CS prevents it from breaking down. GS is well tolerated and it 
causes no major side effects. The recommended dose of GS is 1500 mg per day for at least 
3 months because it may take up to 2 months to see improvement. It is probably best to try a 
different approach if no improvement is seen in that time. 
McAlindon et al.188 conducted a meta-analysis of 15 double-blind, randomized controlled 
trials measuring the effectiveness of GS and CS and reported that all studies demonstrated 
moderate to large treatment effects.  However, the authors point out that after a review of the 
methodology used in these studies, the actual efficacy of the intervention in the studies was 
more modest. The exaggeration might have been a result of issues of quality and publication 
bias50, 188. Subsequently, some well-designed studies of GS supplementation have demonstrated 
a 20%25% reduction in OA symptoms such as pain in patients with mild to moderate disease83, 
190-193. The results of a 3-year double-blind clinical trial showed that symptoms improved in 
patients who received glucosamine treatment and worsened slightly in patients who received a 
placebo. The radiographic results of this study showed that serious narrowing of the knee-joint 
space occurred in only half as many patients in the glucosamine group as in those receiving the 
placebo suggesting possible reductions in the progression of knee OA194. Several other studies 
have also demonstrated the positive effects of GS and CS supplementation on OA symptoms in 
patients with moderate-to-severe knee pain195-199.  While some studies offer radiologic evidence 
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of changes in structural properties in knee OA as a result of CS supplementation200, some of 
these studies have been criticized because of a lack of standard assessment of the radiographic 
data and further studies are suggested to determine the validity of this claim83.  
In contrast, a controlled study of 300 patients with OA of the knee found that chondroitin 
supplementation had no short-term effects on symptoms of OA. However, the authors suggested 
that long-term treatment with CS might have potential in hindering the progression of knee-joint 
narrowing as shown on x-ray films and that the clinical relevance of this belief needs to be 
further studied201. Furthermore, one well-designed study that involved 1583 patients 
demonstrated no significant differences in patients that received GS and CS. In this 
comprehensive 24-week study, patients were randomly assigned to receive one of four 
treatments: 1) GS or CS (500 mg or 400mg, respectively) three times daily, 2.) both GS and CS, 
3.) 200 mg dose of Celebrex daily, or 4.) a placebo. The study revealed that neither GS or CS, 
alone or together, reduced OA knee pain more successfully than a placebo195.   
Thus, it appears that patients with more severe and painful OA do not benefit from GS 
supplementation and that the long-term efficacy of GS and CS remain unclear. Most medical 
experts agree that although the evidence is somewhat incomplete, these products might be worth 
trying for people with OA because they are generally well tolerated and lack serious side-
effects. Using GS and/or CS may be a good alternative for patients that have experienced 
significant side effects from conventional painkillers.  
2.2.2.4 Opioids. Administering opioids is also an option when treating OA. The 
combination of codeine and acetaminophen provides better pain control than paracetamol alone. 
Side effects include dizziness, constipation, nausea, and vomiting, which often lead to 
discontinuation of this combination83, 102. Some patients with persistent pain, who are not suited 
for arthroplasty, may require stronger opiate pain control. Tramadol is a synthetic opioid and 
  48
acts centrally by inhibiting the reuptake of serotonin and noradrenaline. In general, it is well 
tolerated by patients, but because it lowers the threshold of seizures, its use is contraindicated in 
seizure disorders83, 102. 
2.2.2.5 Intra-articular Treatment. Intra-articular treatment includes corticosteroid 
injections and viscotherapy, also called viscosupplementation. This type of therapy is used with 
OA patients that are experiencing moderate to severe pain. Intra-articular injection of 
corticosteroids is commonly used to treat acute exacerbation of pain associated with OA. Joint 
aspiration may be indicated along with a corticosteroid injection if effusion and severe 
inflammation of the joint is present83. Patients can achieve short-term pain relief with the 
combination of aspiration and corticosteroid injection83. Corticosteroid injections should be 
limited to 3-4 times a year because of the chance of cartilage damage from repeated injections. 
Patients requiring more than 3-4 injections per year are possible candidates for surgical 
treatment of OA.  
Intra-articular viscotherapy includes injection of hyaluronan preparations into the knee joint. 
Hyaluronan is a naturally occuring component of synovial fluid and it is responsible for the 
viscoelasticity and lubricant properties of the joint83. The process of OA results in reduced 
concentration of catalytic enzymes and decreased molecular weight of hylaluronic acid in OA 
joints. Thus, viscotherapy with synthetic long-chain hyaluronan components has been 
developed for OA of the knee. This treatment is given as a weekly intra-articular injection for 
3 weeks202. The FDA has approved sodium hyaluronate (Hyalgan) and hylan G-F (Synvisc) 
injections for treatment of OA83 and they are effective in decreasing pain when compared with a 
placebo and as efficient in controlling pain as oral NSAID therapy83. Adverse effects to 
viscotherapy are uncommon, but may include acute joint pain.  
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Bellamy et al.203 conducted a review of 76 studies in which viscosupplementation was 
utilized as a treatment of OA. He found a significant improvement (28-54%) from baseline for 
pain and 9-32% improvement for function in patients who received viscotherapy. The positive 
effects were comparable to the effect of NSAIDs and corticosteroids on OA symptoms. Thus, it 
appears that viscosupplementation is an effective treatment for OA of the knee with beneficial 
effects on pain, function, and general health203. However, there are only a few randomized 
comparisons of different viscosupplements, therefore, the difference between various 
viscosupplementation products is not known. The effect sizes for some products are in the 
moderate to large range. Because of the low risks and positive results of viscosupplementation, 
it is generally well supported among physicians in the treatment of knee OA204. 
2.2.2.6 Topical Treatment.  Some arthritis treatments are applied on the skin. The most 
common include heat and cold (discussed earlier in the non-pharmacologic section). A topical 
anesthetic, skin patch containing 5% lidocaine helps control OA pain locally. Creams are also 
common remedies and have a modest analgesic effect.  Some studies show that Celecaine, a 
cream made of natural oils of pepper plant, improves pain and function better than a placebo83, 
205. Topical treatment can be used as an adjunct to simple analgesia, sole therapy for a single 
symptomatic joint, or for those patients who do not tolerate systemic therapy. Topical NSAIDs 
are also available. A systematic review of topical NSAIDs suggested that 65% of patients that 
received treatment had a good response, while only 30% of patients in the placebo group had 
a good response50. The risks of topical NSAIDs are minimal with no additional risk of upper-
GI bleeding, although some systemic absorption occurs. Furthermore, while topical treatment 
may be adequate in patients with mild-moderate OA, patients with more severe OA are not as 
likely to respond to such treatments and need further intervention. 
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2.2.3 Surgical Treatment of Osteoarthritis   
The goal of conservative (non-operative) treatment of OA is not only to relieve pain and 
increase function, but also to avoid invasive interventions. If all other treatments are 
unsuccessful in relieving pain and improving function, surgery may be the last option to 
consider. Surgical treatments for knee OA include arthroscopy, osteotomy, and partial or total 
knee arthroplasty (TKA), also commonly referred to as knee replacement. Knee replacement has 
been shown to be one of the most successful procedures done on patients with advanced OA. 
2.2.3.1 Arthroscopy. Arthroscopy is a procedure that uses a small instrument (arthroscope) 
that is inserted into the joint. The joint is filled with fluid, which enables the surgeon to see the 
bone surface better and to determine the severity of OA. With the arthroscope, the surgeon can 
trim damaged cartilage, clear out any loose debris within the joint (debriment), and clean the 
joint with irrigation.    
2.2.3.2 Osteotomy. Osteotomy may be recommended if OA affects primarily one 
compartment of the knee. The most commonly involved compartment is the medial 
compartment of the knee joint. Osteotomy involves realigning the bony structures to reduce 
stress on the side of the joint that has severe OA involvement (i.e. medial vs. lateral). The 
realignment is accomplished by cutting the bone and creating a wedge shape on either the 
medial or lateral side. Most commonly the osteotomy is tibial, however, it is possible to also 
perform a femoral osteotomy. The goal of the repositioning of the joint moves the axis of 
weightbearing away from the osteoarthritic area. This procedure can restore knee function and 
lessen OA related pain. It is also theorized that it may stimulate the growth of new cartilage. 
Osteotomy can improve pain and function momentarily, however, the results commonly 
deteriorate over time. Most patients that receive osteotomy will eventually need TKA. Thus, 
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osteotomy is not widely used for this reason and most surgeons opt for a knee arthroplasty 
rather than osteotomy.  
2.2.3.3 Partial Knee Arthroplasty (Unicompartmental Knee Arthroplasty). In a total 
knee arthroplasty all knee components are replaced. In a unicompartmental knee arthroplasty 
(UKA), only the area with degenerative change is replaced. By preserving the undamaged and 
normal surfaces, more normal range of motion is usually kept in the knee29, 206. The UKA 
approach has had a controversial past, mostly due to failure rates of 30% to 35% in early 
procedures206, 207. In recent decades, the UKA has been utilized much more often in Europe than 
in the United States29. However, because of the benefits of the procedure, including reduced 
bleeding, quicker recovery, and better range of motion, as well as survival rates that now equal 
to or surpass those of TKA reported, UKA has received more attention recently among 
American surgeons29. Also, if the UKA fails, a TKA can be done. Furthermore, those who have 
arthrosis of a single compartment of the knee are considered by many sources as great 
candidates for UKA.  
2.2.3.4 Total Knee Arthroplasty. Total knee arthroplasty (TKA), also known as knee 
replacement, has been performed in some form for over 50 years. Over the last 20 years, 
significant advancements in the procedure have been achieved. According to American 
Academy of Orthopaedic Surgeons (AAOS), the number of reported knee replacement 
procedures in 2004 in the US was approximately 478,000208. This is a 15% increase from the 
previous year and a 60% increase from 2000. The mean age for a primary arthroplasty patient is 
69 years old208. Recently, the number of knee arthroplasty patients less then age 60 has 
increased. TKA is effective in relieving pain and improving function and HRQoL in patients 
with rheumatoid or osteoarthritic deformed knee(s)11. There are many concerns and factors that 
should be considered by the patient and physician before deciding on joint replacement. For 
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many patients, the success of their knee replacement will last the duration of their life. However, 
a number of issues, such as age and the patient's lifestyle and activity levels, can impact the 
outcome of joint replacement.  
Women, on average, are more likely to have a TKA than  men, and women actually account 
for nearly two-thirds of all procedures performed. Several possible factors have been uncovered 
that may impact this dominance including greater prevalence of knee OA among women, as 
well as their longer life expectancy. However, women generally get a knee replacement at a 
further progressed phase of the disease than do men, and they are less likely to have a revision 
surgery than men208. 
2.2.3.4.1 History of Total Knee Arthroplasty. Before the advance of knee arthroplasty 
procedures, severe arthritic knees received arthrodesis, a fixation of the knee joint intended to 
create fusion of the joint surfaces and stop movement in that particular joint. This approach 
resulted in the knee not being able to flex, and it usually led to an asymmetrical walking pattern 
that caused extra strain on the back, hip, and ankle. Early arthroplasty procedures, which first 
began in the 1860s, had extremely high failure rates attributed to material incompatibility, 
wear, infection, and loosening of the mechanism. Some of the first materials used included skin, 
muscle, fascia, fat, rubber, ivory, and glass209. With the induction of current materials of 
stainless steel, cobalt-chromium alloy and acrylics, and acrylic resin cements, the success of 
knee replacement procedures has drastically improved. At first, arthroplasty involved 
replacement of just half of the joint, which now is referred to as a partial or unicompartmental 
replacement. Significant advances in design were made later from the 1940s through mid-1960s. 
In 1968, the first metal-on-plastic knee arthroplasty was secured with cement209. 
John Insall, in 1973, developed the prototype for the present TKA210,29. It was known as a 
total condylar implant, and it was the first design to include components to resurface all three 
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components of the knee: the femur, tibia, and patella29, 211. The first total condylar implant was 
used in 1974, and its success made the way for total joint replacement as it is today. Although 
some design changes to the implants have been made, the total condylar implant design is still 
currently used in most TKA procedures 29. Presently, changes that will introduce normal 
kinematics that increase ROM and function are being examined29. The major advantages of this 
replacement are its simplicity and its reliability with good function in a majority of cases. 
However, due to differences in surface geometry and cruciate protection, function will not be 
equal for everyone receiving a condylar knee replacement design212, 213. 
2.2.3.4.2 Mobile-Bearing Designs. Another type of TKA is a mobile-bearing knee 
replacement, which is intended to generate a twofold surface articulation with the goal of 
lessening wear related with polyethylene failures in fixed knee replacements. It has the added 
feature of rotational mobility between the polyethelene insert and the tibial base plate. 
Otherwise, it shares all the features of the condylar implant design. Early on, this knee 
procedure was utilized bi-compartmentally, with a prosthesis in both compartments. Changes in 
the mechanical make-up for the mobile-bearing knee replacement have led to many designs 
being placed on the market. Some advantages of the mobile-bearing knee replacement are its 
reduced wear volume and low deformation, liberty of rotational and/or anterior-posterior 
position, and the capacity to establish a home position in certain activities. Disadvantages 
include the less natural constraint and lack of smooth movement in function29. 
2.2.3.4.3 Varus-Valgus Stability Designs. The last major design variant for knee 
replacement mechanisms are those that provide varus/valgus stability. The end point of this 
design is to make the most of the area of the plastic post for bending stiffness and strength. Two 
major variations in design are available, with the most conventional design being the inter-
condylar hinge and the least traditional being the fixed or rotating hinge. Though initially the 
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rotating hinge knee replacements had elevated failure rates, later designs of the devices have 
shown positive results for compound, salvage knees where other prostheses are unsuitable29, 214, 
215. 
Three areas are associated with the general success of TKA. These are patient selection, the 
technique of surgical intervention, and the rehabilitation process29. Those patients who have 
formerly undergone several arthroscopic procedures for pain, then followed by TKA with 
negligible radiographic changes, are not great candidates for TKA. The surgical skill level of the 
surgeon is also a significant factor in the success of TKA. However, it has been under-studied 
and is gradually getting more attention from researchers29. Finally, the rehabilitation process 
should initiate preoperatively through physical training and education. Patients must know 
before surgery that function of the knee after TKA is not that of a non-diseased knee. Pain relief, 
although typically good, is not certain, and motion may not be normal excluding extraordinary 
cases. 
2.2.3.4.4 Considerations in Total Knee Joint Replacement. There are several major issues 
that should be considered when deciding if TKA is the best choice for the patient. There is an 
abundance of information available, but no specific guidelines exist regarding which factors are 
most significant or which option is most likely to end in a successful procedure. The factors to 
consider include whether a patient receives a UKA or TKA. Tricompartmental or TKA is the 
most frequent surgery conducted for severely arthritic knees. Clinical trials of TKA for the last 
20 to 30 years are supportive of the use of this process. However, the benefits of UKA make it a 
feasible option for the correct patient. Usual causes of failure with the unicompartmental knee 
arthroplasty are associated with patient selection and surgeon technique29, 207.  
Previous surgery is also a consideration before performing a TKA. A great quantity of 
patients who have had upper tibial osteotomy will ultimately need TKA. The surgical approach 
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for knee replacement is frequently exaggerated by the prior osteotomy, and studies have shown 
results for TKA after osteotomy are often comparable to revision TKA. Another factor that 
needs consideration prior to TKA is the implant design . For TKA to execute effectively, three 
significant design objectives must be met: 1) the implant mechanism should offer suitable 
control and sufficient range of motion, 2) the mechanisms must transport the large loads 
crossing the joint structure to the adjacent bony structures, and 3) the prosthesis components 
must offer long-term performance and enduring fixation29.  
Further, the surgeon must decide whether to use a TKA with cement or cementless 
components. Recently, a cementless fixation device was developed using prosthesis with a 
textured, permeable surface in which bone is able to grow and keep the prosthesis in place. The 
knee replacement mechanism can be set to the bone either with or without cement. TKA that 
utilizes cement is based on a modified total condylar knee prosthesis. Current cementing 
techniques usually use polymethylmethacrylate or PMMA in conjunction with the PCL-retaining 
(posterior cruciate ligament) total condylar knees. Studies using these prostheses have shown 
95% and higher survivor rates of 15 years29. Cementless TKA requires a suitable porous 
ingrowth surface and feasible bone with close contact connecting the two surfaces. This is 
obtained by precise cutting of the bone surface. Additional screws may be utilized for fixation. 
Cementless parts are usually covered with tiny beads to promote the patients bone growth. A 
limitation of cementless TKA may be insufficient bony ingrowth into the prosthesis, which then 
can lead to a loose implant that will not function properly29. Proper limb alignment is also 
critical in decreasing the failure rates of cementless replacements. Though there are fewer 
studies of survivorship obtainable for cementless fixation, modern longer term trials are finding 
survival rates of 90% or higher. However, the long term results of cementless fixation are not 
greater when compared to cemented fixation and they actually may be worse, chiefly with 
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metal-backed patellar components29. As a result, the knowledge of choosing this type of fixation 
is frequently examined by the physician, or the course of action is completely abandoned in 
support of cemented arthroplasty with more known outcomes, mainly because the cementless 
procedure typically has a higher cost29. 
2.2.3.4.5 Simultaneous Bilateral TKA. Some percentage of patients nearing end stage knee 
OA will have symmetric joint involvement and will require a TKA of both joints to receive the 
greatest benefit. Due to the overall rise in patients needing TKA, the number of near-end stage 
OA patients requiring bilateral TKA is also increasing. In general, the current literature suggests 
that complications following bilateral TKA are no greater than those associated with unilateral 
TKA26-29. Benefits of simultaneous bilateral TKA to the patients include only one surgical 
"event", single anesthesia, and a shorter hospital stay. Furthermore, the time to recover from 
bilateral TKA is similar to unilateral TKA, therefore, recovery time is cut in half when 
compared to two unilateral TKAs performed separately. Consequently, the cost for healthcare is 
also significantly reduced if the two surgeries are performed at once. There is also some 
variation in terminology in the literature discussing bilateral TKAs. Synchronous bilateral knee 
replacement refers to a two surgeon team operating on one patient at the same time (i.e. both 
knees are operated on at the same time), while simultaneous bilateral TKA often refers to 
bilateral knee replacement performed by one surgeon (i.e. surgeon replaces one knee first, then 
the other under one anesthesia). The previous terms are sometimes confused and the current 
literature may not always indicate the number of surgeons performing the operation. 
Additionally, staged bilateral knee replacement refers to the patient having a unilateral TKA 
first and then, within 1-year, the other knee is replaced. 
There is some variance in opinion in the orthopaedic community on whether bilateral TKA 
should be performed as one simultaneous versus two staged operations. Some conflicting 
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studies have shown greater rates of hospital stay and intensive care for patients undergoing 
simultaneous bilateral TKA compared to unilateral TKA, but one major limitation to these 
studies is that they did not control for age. The general consensus seems to indicate, however, 
that unilateral and bilateral TKA are equally safe and effective. Ritter et al. performed a 
retrospective review of 2050 simultaneous bilateral, 1796 unilateral, and 152 staged bilateral 
TKA patients over 17 years. The investigators did not find any significant differences in the 
incidence of cardiac problems or mortality rates when comparing unilateral to bilateral TKA216. 
After review of a ten year post-operative follow-up, the simultaneous bilateral TKA patients had 
a significantly higher rate of survival than did the unilateral group216. In 2004, Ritter published 
another article based on his retrospective review in which complications and Knee Society 
scores were reported. The average Knee Society knee score was 90 points 3 years 
postoperatively and 87 points 10 years postoperatively. He concluded that the complication rates 
and clinical outcomes were similar to unilateral TKA28.  
Although simultaneous bilateral joint arthroplasty may have many benefits, it may also 
require a commitment from the patient to work hard for a successful outcome. Unver et al. 
concluded that those patients who undergo unilateral TKA gain their independence earlier than 
those who undergo bilateral TKA34. Unver et al.s conclusion was based on the sit-to-stand 
test (i.e. ability to rise independently from a seated position). Other outcome measures in the 
investigation included the Hospital for Special Surgery (HSS) Knee Score and ROM. According 
to the investigators, those receiving bilateral TKA do eventually catch up with the unilateral 
group in terms of regaining independence, however, using one single task for measurement of 
physical function may present a limitation as it may not represent a comprehensive evaluation of 
function or independence34. Additionally, the sit-to-stand test is scored as either positive or 
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negative. Interestingly, the HSS scores or ROM were not significantly different between the two 
groups at 6-month follow-up leaving the conclusion solely based upon the task of chair-rise34.    
Fick et al. conducted a prospective comparison study between bilateral and unilateral 
TKAs33. The Oxford knee score was used as an outcome measure. The investigators reported no 
significant differences in knee ROMs following a TKA. At one year follow-up the bilateral 
group had a significantly higher functional score (p=0.02). However, the author also stated in 
his discussion that the results of the bilateral knee replacement were favorable and no significant 
complications were encountered. He also states that there were no significant differences in 
outcomes between bilateral and unilateral TKA33. This statement did not correspond with his 
findings and one may assume this has been a typographical error in the manuscript.   
Lane et al. studied outcomes of unilateral vs. bilateral using a cost analysis, length of 
hospital stay, relative risk, complications in a prospective study design217. The investigators 
found that the rate of cardiopulmonary complications was approximately three times greater in 
the bilateral TKA group (14%) compared to the unilateral group (5%). It was also suggested that 
the increased stress may make the bilateral TKA contraindicated in certain patient groups217. 
However, the higher complication rate may be a result of a greater total time under anesthesia 
often occurring in bilateral TKA performed by one surgeon. If two surgeons with two operating 
room teams were utilized to perform a synchronous bilateral TKA, the operation and 
anesthesia time would be cut in half, thus the risks of bilateral TKA may be similar or even less 
that unilateral TKA.   
A retrospective review of patients receiving a simultaneous bilateral TKA and those that 
received a staged bilateral TKA was conducted by Stubbs et al. In this study, both groups of 
bilateral TKA patients were compared with a control group of unilateral TKA patients. The 
authors found no difference in the incidence of surgical and medical complications in any of the 
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three groups. Furthermore, there were no differences in outcomes between two different types of 
bilateral knee replacements 2.5 years following the surgery. It was reported that the length of 
hospital stay for bilateral TKA was greater by 2 days compared to unilateral TKA hospital stay. 
However, when adding the costs associated with two hospital stays required with staged 
unilateral TKA, the total cost for the patient group having both knees replaced at separate 
operations was significantly greater218. Based upon this review of studies, the investigators 
suggested that bilateral TKA is a good alternative that has advantages for both the patient and 
the hospital in that it does not increase the risk of complications to the patient and reduces the 
overall cost to the hospital218.  
The benefits of synchronous TKA include a shorter overall hospital stay and reduced overall 
healthcare costs118. When making a decision on whether to perform a simultaneous bilateral 
knee replacement, the decision should be based on symptoms, such as the severity of pain and 
the patients medical health history. If the patient is experiencing pain in both knees that is 
equally severe, bilateral replacement can be recommended. Should the patient have bilateral 
OA, but only one knee is symptomatic or painful, then replacement should be performed on the 
symptomatic knee only.  
No information is available on the return of function in unilateral vs. bilateral TKA patients. 
To objectively quantify and measure physical function, or examine the differences that may 
exist between return of function in unilateral and bilateral TKA, the investigators should utilize 
validated and reliable measures of function. While no known studies objectively address 
function following unilateral and bilateral TKA, there are few studies that examine the 
differences by any means. Cohen et al. examined clinical outcomes associated with bilateral 
TKA in comparison to unilateral TKA utilizing the KSS. It was concluded that undergoing 
simultaneous bilateral TKA does not appear to compromise physical function when compared to 
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undergoing unilateral TKA30.  Similarly, Ritter at al. examined subjective function following 
bilateral and unilateral TKA. They found that for up to 15 years post-operatively, the unilateral 
TKA group actually reported lower Knee Society Scores (p=0.007) than the bilateral group28, 
216. Another similar study examined functional scores and complications following simultaneous 
bilateral TKA and staged bilateral TKA. It was concluded that functional scores were not 
influenced by the type of procedure and suggested that simultaneous bilateral TKA may be the 
more beneficial choice31.   
2.2.4 Return to Function and Full Quality of Life Following TKA 
 
Joint replacement is one of the most successful surgeries performed by orthopaedic 
surgeons29. Outcome research of patients following TKA has shown an instantaneous benefit of 
the surgery on the individuals HRQoL . While over a period of time these benefits may 
stabilize, the improvement resulting from the surgery equals or exceeds that of the control 
groups. Outstanding results are seen at 10 to 23 years for 83% to 100% of TKA recipients. 
Success of joint replacement is typically cited in means of survival rates, which is determined 
by the preservation of knee replacement mechanism.  
Certain pre-operative factors such as age, BMI, gender, knee pain, strength, and co-
morbidities may be able to predict physical function post-operatively. Previous research shows 
that laxity, age, BMI and knee pain all increase the risk of poor function following TKA of the 
knee219. Mental health scores and pre-TKA functional status have also shown to predict 
functional outcome after TKA220, 221. Individuals who are at higher risk for poor function post 
TKA may require more intensive rehabilitation interventions to improve function222. Patient 
satisfaction is usually associated with relief from pain and improved functional ability. Patient 
satisfaction subsequent to TKA is high. A study of 1750 randomly chosen medicare patients 
who underwent primary TKA or revision between 1985 and 1989 indicated that 2 to 7 years 
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post TKA they experienced slight or no pain despite age and increased physical function. 
Largely, 85% of the Medicare patients indicated they were satisfied with the outcome of the 
surgery223, 224. 
Several factors or issues have been recognized that may lead to higher levels of patient 
satisfaction following knee joint arthroplasty. Various factors are linked to the patients initial 
state, while others are attributed to the ability of the surgeon. Further research is required to 
identify which factors are the most significant. The most significant factor in patient outcome is 
the stage of preoperative loss of function. Those who report severe functional limitations are 
more likely to be satisfied than those with nominal preoperative functional loss225. Research 
trials have indicated that older adults report similar or greater satisfaction with TKA outcome 
than younger individuals. While age might be an issue in the level of improvement, with 
numerous patients over 75 still needing assistive devices for ambulation, they usually report less 
pain and increased mobility. While some studies have found similar success in quality of life for 
the patient age 75 and older226-228, other studies have indicated more satisfaction with their 
overall endpoint goal than reported in younger patients225. Those individuals with less co-
morbid issues report fewer complications29, 225. Skill level of surgeons plays an important role in 
the outcome of TKA. Thus, patients of surgeons who regularly perform at least 20 knee 
replacements have reported fewer patients with complications225. There is also data that indicate 
greater mortality rates among patients of surgeons who conduct less than 10 knee replacements 
a year29, 229. Those patients who have their joint replacement surgery done at an institution 
where at least 50 knee replacements are completed annually report fewer complications225 and 
lower mortality230. 
Returning to pre-knee pain activities is a primary issue of many patients having arthroplasty. 
Studies have indicated that patients may get back to activities without serious consequences, 
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especially at leisure levels, if they have previously participated in the activity231-233. Further, 
patients who go back to work after knee replacement are more content than those who are on 
disability234. 
2.3. Impact of Knee Osteoarthritis on Physical Function and Quality of Life 
In addition to the most common physical symptoms of OA, such as pain and stiffness, a 
variety of other physical and psychological health domains are also affected by the condition. 
OA patients often report significant work disability and difficulty falling asleep, in addition to 
an inability to perform ADLs. All of these symptoms contribute to a perceived reduced 
psychological functioning and well-being235-237. Being able to measure these health domains in 
OA patients is important in understanding the magnitude of impairment OA causes on the 
patients overall well-being. Also, with regards to measuring the effectiveness of interventions, 
it is important that all the physical and psychological health domains are assessed 
comprehensively.  
Physical function is a multidimensional construct and it can be defined as  the integration 
of physiological capacity and physical performance capability mediated by psychosocial 
factors16. Physical function of OA patients can be measured subjectively using self-reported 
measures or objectively using performance-based assessments of physical function. Physical 
function has a significant effect on patients overall well-being and quality of life. Thus, one of 
the main objectives of any intervention in the management of OA is to improve physical 
function. 
Quality of life (QoL) is also an important consideration in medical care, and it refers to the 
patient's ability to enjoy normal life activities. Quality of life consists of both subjective and 
objective assessment of the goodness of the patients life overall. The World Health 
Organization has defined QoL to include dimensions of psychological and physical health, 
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spirituality, level of independence, social relationships, and environment238. Health-related 
quality of life (HRQoL) is a component of QoL that can be modified by life-style related 
interventions. Physical function, emotional well-being, and ability to fulfill social roles make up 
HRQoL238. In the medical literature, HRQoL most commonly refers to patients' evaluation of 
their current levels of functioning and satisfaction compared to what they perceive to be ideal237, 
239. Thus, measuring HRQoL in OA patients is imperative in providing a broad picture of the 
impact of OA on overall health of the patient and effectiveness of any interventions236. 
Therefore, HRQoL is now a widely accepted outcome measure in clinical trials and 
observational studies236. The importance of measuring HRQoL in patient centered medicine has 
also been emphasized in recent scientific literature10, 237, 240-243. 
2.3.1 Impact of Osteoarthritis on Physical Function and Quality of Life 
Traditionally, OA has been considered a somewhat benign condition. Studies now suggest 
that psychosocial impact and the degree of disability and pain caused by OA may have been 
underestimated in the general population10, 50. The primary impact of OA is pain and loss of 
physical function. Although the role of psychosocial factors in knee OA is not well understood, 
it is now being recognized that in addition to work-related and functional activities, OA has a 
significant impact on social and emotional well-being35. HRQoL is a health outcome affected by 
knee OA. A number of large population- and community-based studies have examined the 
effects of OA on disability and physical function. Research has shown that individuals with self-
reported arthritis or chronic joint symptoms have poorer HRQoL than those without arthritis237. 
Patients with OA have reported a much greater degree of emotional distress than adults without 
OA or other health limitations. They also report that their feelings interfered with their life more 
than that of the adults without OA50. Osteoarthritic patients also appraise their health status as 
worse when compared to adults without knee OA. More than 40% of patients with knee OA 
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rated their health poor or fair compared to 10% of adults without OA. Other psychosocial 
effects of OA include depression, anxiety and feelings of helplessness244.  
A recent investigation by Cook et al. examined quality of life in patients with OA. Data for 
this study were obtained for comparison from the Behavioral Risk Factor Surveillance System 
(BRFSS) database. Over 37,000 individuals were included in the analysis, including 6,172 OA 
patients. Exercise and activity level, physical and mental health, and joint-related symptoms 
were measured. Investigators discovered that patients with OA were more likely to report 
problems in all categories. These findings suggest that OA patients are more likely to report 
lower levels of quality of life, as well as self-reported physical function237. 
2.3.2 Commonly Used Measures of Function and Quality of Life  
Some of the functional and quality of life indicators most commonly used in knee 
replacement patients include the Western Ontario and McMaster Universities Osteoarthritis 
index (WOMAC), Short Form Physical Function Scale (SF-36), and The Knee Society Clinical 
Rating System (KSS). Other widely used instruments include the timed up and go (TUG) and 
the more recently developed Knee injury and Osteoarthritis Outcome Score (KOOS). The 
WOMAC and the SF-36 are both self-report measures, thus subjective measures of function and 
HRQoL. The KOOS is also a self-administered assessment of pain and knee-related HRQoL 
that includes the WOMAC score245, 246. The KSS measures some objective variables such as 
knee stability, range of motion, and alignment. The KSS also includes self-report measures of 
pain and functionality247. The TUG is an objective measurement of function.  
In addition to these commonly used clinical tools, there are numerous other instruments that 
have to one extent or another been utilized in the orthopaedic research. Some authors report as 
many as 34 instruments identified in the orthopaedic literature between 1972 and 199221, and 
since 1992 the number of assessment tools has increased significantly. Some of the other 
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instruments found in the literature and utilized in orthopaedic research include the AAOS Lower 
Limb Outcomes Instrument (LLOI), the AAOS Hip and Knee Outcomes Support Instruments, 
and the Subjective Knee Score81, 82. More disease specific instruments include the Arthritis 
Impact Measurement Scale (AIMS), Arthritis Self-Efficacy Scale (ASES), Arthritis-specific SF-
36 (ASHI), Functional Assessment Scale, Health Assessment Questionnaire (HAQ) and 
Kettlekamp Knee Scoring Scale. These instruments will be described in thenext section. The 
Hospital For Special Surgery Knee Score, Nottingham Health Profile, Short Form 
Musculoskeletal Function Assessment, and Gait Analysis are additional examples of the various 
instruments employed in orthopaedic studies. While the exploding interest in functional and 
HRQoL assessment for specific patient populations is encouraging, the abundance of 
instruments and lack of consistency in usage presents a limitation in synthesizing the extant 
literature. This is a widely expressed concern among experts in the field20, 21.  
2.3.2.1 Generic Health Instruments. The 36 item short form (SF-36) is a self-report 
measure that was designed for use in clinical practice and research to measure patients HRQL. 
It is a multi-item health survey with 36 questions. The SF-36 consists of the two following sub-
scores: the physical component score and mental component score. The two scores are designed 
to measure eight health concepts: 1) limitations in physical activities, 2) limitations in social 
activities, 3) limitations in usual role activities, 4) pain, 5) general mental health, 6) limitations 
because of emotional problems, 7) energy and fatigue (vitality), and 8) general health 
perceptions248. The Physical Functioning (PF), Role-Physical (RP), and Bodily Pain (BP) scores 
correlate most highly with the Physical Component Summary (PCS). The mental health (MH), 
role-emotional (RE), and social functioning (SF) contribute most to the Mental Component 
Summary (MCS). Vitality (VT), general health (GH), and social functioning (SF) have 
noteworthy correlations with both summary scores249, 250. Out of the eight measured health 
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concepts, PF, RP, and BP are the most responsive in total knee replacement outcome 
assessment251.  Lingard et al. found a significant improvement in SF-36 BP and PF scores from 
before surgery; (BP 35.0 and PF 27.4) to twelve-month post surgery (BP 59.7 and PF 53.8) in 
total knee arthroplasty patients252.       
 The SF-36 is the most widely evaluated generic self-assessment tool in clinical populations 
and it has been used in thousands of clinical studies253. The SF-36 is internally consistent and a 
valid measure of health status for a wide range of patients254. A limitation of the SF-36 is that 
the symptoms and problems that are specific to a particular condition are not included. Thus, the 
SF-36 is a generic measure of health and it does not address the specific problems associated 
with knee-replacement patients. Finally, the SF-36 is also subjective and therefore does not 
provide information on performance based function. A license is required for the use of SF-36, 
which is not difficult to obtain, but can be expensive depending on the purpose of the use.   
2.3.2.2 Disease Specific Instruments. Disease specific instruments are designed 
specifically for patients with arthritis and/or osteoarthritis and commonly include specific 
questions regarding symptoms associated with these conditions.  
2.3.2.2.1 Arthritis Impact Measurement Scales, Second Version. The arthritis impact 
measurement scales, second version (AIMS2) is a health class questionnaire to evaluate 
function, work, social influences, and issues due to arthritis, and it assesses the outcomes of 
arthritis treatments and programs. It is a 78-item questionnaire with 12 scales. These 12 scales 
actually allow for the measurement of multiple sites of OA. Specifically, the knee scales include 
mobility, walking and bending, self-care tasks, household tasks, social activity, support, pain, 
work, tension, and mood. To establish reliability and validity, performance was measured with 
299 subjects with rheumatoid arthritis and 109 patients with OA. The internal consistency 
coefficients for the scales ranged from 0.72 to 0.94. The reliability and validity depended on 
  67
age, gender, and education status. Sixteen previous publications demonstrated the AIMS to 
produce scalable, reliable, and valid measures mutually with combined and individualized 
health status255. 
2.3.2.2.2 Arthritis Self-Efficacy Scale (ASES). The ASES measures a precise state of a 
subjects perceived ability to handle the consequences of chronic arthritis. The self-efficacy 
(SE) theory predicts that current SE will be associated with both present and future health status. 
The ASES consists of 20 items and 3 scales including pain, function, and other symptoms. The 
construct and concurrent validity and reliability of the scale have been established by research 
studies in which the Stanford Arthritis Self-Management Course was implemented. This 
intervention showed good efficacy with health outcomes and SE scores increasing throughout 
the course88. 
2.3.2.2.3 Arthritis-Specific Health Index (ASHI). The ASHI uses an arthritis-specific 
scoring formula in conjunction with the SF-36 Health Survey to increase receptiveness of the 
survey to identify changes in the severity of arthritis. This tool contains two summary measures 
and eight subscales to examine health status. There have been longitudinal clinical data for 
subjects (n=835) in four placebo-controlled studies where comparisons of the SF-36 and ASHI 
for validity, relative validity, and associations to clinical outcomes of condition coefficients 
were made. The ASHI was able to discriminate well between the groups of treated and untreated 
individuals and appeared to be more valid than the SF-36 scales256. However, the pattern of 
correlations between changes in SF-36 scales and the ASHI indicated that ASHI is primarily a 
measure of bodily pain (r = 0.92) and other aspects of physical and role functioning and well-
being (r = 0.69 for Role-Physical, r = 0.68 for Physical Functioning, r = 0.52 for Social 
Functioning, and r = 0.51 Vitality)257.  
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2.3.2.2.4. WOMAC. The Western Ontario and MacMasters Universities Osteoarthritis Index 
(WOMAC) is a questionnaire specifically designed for patients with osteoarthritis of the knee or 
the hip. The WOMAC includes three categories intended to measure pain, disability and joint 
stiffness, and physical function. The WOMAC questions are scored on a 5-point Likert scale 
and the scores are summed for each category using a battery of 24 questions. The WOMAC has 
undergone a rigorous validation process and it is widely used in the assessment of patients with 
hip or knee arthritis 12, 252. Studies show that the WOMAC is reliable and it appears to be a more 
responsive tool to measure the outcome of joint replacement when compared to the SF-36 12, 258. 
Specifically, the WOMAC is superior in measuring subjective function and pain status 
following total knee arthroplasty (TKA)20, 259. The WOMAC underwent a rigorous psychometric 
validation process before it was introduced for the assessment of TKA12. The WOMAC 
discriminates better than the SF-36 among individuals with varying levels of knee problems, 
whereas the SF-36 is more responsive among individuals with varying levels of general health 
and co-morbidities 223, 258. When compared to the KSS, the WOMAC and SF-36 appear more 
responsive and eliminate any possible observer bias 252, 260. Limitations of the WOMAC include 
difficulty to obtain license for use and the cost of use. Also, because it is a self-report 
questionnaire, it may be subject to floor and ceiling effects, and it is not a reflection of 
objectively obtained information.   
2.3.2.2.5. KOOS. The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a self-
report questionnaire that assesses the patients opinion about their knee and associated 
problems. KOOS is a 42-item knee-specific questionnaire based on the WOMAC Osteoarthritis 
Index.  In fact, the KOOS includes the WOMAC questionnaire and the WOMAC score can be 
calculated from the KOOS. The KOOS was developed to be used for short- and long-term 
follow-up studies of knee injuries, and it comprises the five following subscales: Pain, other 
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Symptoms, Activities of Daily Living (ADL), Sports and Recreation Function, and knee-related 
Quality of Life. A separate score ranging from 0100, where 100 represents the best result, is 
calculated for each subscale. The KOOS is valid and reliable in follow-up studies of 
meniscectomy, anterior cruciate ligament reconstruction, and total knee replacement245, 246, 261.  
KOOS is easy to obtain and no license is required for use.    
2.3.2.3 Knee Scores  
2.3.2.3.1 Knee Society Clinical Rating System (KSS). The KSS is a commonly used 
outcome measure in OA and TKA patients. It is a dual rating system that includes self-report 
measures of function and a partially objective knee score for measurement of pain, stability, and 
ROM. The KSS was developed to objectively assess the total knee replacement outcomes and to 
replace the commonly used Hospital for Special Surgery system (HSS) assessment14. The 
benefits of KSS are that this measurement system separates knee function from overall patient 
function by measuring two distinct parts: Knee Score (pain, ROM, and stability) and Function 
Score (walking and stair climbing). This enables the knee score to be independent of function 
and hence not subject to deterioration resulting from other co-morbidities21.   
The Knee Score of the KSS consists of self-reported pain (50 points) and clinician measured 
ROM (25 points) and stability (25 points) adding up to 100 points maximum. For the ROM 
score, the maximum score for arc of movement is achieved at 125° of arc. For the Stability 
score, the antero-posterior and medio-lateral portions are measured separately. If there are any 
deficiencies present in flexion contracture, extension lag, or alignment, deductions are made in 
the scores. The Function Score simply includes self-reported ability to walk (50 points) and 
climb stairs (50 points). Deductions are made if the patient uses a stick or a crutch14. 
Although the KSS represents a nice attempt of separating knee function from overall 
function, some limitations still exist. The KSS does not account for possible analgesic use and it 
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does not indicate the type of activity provoking pain if pain is present. Although the distinction 
between knee score and overall function is appropriate, the knee score is partly subjective and 
therefore will be subjected to the limitations of self-report tools. The function score also 
involves only walking and stair climbing and therefore might not be a comprehensive reflection 
of true functional performance.   
The validity and responsiveness of the KSS have been studied by Lingard et al. who found 
that the KSS had adequate construct validity, but poor correlation among its items252. Bach et al. 
found that the Knee Score offered only poor reproducibility and the function score showed good 
reproducibility262. The wide variations in inter-observer correlation coefficients need to be 
considered when using the KSS. The inter-observer correlation coefficient for the function score 
was 0.78, and 0.48 for the knee score262. The disagreement between observers presents a 
limitation when using this scoring system. Liow et al. found a high inter-observer and moderate 
to high intra-observer scores for the knee and the function scores of the KSS263. Lingard 
compared the KSS to the SF-36 and the WOMAC. According to the findings from this study, 
the Knee Societys System was found to be the least responsive to change of the three 
assessment protocols252.   
2.3.2.3.2 AAOS Lower Limb Outcomes Instrument. The general focus of the AAOS Lower 
Limb Outcomes Instrument (LLOI) is to measure pain and disability of lower limbs. It consists 
of 29 items that represent six scales and six individual items. Some of the dimensions of the 
assessment tool include pain, stiffness, swelling, limb giving way, limb catching/locking, use of 
aids, numbness, limping, balance, putting on socks, getting in/out of car, and happiness with 
looks. Other components include hip and knee specific items, hip and knee support 
questionnaires, physical exam form, knee operation form, and a post discharge complications 
form. In addition, physical attributes, range of motion, stability, gait, and physician assessment 
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of pain are reported. The reliability, validity, and sensitivity to change were examined with 205 
subjects with lower limb issues264. Every scale demonstrated construct validity, with the short 
form discerning among groups. Specialty components (e.g., knee giving way) supplied details 
over and beyond the lower limb and SF-36 scales. In a follow-up study of 71 patients, the scales 
demonstrated sensitivity to change and they were able to differentiate between subjects who 
improved and those who did not264. 
2.3.2.3.3 AAOS Hip and Knee Outcomes Support Instrument. The major focus of this 
instrument is general pain and disability related with the knee, specifically joint replacement. 
This instrument consists of two different scales for examination including the core disability 
scale (seven items), and a right and left knee pain scale (3 items). Dimensions include 
components of hip and knee specific items, hip and knee support questionnaires, a physical 
exam form, a knee operation form and a post discharge complications form. In addition, 
physical attributes, range of motion, stability, gait, and physician assessment of pain are 
reported. Reliability and validity were established in a clinical trial of 1799 general population 
participants. Both knee scales had a Cronbachs alpha of .89 and .90, respectively, and the 
hip/knee core scale had Cronbachs alpha of .90. Inter-item associations of the right/left knee 
scale were .64 and .60, respectively, and the hip/knee core scale was equal to .56 265. 
2.3.2.3.4 Oxford Knee Score (Oxford-12). The Oxford knee score was developed to measure 
functional change after TKA. It is a 12-item single scale and it assesses mobility and ability to 
function in normal activities, as well as pain. Early tests of reliability and validity during 
instrument development compared the Oxford-12 to the SF-36, HAQ, and AKS clinical knee 
score on numerous subject samples and also in a prospective study of 117 patients. The internal 
consistency, reproducibility, construct validity, and sensitivity to change of this instrument were 
reported at comparable levels to the comparison tests266. 
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2.3.2.3.5 Kettlekamp Knee Scoring Scale. The primary focus of the Kettlekamp scale is the 
assessment of pain and functional capacity. The test consists of a single overall score, with the 
total potential points ranging from 0-103. When determining the meaning of the score, the 
higher score represents less pain and greater functional ability. The dimensions of the test 
include all of the following: pain with activity, shoes and socks, stairs, gait, synovial thickening, 
flexion contracture, flexion in degrees, anterior drawer, rotational instability, lateral collateral 
ligament stability, pain with flexion and extension, pain on rotation, and varus-valgus. Validity 
measures, up to this point, are based on a Chi-square test, indicating a strong relationship 
involving clinical categorization and the Knee Scoring Scale classification. Reliability 
information about this instrument has not been published insofar as we are aware. 
2.3.2.3.6 Subjective Knee Score. The subjective knee score is a measure of knee function 
throughout activities and includes two scores: questionnaire score and a visual analog composite 
knee score. The questionnaire scores can be a maximum of 110 with scores of ≥85 indicating 
the ability of an individual to return to strenuous exercise on a normal basis. Elements of the 
instrument include pain, swelling, stability, overall activity level, walking, stairs, running, 
jumping and twisting, as well as an overall knee score. The overall knee score is a visual analog 
scale ranging from 0-100. In a 50 patient trial, the two scores (questionnaire and visual analog) 
were comparable for all patients267. However, reliability of these scales has not been established. 
2.3.2.3.7 Lequesne Index of Severity for OA of the Knee. The Lequesne Index of Severity 
for OA of the Knee (ISOA Knee) is an algofunctional (i.e., pain) or severity index for knee 
diseases, in particular OA. One must understand that the ISOA is designed where all items are 
subjective in nature, relying solely on self-reports. However, it is useful for drug trials, long-
term follow-up with chondroprotective agent studies, and it is helpful in decision making in 
regards to knee prosthesis268-270. This index consists of 11 items, with a total possible score of 
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24, where scores ≥14 are suggestive of a patient with an extremely severe handicap. Some of the 
primary dimensions of the Lequesne index include pain, distance walked, and activities of daily 
living. The ISOA has been continually undergoing validation trials since it was first developed. 
The validity of the severity indices of OA has been continually established. Generally, index 
findings are close to, but function separately from, other outcome measures for pain or global 
measurement. The responsiveness and effect-size is acceptable for use as an outcome measure 
to aid in objectively determining treatment or the correct time for surgery269, 271.  
2.3.2.3.8 The Kellgren and Lawrence Scale (KL). Several indices are currently used for 
assessing radiological progression of OA including individual radiographic features, composite 
indices, and quantitative measures. The Kellgren and Lawrence grading system is one of the 
more commonly used methods. The KL grading scale classifies overall severity of OA and it is 
defined as follows: 0 = normal; 1 = doubtful narrowing of joint space and possible osteophytic 
lipping; 2 = definite osteophytes and possible narrowing of joint space; 3 = moderate multiple 
osteophytes, definite narrowing of joint space, some sclerosis, and possible deformity of bone 
contour; 4 = large osteophytes, marked narrowing of joint space, severe sclerosis, and definite 
deformity of bone contour.  
2.3.2.4 Functional Measures 
2.3.2.4.1 Functional Assessment Scale. The functional assessment scale represents a test of 
standing balance in the general adult population with OA. Its score consists partially of mobility 
and physical activity portions of the AIMS. The functional assessment scale includes 
dimensions of pain, walking distance, walking supports, ability in standing, and stairs. The 
reliability of the test in OA patients has been demonstrated; however, the validity of the tool has 
not been tested272. 
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2.3.2.4.2 Health Assessment Questionnaire (HAQ). The HAQ was developed in 1978 and it 
is a self-report functional ability measure that is considered to be one of the most used 
instruments throughout the world for assessing arthritic conditions. The instrument includes 27 
items that collectively assess medical history. The short-form version of the instrument 
(Disability Index and Pain Scale) includes eight classifications of disability and pain with one 
disability factor. The long-form version is a cumulative outcome index that examines a 
hierarchy of patient outcomes for 1) disability, 2) discomfort and pain, 3) drug side effects and 
4) costs. Previous validity tests used major components examination to analyze multi-focal 
patterns of patient responses, and association analysis between questionnaire and interview. The 
reliability was studied with duplication of the study with two patient samples (n=20 and 28). 
Over the past 20 years, adjustment and enhancement of the questionnaire has occurred273. 
2.3.2.4.3 Timed-Up-and-Go (TUG).  The TUG basic test of functional mobility was 
developed through the modification of the Get-up and Go test to increase reliability, in part by 
adding a timed component274. The TUG is a sensitive and objective assessment of function that 
does not require much equipment, training, or expertise, and it can be done in almost any 
clinical setting. It is a screening tool and an assessment tool for functional mobility for older 
adults274,  and it may also be valuable in following clinical changes that may occur over time274. 
The TUG is a simple test that requires the individual to begin seated in an armchair, stand up, 
walk three meters, turn around, walk back to the chair, and sit down again. The participant is 
timed to determine if any functional limitations are present. Previous research has shown the 
TUG to be a reliable and valid test for quantifying functional mobility 274. The TUG has been 
widely recommended for use as a screening tool to help identify those individuals who are at 
risk of falling275. It has been previously reported that TUG times from 13 to 16 seconds are 
considered cutoff values for helping predict falls in older adults275. Retest reliability of the TUG 
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is high 274, 276,277. Exceptional concurrence in timed scores was established between raters 
(intraclass correlation coefficient [ICC] = .99) in addition to the same rater during successive 
clinic visits (ICC = .99)277. The TUG has also been validated against other currently used 
measures of basic functional mobility including the Berg balance Scale (r = -0.81), gait speed (r 
= -0.61), the Barthel index of ADL (r = -0.78)274, and the Tenetti Balance Scale (r = .74)278, 279. 
In general, the TUG provides a quick assessment of functional ability that does not require 
extraordinary equipment and can effortlessly be incorporated as part of a routine medical 
examination.  
2.3.2.4.4 Continuous Scale Physical Functional Performance Test. Many scientists and 
practitioners have expressed an urgent need for a better and more universally applicable tool for 
measuring function in the general population of older adults and across a wide variety of patient 
groups20, 21. One objective instrument is the 10-item Continuous-Scale Physical Function 
Performance Test (CS-PFP10)16, 25. The CS-PFP10 is an ADL performance-based functional test 
battery that is validated against risk of disablement and it is sensitive to change over time 16, 280. 
It was developed by Cress et al.16 to provide a comprehensive, in-depth measure of physical 
function. The CS-PFP10 is a 10-item test battery that originated from the CS-PFP,  which 
included 15-items 16, 25. It requires participants to perform basic and instrumental ADL in a 
standardized testing environment. Both CS-PFP and the CS-PFP10 have been validated and are 
reliable measures of function that also reflect abilities in several separate physical domains. The 
rationale for the development of CS-PFP and the CS-PFP10 was the lack of reliable and 
objective measures of physical function and the problems with self-report measures of physical 
function281. Thus, precise assessment of physical function is important in predicting risk factors 
for functional dependence, in designing intervention strategies, institutional discharge planning, 
and medical reimbursement16.  
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The development of the original CS-PFP test was predicated upon the need to measure 
physical function according to its definition as the integration of physiological capacity and 
physical performance capability mediated by psychosocial factors16. The tasks for the CS-PFP 
test were chosen by a multidisciplinary panel of experts including a geriatrician, a physiatrist, an 
occupational therapist, a physiologist, a retirement home administrator, as well as some 
biomechanists and physical therapists. These experts categorized the ADL-based tasks into five 
physical domains of upper body strength, upper body flexibility, lower body strength, balance 
and coordination, and endurance. The validation study of the original version of the CS-PFP-test 
included 148 older adults from three different categories based on their living status: community 
dwellers, continuous care retirement residents who were independent, and continuous care 
retirement residents reporting mild limitation16. As hypothesized by the investigators, the 
community dwellers had the highest fitness and physical function scores and the continuous care 
retirement residents with limitations had the lowest scores16.  
The CS-PFP and CS-PFP10 testing protocols require the participant to perform a variety of 
ADL in a standardized fashion. The test items include such activities as carrying groceries, stair 
climbing, sweeping, doing laundry, putting on a jacket, and the 6 min walk. The test results 
provide investigators with an overall functional fitness score, as well as scores in a variety of 
fitness domains thought to be important for functional fitness (i.e., lower body strength, upper 
body strength, upper body flexibility, balance and coordination, and endurance)16, 25, 280, 281.  
The CS-PFP and CS-PFP10 have high test-retest reliability (r = 0.84-0.97) and are more 
sensitive measures of function as compared to other traditional measures such as the SF-3616. 
The CS-PFP and CS-PFP10 discriminate between independent-living older adults and those 
with dependent-care needs16, 280. Other advantages of these instruments include the use of a 
continuous scale for scoring ranging from 0-100, rendering the data appropriate for linear 
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statistical models. Higher scores indicate better levels of physical function. Further, other more 
subjective or generic measures might be limited by floor and ceiling effects, whereas the CS-
PFP10 may be able to provide information not limited by these effects. In fact several aspects of 
the testing process actually contribute to the minimization of these effects, including evaluation 
of several domains and continuous scaling25     
Published data indicate that the metabolic requirements of the test items are under 6 METs. 
Therefore, the tests meet at least one accepted definition of moderate activity, indicating that the 
test is a relatively safe testing method for populations with health problems and limited 
functional capacities. The CS-PFP10 has been extensively validated for use in the general 
population of older adults and it is known to have high convergent validity and predictive 
validity insofar as the test correlates well with other measures of function and lab tests of 
physical fitness, and discriminates between adults living independently and those requiring 
assistance16, 25, 280.  
In summary, the CS-PFP and CS-PFP10 are valid, reliable, and sensitive measures of 
physical function that are applicable to a wide range of populations and functional levels. The 
tests may be used in evaluation of physical functional performance for research and clinical 
purposes. The insight into specific functional abilities or limitations has critical and wide 
ranging implications for the care of the patient. 
The CS-PFP and CS-PFP10 testing paradigm has been employed in the TKA population in 
only few published studies that appeared in abstract form13. In one of these studies, Petrella et 
al. measured physical function with the CS-PFP10 in 13 TKA patients that received an early 
rehabilitation program focusing on functional ROM. They found 19% improvements in 
functional scores from one month to three months following the surgery. The reported mean 
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values for CS-PFP10 scores were 49.2+15 at baseline and 78.7+15 for age-matched controls. 
For 1 or 3 month follow-ups, no mean scores of CS-PFP10 were reported for this study282.  
Another preliminary study suggested that the CS-PFP10 appears to be sensitive to change in 
the TKA population283.  Furthermore, in a study conducted by Garrison et al. the convergent 
validity of the CS-PFP10 in TKA patients before surgery was investigated 283, 284. Moderate 
associations between the CS-PFP10 and other commonly used measures of physical function 
were reported and the largest correlation coefficients were between the CS-PFP10 scores and 
the KSS function score (r=0.605) and WOMAC Physical Function score (r= -0.551)284. A 
comparison of functional improvement in CS-PFP10 scores revealed that the percent 
improvement in scores following TKA reported by Garrison et al. were similar (pre-TKA to 3 
months post= 24.7%) to those reported by Petrella et al. (pre-TKA to 3 months post = 19%)282, 
283. The findings from these preliminary studies282-284 suggest that the CS-PFP10 is a useful and 
sensitive tool for  measuring function in the severe OA patients/knee replacement candidates283, 
284. However, further investigation to confirm these inferences is necessary. 
2.3.2.5 Discussion of the Instruments. Traditionally, physical function in knee OA patients 
has been measured by rating systems such as the WOMAC 12, 13, the KSS14 and the SF-3615. 
Problems that exist with self-report assessment tools include that they may be imprecise and 
lack sensitivity to change, and they are subject to errors in judgment or memory, the ability and 
willingness to answer questions correctly, and discrepancies between perception and actual 
ability16, 17. Sometimes patients may either under- or overestimate self-reported physical 
function when compared to objective physical function. For example, a younger OA patient may 
be quite functional when measured objectively, however, their self-reported function may be 
poor. In contrast, sometimes a patients self-reported function exceeds that of actual (objectively 
measured) physical function. The differences between self-reported and objective physical 
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function may be due to varying levels of patient expectations. If one expects high-levels of 
activity and functionality and is restricted by symptoms of OA, physical function will probably 
be reported as poor by self-report measures. In contrast, if a patient has been disabled for a long 
time and does not expect high levels of function, they may perceive their functional level as 
acceptable. 
The KSS may offer some advantage in this regard. While this instrument incorporates 
certain self-reported outcomes of pain and functionality, it also includes objective measures of 
stability, alignment, and ROM in the overall assessment of the knee247. However, one could 
argue that these are measures of impairment rather than functional ability. Many authors and 
practitioners have expressed an urgent need for a better and more comprehensive measurement 
tool to be developed for measuring physical function in various patient groups26,38. 
Consequently, there has been considerable interest in the development of universally applicable 
objective measures of physical function that will allow scientists and clinicians to measure 
functional outcomes in various patient groups with greater specificity and sensitivity20, 21. 
Moreover, standardizing the approach to measure clinical outcomes will offer investigators the 
advantage of making comparisons across studies.  
Alternatively, several attempts have been made to gather information about functional 
fitness using traditional measures of physical fitness that measure work capacity such as 
maximal aerobic power and maximal strength. These tests do not, however, discriminate across 
a wide array of functional status, and they are questionable for use in older populations285. The 
CS-PFP and CS-PFP10 are thought to remove problems inherent in self-report measures such as 
the SF-36 and WOMAC, and discriminate across a wide array of conditions.  
Performance-based tests also provide important information about future disability and 
mortality, they are thought to be a meaningful reflection of the conduct of similar tasks usually 
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performed at home, and they appear to be better suited for between-subject comparisons than 
self-report because the basis of comparison is the same22. Other advantages include the 
opportunity for individuals to learn that their ability to perform ADLs may be different from 
what they perceive16. Therefore, it is important to continue to examine and refine the 
quantifiable measures of function that reflect the ability of the person to execute basic and 
instrumental ADLs in knee OA patients so that clinicians and scientists can evaluate treatment 
outcomes with greater sensitivity.   
However, there is a need for self-report measures in clinical settings. Only the patient can 
assess their pain level, emotional health, social activities, or energy and fatigue levels. Further, 
the patients overall perception of their health is strongly affected by factors such as vitality and 
social functioning249, 250. Thus, measures such as HRQoL can only be measured by patient self-
report measures and they are necessary in the global assessment of patients health and well-
being. Further reason to measure HRQoL in clinical populations is a commonly observed 
phenomena of two patients with the same clinical criteria having dramatically different 
responses286. Guyatt et al. gave a good example of this phenomenon by describing the 
following: two patients with the same range of motion and even similar ratings of back pain 
may have different role function and emotional well-being. Although some patients may 
continue to work without major depression, others may quit their jobs and have major 
depression286. It has been demonstrated that there is a lack of association between HRQoL and 
objective indices of fitness or disease status238. Because HRQoL is not simply a reflection of 
ones objective health, but rather a reflection of perceptions, thoughts, and feelings, it is 
essential to include both objective and subjective measures in the assessment of clinical 
populations. These variations between physiological measures of function and HRQoL explain 
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why patients, clinicians, and health care administrators are all keenly interested in the effects of 
medical interventions on HRQoL, as well as physical function. 
Therefore, one aspect of the patients life should not be viewed more important than another. 
All aspects, including all dimensions of health (physical, emotional/ psychological, spiritual, 
occupational, environmental, social, intellectual) are important. While physiologic measures 
provide valuable information to clinicians, they may be of limited interest and usefulness to 
patients. Thus, the importance of globally measuring different aspects of the patients life is 
crucial in gaining an overall understanding of patients recovery process. This knowledge may 
help clinicians in planning for better and more individualized management strategies and 
interventions for chronic diseases. It is also important to wisely choose the outcome instruments 
utilized so that a valid, reliable, and global representation of the patients condition is obtained.  
2.4 Conclusion 
Osteoarthritis is one of the most prevalent chronic conditions among older adults, and it 
significantly contributes to the increasing numbers of adults living with disabilities, and further 
impacts HRQoL. Chronic conditions such as OA will most likely require a combination of 
treatment modalities depending on the severity of the disease. These treatments vary from 
education to pharmacologic treatments and surgery. Educational programs, exercise, weight loss 
and other non-pharmacologic treatments, as well as pharmacological treatments have been 
successful in the management of OA. Exercise as a treatment for OA is underutilized due to 
various factors. While several studies demonstrate the benefits of exercise in the treatment of 
OA, some clinicians believe that the repetitive stress resulting from physical activity can 
actually worsen the symptoms. While there is plenty of evidence to show that exercise does not 
exacerbate the progression of the disease, its use as a treatment modality by physicians could be 
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more extensive. Thus, increased awareness of the benefits of exercise as a treatment for mild-to 
moderate OA is needed.  
Some patients OA is so severe though, that exercise is no longer an option or physically 
possible. Surgery may be the only treatment option at this point that will result in a positive 
outcome. While the majority of OA patients will not require surgery, it is an option that must be 
considered when other treatments fail and when there is significant joint damage. Surgery can 
result in significant improvements in pain, joint ROM and alignment, and thus improve overall 
physical function and HRQL. There are several surgical procedures utilized in the treatment of 
knee OA, but the most common and successful surgical treatment is TKA. The TKA procedure 
removes the damaged parts of the joint replacing them with new artificial components. 
However, there are some patients that are disabled by the involvement of OA in both knees and 
may require bi-lateral TKA. A recent debate in the literature has been whether a simultaneous 
bilateral TKA is better compared to a staged bilateral TKA or a single TKA. While this question 
remains unanswered, there is also a question regarding which outcome instruments are best 
for measuring the success of TKA.  
Because the outcome assessments following a TKA have been under scrutiny, many experts 
have expressed a need for universally applicable measures of performance based physical 
function to be utilized in this population. While subjective disease specific and generic measures 
have been widely applied and validated in TKA patients, objective and valid measures of 
physical function have not been established in this population. In addressing the treatment of 
OA, it is essential that scientists and clinicians identify meaningful, valid, and sensitive outcome 
measures. Not surprisingly, there is no consensus as to which instrument(s) provides the best 
measure of function and HRQL in the OA patient.  
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There are several aspects of the patients recovery that should be considered including 
functional status, pain, psychosocial variables, as well as objective clinical measures such as 
ROM and alignment. Moreover, the intention of various treatments may be to target certain 
outcomes (i.e. function, pain, or HRQoL). Thus, it may be best to utilize a combination of 
subjective and objective measures of physical function and HRQoL. While there are many 
instruments that have been used to assess outcomes in OA, it appears that the SF-36 is one of 
the most universally accepted self-appraisals of HRQoL, and with respect to physical function 
in OA patients, the WOMAC and KSS have been utilized most often in the knee OA population, 
but other instruments such as the CS-PFP and CS-PFP10 are gaining popularity as they provide 
insight into the global functioning of the patient, and they also allow investigators to make 
comparisons between OA patients and relatively healthy controls. Also, the CS-PFP10 is an 
objective, performance based measure of physical function and is therefore an unbiased 
reflection of the patients true physical function. 
Finally, collaboration between clinicians and researchers would be ideal and should be 
promoted because support from physicians in clinical research is crucial. The question remains, 
why arent more physicians and researchers collaborating? While this question remains 
unanswered, we must start to see the big picture and understand the importance of forming 
these relationships. With a collaborative team effort, it may be possible to achieve optimal 
interventions and outcome measures for treatment of chronic disease. 
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CHAPTER 3 
STUDY 1: VALIDITY OF CS-PFP10 TEST IN UNILATERAL AND BILATERAL TKA 
PATIENTS 
 
Knee osteoarthritis (OA) accounts for a large percentage of mobility disability in the United 
States and is one of the most common chronic diseases3, 4. It has a significant negative effect on 
physical function and the ability to perform activities of daily living(ADL)5. Traditionally, 
physical function in these patients has been measured using the Western Ontario and McMaster 
Universities Ostoeoarthritis Index (WOMAC) 12, 13, the Knee Society Clinical Rating System 
(KSS),14 or the Short Form Health Survey (SF-36)15. The WOMAC and the SF-36 are 
subjective survey instruments that rely solely on patient self-reported information, and the KSS 
contains clinical (objective) and self-report (subjective) items.  
There are some known limitations of self-report measures including possible floor and 
ceiling effects, lack of sensitivity to change, and errors in participant judgment or memory. In 
addition, the ability and willingness of patients to answer questions correctly and discrepancies 
between perception and actual ability need to be considered when using self-report measures16, 
17. Furthermore, studies have shown that OA can lead to increased emotional distress, anxiety, 
depression, and fatigue. These factors may influence self-perception of function and pain, 
potentially presenting further limitations with survey-type measures of physical function208, 6. 
Thus, assessing and quantifying the degree of functional disability caused by knee OA solely 
based on self-report is problematic insofar as the influence of psychosocial factors on self-
perceived function is not known and is likely a source of significant random error. 
Of the traditional approaches to measuring function in knee OA patients, the KSS is the only 
one that incorporates some objective items. In addition to self-report items, this assessment 
includes physician appraisal of knee stability, alignment, and range of motion 247. Unfortunately, 
however, knee stability, alignment, and range of motion are more aptly defined as measures of 
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impairment and not measures of functional ability per-se. Thus, valid objective measures of 
function for knee OA patients are virtually unavailable. Thus, there has been considerable 
interest in the development of measures of physical function that can be universally applied 
across various patient groups with greater specificity and sensitivity in comparison to those 
instruments that are presently available20, 21, 26, 38. Additionally, standardization of measures 
would allow investigators the opportunity to make comparisons across studies.  
In 1996, Cress et al. introduced the Continuous Scale Physical Function Performance test 
(CS-PFP), which is a collection of 16 items requiring the subject to execute basic and 
instrumental ADL in a standardized fashion. The CS-PFP was introduced as an option for 
attaining objective measures of physical function in older adults. More recently Cress et al 
published a 10-item version of the test (CS-PFP10)16, 25, 40. Because the CS-PFP and CS-PFP10 
include items that are not based on patients perception and follows a standardized laboratory 
set-up and protocol, it is not subject to certain problems inherent in self-report measures such as 
the SF-36 and WOMAC. The CS-PFP10 has been extensively validated for use in the general 
population of older adults and has high convergent validity and predictive validity16, 25, 280. The 
tests correlate well with other measures of function and laboratory tests of physical fitness, and 
discriminates between adults living independently and those living with assistance16, 25, 280.   
Other advantages of performance-based tests, such as the CS-PFP and CS-PFP10, include 
that they may be better suited for between-subject comparisons than self-report measures 
because the basis of comparison is the same22. Performance based-tests can also be predictive of 
future disability and mortality, and provide us information about how a patient may perform in 
similar tasks during daily activities, which may be different from their perceived functional 
ability16. Thus, the need for examining and refining quantifiable measures of function that are 
capable of reflecting the OA patients ability to execute basic and instrumental ADL is apparent.  
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The CS-PFP10 testing paradigm has been employed in the knee OA population  in a few 
preliminary studies of patients following total knee arthroplasty (TKA), and these were only 
published as abstracts282-284. Petrella et al. measured physical function with the CS-PFP10 in 13 
TKA patients that received an early rehabilitation program focusing on functional ROM. The 
reported mean values for the total CS-PFP10 scores at baseline were 49.2±15 for TKA 
candidates and 78.7±15 for age-matched controls. Furthermore, the authors report a 19% 
improvement in functional scores that occurred over the time period between 1- and 3-month 
post-surgery282. Garrison et al.283, 284, examined the convergent validity of the CS-PFP10 in 
TKA patients immediately prior to TKA surgery. Moderate associations between the CS-PFP10 
and other commonly used measures of physical function were reported and the largest 
correlation coefficients were between the CS-PFP10 scores and the KSS function score (r = 
0.605) and WOMAC Physical Function score (r = -0.551)284. A comparison of functional 
improvement in CS-PFP10 scores revealed that the percent improvement in scores following 
TKA reported by Garrison et al. (pre-TKA to 3 months post= 24.7%) were somewhat similar to 
those reported by Petrella et al. (1 months post TKA to 3 months post = 19%)282, 283. The 
findings from these preliminary studies282-284 suggest that the CS-PFP10 may be a useful tool for 
measuring functional performance in the severe OA patients/knee replacement candidates283, 284. 
3.1 Specific Aims and Hypothesis 
The primary purpose of this investigation was to examine the convergent validity of the CS-
PFP10 test in a sample of patients with knee OA awaiting TKA including uni- and bilateral 
TKA candidates. More specifically, the CS-PFP10 scores were compared to the WOMAC, KSS, 
and the SF-36 physical function scores. The hypothesis of this investigation was that correlation 
analysis would reveal at least moderate associations between the CS-PFP10 test scores and the 
WOMAC, KSS, and SF-36 scores in TKA candidates. 
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3.2 Method   
3.2.1 Participants 
A sample of 68 (n = 68) TKA candidates were recruited from one orthopaedic clinic with 
two participating surgeons. The sample included 18 men and 50 women between the ages of 50-
85. There were 32 bilateral and 36 unilateral TKA candidates, and TKA candidacy was 
determined by the examining physician based on several factors including (but not limited to) 
impaired quality of life, severe knee pain and stiffness that limits the patients daily activities, 
limited function or mobility, knee deformity, and failure to obtain pain relief from previous 
treatment methods.  
Prior to enrollment in the study, all candidates received a medical evaluation that included 
screening for inclusion and exclusion criteria. Inclusion criteria consisted of TKA candidates 
who were electing to pursue TKA, and who were otherwise apparently healthy or had a 
diagnosis of stable heart disease (AHA Class A and B and C-stable). Candidates in American 
Heart Association Class C- unstable or Class D (i.e., symptoms of cardiovascular and/or 
metabolic disease at rest) were excluded from the study287. Patients with other significant co-
morbidities such as active infection, immunosuppressive disorders, collateral ligament 
insufficiency (grade 3), posterior cruciate ligament insufficiency (grade two or more), drug or 
alcohol abuse, serious mental illness, or general neurological conditions such as Parkinsons 
disease, Multiple Sclerosis, were also excluded from the study. The inclusion and exclusion 
criteria are described in detail in tables 3.1. and 3.2.  
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Table 3.1 Inclusion criteria. 
Inclusion Criteria: 
 
• Men and Women age 50 to 85. 
• Apparently healthy individuals, and those with stable heart disease (AHA 
Class A and B). 
 
Class A: Apparently Healthy Individuals of any age without known heart disease or 
major risk factors and who have a normal exercise test 
 
Class B: Documented, stable cardiovascular disease with low risk for vigorous 
exercise but slightly greater than for apparently healthy individuals. Includes 
individuals with (1) CAD (MI, CABGS, PTCA, angina pectoris, abnormal exercise 
test, and abnormal coronary angiograms) whose condition is stable and who have the 
clinical characteristics outlined below; (2) valvular heart disease; (3) congenital 
heart disease; (4) cardiomyopathy; and (5) exercise test abnormalities that do not 
meet the criteria outlined in  
Class C: Clinical characteristics:  (1) New York Heart Association (NYHA) class 1 
or 2; (2) exercise capacity of >6 METs; (3) no evidence of heart failure; (4) free of 
ischemia or angina at rest or on the exercise test at or below 6 METs; (5) appropriate 
rise in systolic blood pressure during exercise; (6) no sequential ectopic ventricular 
contractions; and (7) ability to satisfactorily self-monitor intensity of activity 
 
• Patient presents with non-inflammatory osteoarthritis and requires a 
unilateral or bilateral total knee replacement. 
• Patient has moderate to severe pain in affected knee(s). 
• Patient is willing to consent to participate in the study by signing and dating 
an IRB-approved consent form. 
• Patient plans to be available for follow-up through 3 months postoperative 
period. 
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Table 3.2 Exclusion Criteria. 
Exclusion Criteria: 
 
• Patients in American Heart Association Classes D: known to have any of 
the following will be excluded from the study: A recent significant change 
in resting ECG, significant valvular heart disease, significant 
cardiomyopathy, previous episode of ventricular fibrillation or cardiac 
arrest, complex resting ventricular arrhythmias, significant three-vessel 
disease, low ejection fraction (<30%), recent complicated myocardial 
infarction, unstable angina, uncontrolled ventricular dysrhythmia, 
uncontrolled atrial dysrhythmia, third-degree atrioventricular block, acute 
congestive heart failure, severe aortic stenosis, suspected or known 
dissecting aneurysm, active or suspected myocarditis, thrombophlebitis or 
intracardiac thrombi, recent systemic or pulmonary embolus 
• Acute infection. 
• Significant emotional distress. 
• Patient known to have insufficient femoral or tibial bone stock resulting 
from conditions such as cancer, distal femoral/proximal tibial osteotomy, 
significant osteoporosis or metabolic bone disorders.  
• Patient has failed total or unicondylar knee replacement, or high tibial 
osteotomy (HTO) of the affected knee. 
• Patient has an active, local infection or systemic infection. 
• Patient has physical, emotional or neurological conditions that would 
compromise the patients compliance with postoperative rehabilitation and 
follow-up (e.g.: drug or alcohol abuse, serious mental illness, or general 
neurological conditions such as Parkinson, Multiple sclerosis, etc.).  
• Patient has grade 3 collateral ligament insufficiency.  
• Patient has knee flexion < 90°. 
• Patient has fixed flexion deformity >20°. 
• Patient has posterior cruciate ligament insufficiency of grade two or more. 
• Patient has ipsilateral hip arthritis resulting in any flexion contracture. 
• Patient has lumbar spine disease resulting in significant leg pain. 
• Patient has an immunosuppressive disorder (chronic condition 
characterized by markedly inhibited ability to respond to antigenic 
stimuli.) Examples of such conditions include patients who are on 
immunosuppressive therapy (corticosteroid hormones in large amounts, 
cytotoxic drugs, antilymphocytic serum or irradiation in large doses), 
patients with acquired immunodeficiency syndrome (AIDS) or auto-
immune diseases (except inflammatory arthritis). 
•    Patient is pregnant or plans to become pregnant during the course of the 
study. 
• Patient has a known sensitivity to materials in the device. 
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3.2.2. Design 
 A cross-sectional, correlational research design was employed to examine the relationship 
between the different instruments used to measure physical function in bilateral and unilateral 
TKA candidates. We simultaneously measured physical function with the WOMAC, KSS, SF-
36, and CS-PFP10 approximately 1-3 weeks prior to surgery. Data were collected at a single 
location (The American Musculoskeletal Research Institute or AMRI) in Alexandria, LA. Two 
supporting physicians, Dr. David Pope and Dr. Jeffrey Garrison agreed to support the data 
collection procedures and provided the TKA candidates for the study.  
3.2.3 Procedures 
The Institutional Review Board of Louisiana State University approved all procedures 
described herein. After agreeing to participate in the study, all participants signed an informed 
consent form. The KSS was conducted by one of the participating clinicians who were trained in 
obtaining the KSS clinical measurements and followed the KSS assessment protocol. 
Immediately following this evaluation, TKA candidates who passed the screening and 
consented to participate in the study completed the SF-36 and WOMAC self-report 
questionnaires, and performed the CS-PFP10 test. The questionnaires were given to the patient 
in the clinic by one of two research administrators, who also collected the questionnaires 
immediately upon their completion.  
The same research administrator then conducted the CS-PFP10 test according to the 
standardized protocol. Heart rate, blood pressure, and ratings of perceived exertion were 
monitored throughout the CS-PFP10 testing. In addition, the participants were instructed to 
relate any symptoms of chest pain, dizziness, nausea, fatigue, or otherwise. The CS-PFP10 
sessions were conducted by a trained CS-PFP10 technician at a facility that had on-site medical 
support teams equipped to respond in the event of an emergency. Unpublished data from our 
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laboratory indicate high inter-rater reliability between these two test administrators on all CS-
PFP10 domains and total score (n =13; intraclass r > 0.90).  
3.2.4 Instruments  
 3.2.4.1 Western Ontario and McMaster Universities OA Index. The Western Ontario and 
McMaster Universities Osteoarthritis index (WOMAC) is a 24-item self-administered health 
questionnaire specifically designed for patients with OA of the knee or the hip. The WOMAC 
includes three scores purported to measure pain, disability and joint stiffness, and physical 
function. The WOMAC questions are scored on a 5-point Likert scale and the scores are 
summed for each score. A high WOMAC score indicates a high level of difficulty or disability. 
The WOMAC has undergone a rigorous validation process and it is widely used in the 
assessment of patients with hip or knee OA12, 13, 252, 288. It is a reliable and responsive tool to 
measure the outcome of joint replacement when compared to SF-36252. The WOMAC requires a 
license for use and can be obtained at www.womac.org. 
 3.2.4.2 36-Item Short Form. The 36-item short form (SF-36) is a 36-item survey designed 
for use in clinical practice and research to measure self-reported health-related quality of life 
(HRQL). The SF-36 consists of two sub-scores: the physical component score and mental 
component score. The two scores are designed to measure eight health concepts: (1) limitations 
in physical activities, (2) limitations in social activities, (3) limitations in usual role activities, 
(4) pain, (5) general mental health, (6) limitations because of emotional problems, (7) energy 
and fatigue (vitality), and (8) general health perceptions248. The Physical Functioning (PF), 
Role-Physical (RP), and Bodily Pain (BP) scores contribute to the Physical Component 
Summary (PCS). The mental health (MH) and role-emotional (RE) scores contribute to the 
Mental Component Summary (MCS). Vitality (VT), general health (GH), and social functioning 
(SF) contribute to both summary scores249. The SF-36 is the most widely evaluated generic self-
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assessment tool in clinical populations and it has been used in thousands of clinical studies253. 
More detailed information on how to obtain a license is for the SF-36 is available at www.sf-
36.org. 
3.2.4.3 Knee Society Clinical Rating System. The Knee Society Clinical Rating System 
(KSS) is a commonly used outcome measure in TKA patients. It is a dual rating system that 
includes self-reported measures of function and a partially objective knee score for 
measurement of pain, stability, and range of motion (ROM). The KSS was developed in 1989 to 
objectively assess the TKA outcomes and to replace the commonly used Hospital for Special 
Surgery system assessment14. The benefits of the KSS are that this measurement system 
separates knee function from overall function by measuring two distinct parts: Knee Score 
(pain, ROM, and stability) and Function Score (walking and stair climbing). This enables the 
knee score to be independent of function and hence not subject to deterioration resulting from 
other co-morbidities21.   
The Knee Score of the KSS consists of self-reported pain (50 points) and clinician measured 
ROM (25 points) and stability (25 points) adding up to 100 points maximum. For the ROM 
score, the maximum score for arc of movement is achieved at 125° of arc. For the Stability 
score, the antero-posterior and medio-lateral portions are measured separately. If there are any 
deficiencies present in flexion contracture, extension lag, or alignment, deductions are made in 
the scores. The Function Score simply includes self-reported ability to walk (50 points) and 
climb stairs (50 points). Deductions are made if the patient uses a cane or a crutch. Low scores 
indicate low levels of physical function.    
3.2.4.4 Continuous-Scale Physical Functional Performance 10-Item Test. The 
Continuous-Scale Physical Functional Performance 10-item Test (CS-PFP10) is a valid, 
reliable, and sensitive measure of physical function16, 25. This test is a performance-based 
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functional test battery in which tasks are derived from ordinary ADL. The protocol requires the 
participant to perform a variety of ADL progressing from low effort to high effort in a 
standardized fashion. It includes items such as carrying groceries, stair climbing, sweeping, etc. 
The tasks are scored on a continuous scale based on time, weight, or distance. The CS-PFP10 
scores the tasks in five functional fitness domains including upper body strength, upper body 
flexibility, lower body strength, balance and coordination, and endurance, as well as calculating 
a total physical function score. Scores range from 0 to 100 with higher scores representing better 
physical function.  
The CS-PFP10 has high test-retest reliability (r = 0.84-0.97) and it is more sensitive for 
measuring function than some traditional measures such as the SF-3616. The CS-PFP10 
discriminates between independent-living older adults and those with dependent-care needs16, 
280. Functional performance as measured by the CS-PFP10 has no known ceiling effect and it 
can be used as a predictor of independence level289. Other advantages of the CS-PFP10 include 
that scoring occurs on a continuous scale, and it is therefore applicable for linear statistical 
models. Furthermore, the CS-PFP10 provides the investigators with information about various 
aspects of physical fitness (e.g. lower body strength, muscular endurance, flexibility) as they 
contribute to physical function.   
3.2.5 Statistical Analyses 
All statistical analyses were conducted using the SPSS 11.0 (Chicago, IL). Before the 
analyses, tests for normality and univariate and multivariate outliers were conducted. 
Descriptive statistics were used to demonstrate the sample characteristics. To test the research 
hypothesis, partial correlation (controlling for age) was employed to examine the convergent 
validity of the CS-PFP10 in TKA candidates by comparing the CS-PFP10 subscales and total 
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functional score to the physical function scores of the WOMAC, the KSS, and the SF-36 
instruments at baseline (prior to surgery). 
3.3 Results 
 Sixty-eight participants met the inclusion criteria for participation in this study; however, 
after inspection of the data for univariate and multivariate outliers, we excluded four cases from 
the analysis. Another six participants were eliminated from the sample because of missing or 
incomplete data. Therefore, findings are presented for 58 patients who were candidates for TKA 
and elected to pursue a TKA surgery. The patient characteristics are described in Table 3.3 and 
table 3.4 contains the descriptive characteristics for all variables measured in this study. The age 
range of the study sample was 50 to 83 years (mean = 64.9±9.4). Seventy-four percent of the 
study sample were female (m = 18, f = 40) and the majority (70%) of this study sample were 
overweight or obese based on BMI. The mean values for the CS-PFP10 total score, WOMAC 
Total Score, WOMAC physical function, function score of the KSS, and SF-36 Physical 
Composite scores were 38.34±19.40, 60.51±14.41, 59.43±16.69, 39.74±15.87, and 27.17±6.41, 
respectively. 
Table 3.3 Patient Characteristics.  
 
 TKA patients 
n 58 (40 female, 18 male; 28 bilateral, 30 unilateral TKA patients ) 
 Mean ± Standard Deviation 
Age 64.93 ± 9.4 
Height (cm) 167.53 ± 9.81 
Weight (kg) 93.74 ± 16.83 
BMI 33.69 ± 6.64 
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Table 3.4. Descriptive Characteristics, n = 58. 
Instrument/subscore Mean ± Standard Deviation 
CS-PFP10  UBS 39.64±21.89 
CS-PFP10  UBF 61.18±18.71 
CS-PFP10  LBS 27.54±16.73 
CS-PFP10  BAL 36.03±18.99 
CS-PFP10  END 35.08±18.59 
CS-PFP10  Total 38.34±19.40 
WOMAC Pain 60.25±16.99 
WOMAC Stiffness 61.85±16.46 
WOMAC PF 59.43±16.69 
WOMAC Total 60.51±14.41 
KSS Knee Score 33.86±18.37 
KSS Function Score 39.74±15.87 
SF-36 PF 18.45±17.87 
SF-36 RP 25.43±23.09 
SF-36 BP 22.71±13.94 
SF-36 GH 61.31±19.70 
SF-36 VT 39.98±20.44 
SF-36 SF 46.55±27.18 
SF-36 RE 52.58±33.52 
SF-36 MH 64.65±21.94 
SF-36 MCS 44.65±13.74 
SF-36 PCS 27.17±6.41 
 
 
 
 
 
 
 
 
 
CS-PFP10= Continuous Scale Physical Functional Performance 
UBS = upper body strength score  
BAL = balance and coordination score 
UBF = upper body flexibility score  
END = endurance score 
LBS = lower body strength score    
CS-PFP10 Total = total function score 
KSS = Knee Society Score 
WOMAC Total = WOMAC Total score 
PF = SF-36 physical function score   
RP = SF-36 role physical score 
BP = SF-36 bodily pain score   
GH = SF-36 general health score 
VT = SF-36 vitality score    
SF = SF-36 social function score 
RE = SF-36 role emotional score   
MH = SF-36 mental health score 
MCS = SF-36 mental component summary  
PCS = SF-36 physical component summary 
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Pearsons product-moment correlation was employed to examine associations among 
variables and indicated a significant relationship between age and functional measures. All 
subscales and the total score of the CSPFP-10 had significant associations with age (r = -0.315 
to 0.438, p≤0.05) Therefore, age was included as a covariate in deriving partial correlation 
coefficients to describe that associations among CS-PFP10 scores and the other outcomes. The 
results of the partial correlation are located in table (3.5).  
There were numerous associations between CS-PFP10 subscales and total score with other 
functional outcomes including the total and physical function subscales of the WOMAC and the 
KSS. Correlation between the CS-PFP10 and the WOMAC scores were moderate290 (WOMAC 
Total Score: r = -0.36; p =.006; and WOMAC Physical Function-score: r = -0.598; p<.001, 
respectively). The CS-PFP10 total score also correlated with the KSS Knee Score (r =.474, p 
<.001) and the KSS Function Score (r=.513, p<.001).  
Weak associations were detected between the CS-PFP10 and the SF-36 physical function 
subscales, (r = 0.364, p = .005) and with some of the other SF-36 subscales. Interestingly, the 
CS-PFP10 correlated with several sub-components/sub-scores of the SF-36 including 
components that measured social and emotional well being. These items that positively 
correlated with the CS-PFP10 included the vitality (r = .465, p < .001), role physical (r = .340, p 
= .049), social functioning (r = .4714, p < .001), and role emotional (r = .522, p < .001) 
components of the SF-36 questionnaire, as well as the mental composite score (r = 0.501, p < 
.001) of the SF-36.   
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3.4 Discussion 
The aim of this study was to examine the convergent validity of the CS-PFP10 test in uni- and 
bilateral TKA candidates by comparing the CS-PFP10 to accepted measures of physical function in 
this population (WOMAC, KSS, and the SF-36 physical function scores). Seventy-four percent of 
the study patients were female, which is consistent with the general OA population , that is believed 
to be up to 75% female62, 291. Furthermore, the majority of the study patients were obese, which is 
also a typical characteristic of the knee OA patient population because overweight individuals tend 
have a high prevalence of knee OA74.  Lastly, the age range of the study sample is reasonable given 
the ages at which the incidence and prevalence of OA of the knee rises and peaks58, 74.  
The scores obtained from this study correspond with the scores in other studies that have 
utilized the same instruments in OA patients. For example, the WOMAC Scores in this study were 
similar to those obtained in a large study (n = 862) of OA patients by Lingard et al. in 2001 and 
2004 with WOMAC Physical Function Scores of 46.4±18.5 and 42.3±19, respectively.  
Furthermore, in 2005, Coleman et al.292 reported almost identical WOMAC Total Scores of 56.6 in 
comparison to the mean WOMAC Total Scores in our study (56.4). In addition, the SF-36 Physical 
Function Scores in this study were similar to other studies examining knee OA patients or TKA 
candidates. Lingard reported SF-36 Physical Function scores of 27.4±20.1 and 24.4±20.2 in 2001 
and 2004, respectively, which compare well with the average SF-36 PF scores in our study 
(20.28±18.20). Finally, the KSS scores in our study sample were similar to those of reported by 
Bullens et al. and Lingard et al11, 252.   
The CS-PFP10 scores from this study were similar to those in comparison with the data from 
Cress and Meyers study in 2003280. The mean value for the study sample fell in between the mean 
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CS-PFP scores for the independent (mean 46.3±16) and dependent (mean 25.7±10) congregate care 
facility residents in Cress and Meyers study.  The range of values in this study (6.71-81.30) was 
also similar to the range of values of the above two groups in Cress and Meyers study (7.0-82.3)280. 
To our knowledge, however, this is the only study that has utilized the CS-PFP10 instrument 
simultaneously with the KSS, WOMAC, and SF-36 in this population.   
Consistent with our hypothesis, the findings from this study reveal several significant 
associations between the CS-PFP10 test scores and the other assessment tools. In particular, the CS-
PFP10 total scores were associated with the KSS knee and knee function scores, the WOMAC 
physical function and total scores, as well as several SF-36 scores including physical function. 
Moreover, the domains scores for the CS-PFP10 (upper body strength, upper body flexibility, lower 
body flexibility, balance/coordination, and endurance) correlated significantly with numerous 
functional indicators.  
The present findings show, that the CS-PFP10 in fact is a valuable tool in measuring physical 
function in these patients and confirms the convergent validity of the CS-PFP10 test in this patient 
population. To our knowledge, these are the first published data regarding the validation of the test 
in this patient population.   
The PFP 10 scores were highly correlated with age, whereas the WOMAC and the KSS scores 
were not in this study sample. The WOMAC, especially the physical function score of WOMAC, 
generally correlates with age293-295. Further, the KSS scores are also found to negatively correlate 
with increasing age (p<0.001)296.  
There were limitations of this study, some of which were imposed by the study design. As a 
result of the number of instruments, many patients expressed dissatisfaction with the amount of time 
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required for testing. In addition, having expressed dissatisfaction with too many 
questionnaires/questions, some of the patients indicated that they would be unwilling to participate 
in future follow-up studies. This study is also somewhat limited by its small sample size. However, 
with the number of nature of significant associations, the inferences of the present investigation do 
not appear to be influenced by an inability to reject the null hypothesis. The existence of significant 
positive associations, in spite of the small sample size, is somewhat impressive.   
Clearly, there are limitations to all of the instruments used in the study, hence the premise of this 
study. Using measures that rely on at least in part subjective appraisals of function as a basis for 
comparison (as is the case with the KSS, WOMAC, and SF-36) allow us to make inferences about 
the convergent validity of the CS-PFP10, which is a type of criterion-related validity. As with all 
function measures, the lack of a true criterion always imposes some limitation to the generalizability 
of the data. 
While it is impossible to say that the CS-PFP10 is a better estimate of function that the other 
measures, there are numerous advantages of objective assessments that make the CS-PFP10 
attractive. One important strength of objective assessments is that they are often more sensitive to 
change than subjective instruments. Future investigations should compare the sensitivity of the CS-
PFP10 to the other commonly accepted measures so that investigators might be able to employ the 
most sensitive tools in their clinical outcomes investigations. Furthermore, these findings might be 
helpful for clinicians and researchers in choosing the appropriate method for measuring physical 
function in their respective patient populations. Furthermore, the CS-PFP10 gives us information on 
variety of fitness domains and is able to point out possible weaknesses of the patients, which the 
other tests do not. The knowledge gained from the CS-PFP10 test may help clinicians in 
determining appropriate rehabilitation protocols for patients.   
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3.5 Conclusion 
The data support our hypothesis that the CS-PFP10 scores would be associated with the scores 
from the other instruments.  This finding is important insofar as it suggests that there is convergent 
validity of the CS-PFP10 for use in the TKA population. As such, it appears that this instrument is 
capturing the information gained from the other widely accepted outcome measures in the TKA 
patient population.   
The associations between the CS-PFP10 and other functional measures demonstrate that the CS-
PFP10 test is a useful and valid measure for quantifying physical function in TKA patients. 
Information gathered from this study may provide valuable applications for the CS-PFP10 including 
physical function research, intervention strategies, and program outcome. Continued examination of 
the CS-PFP10 and other outcomes measurement tools may provide insight into choice of functional 
assessment instruments when working with OA patients. 
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CHAPTER 4 
STUDY 2: PHYSICAL FUNCTION IN TKA PATIENTS 
Knee osteoarthritis (OA) patients suffer from pain, loss of mobility in joints, muscle weakness, 
and atrophy as a result of the condition, which all contribute to severe functional limitations in basic 
and instrumental activities of daily living (ADL)9, 10. Thus, OA of the knee causes more functional 
limitations and disability than any other disease affecting the quality of life of thousands of older 
adults5, 6. As a result of the negative effects of OA, total knee arthroplasty (TKA) may be required, 
and is often the only effective treatment in reducing joint pain, improving knee function and quality 
of life in patients with severe knee osteoarthritis (OA)11. In order to evaluate the return of physical 
function and functional independence following TKA, outcomes instruments such as the Western 
Ontario and McMaster Universities Osteoarthritis index (WOMAC)12, 13, the Knee Society Clinical 
Rating System (KSS)14 and Short Form Health Survey (SF-36)15 have frequently been utilized. 
While the WOMAC and the SF-36 are patient self-report measures, in which the outcome 
assessment focuses on the perspective of the patient, the KSS includes self-report and clinician 
based assessments.  
Thus, the KSS is a dual rating system and seems to have an advantage as a more well-rounded 
outcomes tool when compared to the self-report WOMAC and the SF-3614, 297.  The KSS includes 
both self-report outcomes and clinician measured appraisals of stability, range of motion, and knee 
alignment in the assessment, thus reflecting both the patient and physicians perspectives. While the 
KSS is widely accepted outcomes instrument in OA and TKA patients, it can be argued that the 
clinical variables measured with the KSS may be better indicators of impairment rather than 
functional ability. Furthermore, the validity and responsiveness of the KSS has been questioned by 
some authors, and it has been suggested to be more sensitive to inter-observer bias than, for 
example, the WOMAC252, 263.   
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In the recent years, the development of universally applicable objective measures of physical 
function has gained attention of scientists and clinicians because of the known limitations that the 
currently utilized measures may have in measuring physical function20, 21, 297. These known 
limitations are those often associated with self-report tools and includes possible floor and ceiling 
effects and lack of sensitivity to change. Discrepancies between perception and actual ability may 
cause further limitations when using self-report measures16-19 and they are also subject to errors in 
judgment or memory.  Furthermore, self-report measures are impacted by some psychosocial 
parameters such as depression and fatigue20 and have been linked to dispositional optimism23, 24 
suggesting that responses may also be impacted by a personality trait of dispositional optimism.   
Dispositional optimism, considered a stable personality trait over time, can be defined as global 
positive outcome expectancies and may have an effect on self-reported outcomes298, 299. Thus, self-
reported functional measures may not reflect accurate changes in function, which further 
emphasizes the importance of using alternative outcomes instruments in intervention studies. Most 
clinicians would also agree that it would be beneficial if the approach in measuring clinical 
outcomes would be standardized, which would offer investigators the advantage of making 
comparisons across studies297.  
Nevertheless, it is imperative to continue to identify and improve quantifiable measures of 
function that mirror the ability of the person to carry out ADLs in TKA patients so that clinicians 
and scientists can evaluate different treatment outcomes with greater sensitivity and gain 
information regarding other factors as well. Thus, performance-based tests may be a solution at 
providing information about the patients functional status and future disability and mortality.  
Furthermore, performance-based tests are thought to be a good demonstration of how well or poorly 
similar tasks are managed at home, and they may be better suited for between-subject comparisons 
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than self-report because the basis of comparison is the same22. Further benefits of using 
performance-based tests include that the information obtained may present an opportunity for 
patients to learn that their actual ability may be different from their perceived ability to execute 
ADLs16.  
Therefore, regardless of their established reliability and validity, investigators should consider 
the limitations of the traditionally employed function scales and critical evaluation is needed to 
prospectively examine the utility of the current instruments and performance based measures of 
function.  
4.1 Specific Aims and Hypotheses 
 The primary purpose of this study was to examine the return of function and sensitivity of the 
CS-PFP10 to change in TKA patients from baseline (pre-surgery) to follow-up (3 wks, 6 wks, and 
12 wks) by comparing effect sizes of observations.  
 The hypotheses of this investigation included that: the CS-PFP10 would detect functional 
changes in TKA patients and that the effect sizes from week 3 to week 6 post-surgery would be 
greatest for the CS-PFP10 and the KSS compared to the WOMAC Physical Function, the SF-36 
Physical Function (PF) subscale, and the SF-36 Physical Component Summary Score (PCS). 
Finally, we hypothesized that improvements in CS-PFP10 (i.e. objective physical function measure) 
in TKA patients would be independent of dispositional optimism, as measured with the Life 
Orientation Test (Revised), but the subjective measures of physical function would not.  
4.2 Method   
4.2.1 Participants   
Data were collected from a study in which we have a total of 68 patients enrolled currently. The 
data collection is ongoing, and we have several patients whom we have collected data on visit 1 and 
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2 (pre-op and 3 wks post), but not yet on visits 3 and 4 (6 and 12 weeks post-operatively). We were 
able to gather data on n =17 patients with data on 4 observations (repeated; pre-operative , 3wks 
post-operative, 6wks post-operative, and 12 wks post-operative). In addition, data were collected on 
n = 30 participants for whom 3 observations were available.  Patients who were candidates for TKA 
and between the ages of 50-85 were invited to participate in this study. These participants were 
recruited from one orthopaedic clinic with two participating surgeons. TKA candidacy was 
determined by the examining physician based on several factors including (but not limited to) 
impaired quality of life, severe knee pain and stiffness that limits the patients daily activities, 
limited function or mobility, knee deformity, and failure to obtain pain relief from previous 
treatment methods.  
Prior to enrollment in the study, all candidates received a medical evaluation, which included 
screening for inclusion and exclusion criteria (see Chapter 3, tables 3.1 and 3.2). Inclusion criteria 
consisted of TKA candidates who were electing to pursue TKA, and who were otherwise apparently 
healthy or had a diagnosis of stable heart disease (AHA Classes A and B and C-stable). Candidates 
in American Heart Association Class D (i.e., symptoms of cardiovascular and/or metabolic disease 
at rest) were excluded from the study287. Patients with active infection, immunosuppressive 
disorders, collateral ligament insufficiency (grade 3), posterior cruciate ligament insufficiency 
(grade two or more), drug or alcohol abuse, serious mental illness, or general neurological 
conditions such as Parkinson, Multiple Sclerosis, were also excluded from the study.  
4.2.2 Design 
 A prospective cohort, pretest-posttest/time-series design was used to test the hypotheses. We 
simultaneously examined the return to function in patients undergoing simultaneous bilateral TKA 
or unilateral TKA using the WOMAC, KSS, SF-36, and CS-PFP10 prior to, 3 weeks, 6 weeks, and 
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12 weeks after surgery. Data were collected in a single location (The American Musculoskeletal 
Research Institute or AMRI) in Alexandria, LA. Two supporting physicians, Drs. David Pope and 
Jeffrey Garrison agreed to support the data collection procedures and to provide the investigators 
with the TKA patients.  
4.2.3 Procedures   
The study and all procedures were approved by the Institutional Review Board of Louisiana 
State University (see Appendix B) and are described here in more detail. All patients whom agreed 
to participate in the study, signed an informed consent form, and subsequently received a medical 
examination by one of the participating clinicians. In conjunction with the medical evaluation, the 
KSS assessment was conducted. The clinicians were trained in obtaining the KSS clinical 
measurements and followed the KSS assessment protocol. Immediately following this evaluation, 
TKA candidates who passed the inclusion/exclusion criteria and consented to participating in the 
study completed the SF-36, WOMAC, and LOT-R self-report questionnaires. Participants were then 
asked to execute the CS-PFP10 test according to the test protocol. The questionnaires were provided 
to the patient by one of two research administrators, whom then collected the questionnaires 
immediately after completion. The same research administrator also conducted the CS-PFP10 test 
following the standardized protocol. Heart rate and blood pressure were measured before testing, 
and ratings of perceived exertion were obtained following the CS-PFP10 testing. In addition, the 
participant was instructed to communicate any symptoms of chest pain, dizziness, nausea, fatigue, 
or any other abnormal responses to the test administrator. The CS-PFP10 sessions were conducted 
by trained CS-PFP10 technician at a facility, which had on-site medical support teams equipped to 
respond in the event of an emergency.  
Each research testing session took approximately 1.5 hour with the CS-PFP10 taking 
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approximately 45 minutes and the questionnaires taking about 30-45 min. Knee replacements were 
performed by one of two surgeons (in unilateral TKA) or both surgeons simultaneously (in bilateral 
TKA), within three weeks of the initial/baseline functional testing. All knee compartments were re-
surfaced to accomplish a traditional cemented TKA. All patients followed a standard protocol for 
postoperative rehabilitation.  
4.2.4 Instruments  
 Physical function was simultaneously measured in the study sample by four instruments: 1) the 
Western Ontario and MacMaster University Index (WOMAC), 2) Knee Society Clinical Rating 
System (KSS), 3) the Short Form 36 (SF-36) and 4) the Continuous Scale Physical Function 
Performance tests (CS-PFP10). Furthermore, we measured dispositional optimism with the revised 
Life Orientation Test (LOT-R). A brief description of the functional measurements is provided 
below as these have been previously described in chapter 3. 
 4.2.4.1 Western Ontario and McMaster Universities OA Index. The Western Ontario and 
McMaster Universities Osteoarthritis index (WOMAC) is a self-administered health questionnaire 
specifically designed for patients with osteoarthritis of the knee or the hip.  The WOMAC has 24-
items and includes three categories intended to measure pain, disability and joint stiffness, and 
physical function. The questions are commonly scored on a 5-point Likert scale and the scores are 
summed for each category. The WOMAC scores express the amount of difficulty or disability so 
that higher the score, the greater the level of disability. The WOMAC is widely used in the 
assessment of patients with hip or knee arthritis and is well validated12, 13, 252, 288. It has shown to be 
a reliable assessment and more responsive tool in measuring the outcome of joint replacement when 
compared to SF-36252. The WOMAC is requires a license for use and can be obtained by contacting 
the author via www.womac.org. 
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 4.2.4.2 36-Item Short Form.  The 36-item short form (SF-36) is the most widely used generic 
health-survey in clinical populations and has been used in thousands of clinical studies253. The SF-
36 is a 36-item survey designed for use in clinical practice and research to measure self-reported 
health-related quality of life (HRQL). The SF-36 is designed to measure eight health concepts: (1) 
limitations in physical activities, (2) limitations in social activities, (3) limitations in usual role 
activities, (4) pain, (5) general mental health, (6) limitations because of emotional problems, (7) 
energy and fatigue (vitality), and (8) general health perceptions248. These health concepts contribute 
to two sub-scores: the physical component score (PCS) and mental component score (MCS). More 
specifically, the Physical Functioning (PF), Role-Physical (RP), and Bodily Pain (BP) scores factor 
in to the Physical Component Summary (PCS) and the mental health (MH) and role-emotional (RE) 
scores contribute to the Mental Component Summary (MCS). Vitality (VT), general health (GH), 
and social functioning (SF) contribute to both summary scores249.  The SF-36 questionnaire also 
requires a license for use and can be obtained by contacting www.sf-36.org or 
www.qualitymetric.com. 
 4.2.4.3 Knee Society Clinical Rating System.  The Knee Society Clinical Rating System 
(KSS) is a dual rating system commonly used in both research and clinical practice in OA and total 
knee replacement patients. It includes two separate scores, the knee score and function score, and 
includes both self-reported and objective clinical measures. The knee score consists of pain, 
stability, and range of motion (ROM), and the function score consists of patient self-reported 
function.  
A maximum score of up to 100 points in the Knee Score of the KSS is possible and consists of 
self-reported pain (50 points) and clinician measured ROM (25 points) and stability (25 points). For 
the ROM score, the maximum score (25 points) for arc of movement is achieved at 125° of arc. The 
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KSS Function Score is based on patients self-reported ability to walk and to climb stairs, in which 
a use of an assistive device such as a cane or a crutch will lower the score. High scores indicate high 
levels of physical function.    
4.2.4.4 Continuous-Scale Physical Functional Performance 10-Item Test. The Continuous-
Scale Physical Functional Performance 10-item Test (CS-PFP10) is a validated, reliable, and 
sensitive measure of physical function commonly used in older adults16, 25. The CS-PFP10 consists 
of tasks based on ADL and reflects performance based physical function. The test entails that the 
participant perform a variety of ADL progressing from low effort to high effort in a standardized 
method. The tasks, such as carrying groceries, stair climbing, and sweeping, are scored on a 
continuous scale based on time, weight, or distance. Scores range from 0 to 100 with higher scores 
representing better physical function.  
 The CS-PFP10 provides a total physical function score as well as valuable information on five 
functional fitness domains including upper body strength, upper body flexibility, lower body 
strength, balance and coordination, and endurance. In older adults, the CS-PFP10 is able to 
differentiate independent-living from those with dependent-care needs based on their functional 
scores and the scores can be used as predictors for level of independence16, 280, 289. The CS-PFP10 is 
highly reliable and more sensitive in measuring function when compared to some traditional 
measures such as the SF-3616. Finally, the CS-PFP10 is applicable for linear statistical models as it 
is scored on a continuous scale. More specific description of the CS-PFP10 laboratory and testing 
set-up and lisence can be found at the official CS-PFP10 web-site at: http://www.coe.uga.edu/cs-
pfp/overview.html.  
4.2.4.5 Life Orientation Test-Revised. The Life Orientation Test-Revised (LOT-R)300 is a 
widely used 10-item self-report measure of dispositional optimism. Dispositional optimism can be 
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defined as expectations that good things, instead of bad things, will occur298, 299. The LOT-R 
includes six main items, which are scored on a Likert-scale. The remaining four items are not 
included in scoring and used to obscure the intent of this scale. The six main items are evenly 
divided between negatively- and positively-worded items. Participants indicate their degree of 
agreement with statements such as, "In uncertain times, I usually expect the best," using a response 
scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). Negatively worded items are 
reversed, and a single score is obtained. Total scores ranges from 0 to 24 with higher scores 
indicating greater optimism and low scores suggesting pessimistic life orientation. Internal 
consistency of LOT-R total score is estimated at .82 (Cronbachs alpha) and test-retest reliability is 
adequate (r= .79)300. Scheier and colleagues reported only modest correlations between the LOT-R 
and measures of neuroticism, self-esteem and trait anxiety (range r = -.35 to r = .54) suggesting 
convergent and discriminant validity of responses to the LOT-R and that LOT-R responses measure 
a construct distinct from established personality traits300. The LOT-R has been used extensively in 
studies of stress, with college students and with people going through stressful events, such as 
medical populations facing or recovering from serious diseases or treatments298-301.  
4.2.5 Statistical Analyses 
Before the analyses, tests for normality and univariate and multivariate outliers were conducted. 
Descriptive statistics are included in table 4.4. Because the outcomes of subjective/self-report 
measures may be affected by general outlook or orientation in life, we controlled for dispositional 
optimism by using the LOT-R score as a covariate in the analyses. To examine the change in 
function over time in TKA patients, repeated measures analysis of covariance (ANCOVA) with 4 
observations (repeated) was employed with baseline LOT-R score as the covariate on n =17 
patients. The four observations were pre-operative, 3wks post-operative, 6wks post-operative, and 
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12 wks post-operative. In addition, repeated measures ANCOVAs were performed on n =30 
participants for whom 3 observations were available. Least square difference (LSD) pair-wise 
comparisons were employed to further describe changes in functional scores the four observations. 
To examine sensitivity to change of the CS-PFP10, KSS, WOMAC, and SF-36 tests, we derived 
effect sizes between observations (baseline, 3wks, 6wks, 12 wks) as according to the computation 
of Cohen's d (where a positive effect size represents improvement). This approach suggests that the 
effect size is equal to mean score of post test subtracted from mean score of pretest divided by the 
overall pooled standard deviation (d = M1 - M2 / σ where σ = √ [∑ (X - M)² / N] where X is the raw 
score, M is the mean, and N is the number of cases).In all cases we will set the Type I error rate at 
0.05.  
4.3 Results 
Findings are presented for n =30 TKA patients, who were observed before, 3 weeks, and 6 
weeks after surgery, 17 of whom (n=17) who were followed for 12 weeks. The patient 
characteristics are described in Table 4.1.  
Table 4.1 Patient Characteristics.  
 
TKA  female, male 
n=30 (obs1,2,3) 
n=17 (obs 1,2,3,4) 
 23 female, 7 male 
 14 female, 3 male 
 Mean ± Standard Deviation 
Age 66.60 ± 9.93 
Height (cm) 166.73 ± 8.00 
Weight (kg) 93.25 ± 16.02 
BMI 33.69 ± 6.26 
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Repeated measures ANOVA consistently revealed main effects of time on all functional 
measures, regardless of whether using three or four observations. However, including LOT-R as a 
covariate in the analyses reduced the statistical power, resulting in no significant main effects of 
time. Because of the significant main effects of the ANOVAS, and the poor power with the 
ANCOVAS, we elected to perform follow-up LSD pair-wise comparisons. With respect to CS-
PFP10,  significant changes from baseline to 3 weeks, between 3 and 6 weeks post-op, and a further 
change from 6 weeks to 12 weeks post-op, F (3,51) = 19.59, p<0.001, were detected.  
 However, baseline and 6-wk scores were not significantly different. Figures 4.1 and 4.2 
illustrate the changes in total CS-PFP10 scores over the course of the study. A somewhat 
unexpected finding was the initial drop after surgery (at 3 wks post) in physical function below 
baseline (pre-op) levels, detected by the CS-PFP10 at 3-weeks after surgery.  
          
Figures 4.1 and 4.2 CS-PFP10 Scores in TKA patients 
(n=30 and n=17, respectively). 
The bars that share a different letter, are different from each other (p<0.05). 
 
Pair wise comparisons also reveal a general improvement in KSS function scores over 3 
observations (n=30) and over 4 observations (n=17) (figures 4.3 and 4.4). The mean score for KSS 
Function at baseline was 39.57±15.07 and significant improvements in scores were detected 
between 3 weeks and 6 wks post-operatively (ES=0.81), baseline (pre-op) and 6 weeks and 12 
 A     B                    A       A              B              A              C 
  
  
 
113 
 
 
 
weeks after surgery (ES=0.62 and 1.29, respectively), F (3,51) = 20.9, p<0.001.  The Largest effect 
in KSS Function was detected between 3 weeks and 12 weeks post-TKA with an ES of 1.56. 
However, there were no significant differences between baseline and 3 weeks post-op. 
 
Figures 4.3 and 4.4 KSS Function Scores in TKA patients (n=30 and n=17, respectively). 
The bars that share a different letter, are different from each other (p<0.05). 
 
 Pair wise comparisons reveal that the SF-36 Physical Function scores improved from before 
TKA to 3, 6, and 12-week follow-up scores, and between 3weeks, 6 weeks, and 12 weeks as well, F 
(3,51) = 14.59, p<0.05 (Table 4.1 and Figures 4.5 and 4.6). Largest improvements in SF-36 PF 
scores were noted between the baseline SF-36 scores and 12 weeks post-operatively with an ES of 
1.51.               
 
Figures 4.5 and 4.6 SF-36 Physical Function Scores in TKA patients (n=30 and n=17, 
respectively).The bars that share a different letter, are different from each other (p<0.05). 
   A            A                         B    A      B                 C          D  
 A                             A                   B    A                A                B               C 
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SF-36 Physical Composite Score (PCS) also demonstrated similar gradual improvement from 
baseline (pre-op) to 12-weeks after TKA, F (3,48) = 10.21, p<0.001, (figures 4.7 and 4.8). 
However, the baseline (pre-op) values were different from 6-and 12-week scores, but not 3-week 
scores. There were significant differences between 3 and 6-weeks, as well as between 3- and 12-
weeks (see table 4.1 and figures 4.7 and 4.8).   
 
Figures 4.7 and 4.8 SF-36 PCS Scores in TKA patients (n=30 and n=17, respectively). 
The bars that share a different letter, are different from each other (p<0.05). 
 
With respect to WOMAC, pair wise comparisons indicate that the patients reported significant 
improvement in physical function (demonstrated as reductions in WOMAC physical function 
scores) from pre-operative observation to all post-operative observations (3 weeks, 6weeks, and 12 
weeks following surgery) with the greatest ES between baseline (pre-operative observation) and 12 
weeks post-operative observation (ES=2.03), F (3,51) = 23.08, p<0.05. The effect sizes for change 
in function from baseline to 3 weeks, 6 weeks to 12 weeks, and from baseline to 6 and 12 weeks are 
presented in table 4.1.    
 A                          A                       B  A                A                 B                 B 
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Figures 4.9 and 4.10 WOMAC Physical Function Scores in TKA patients (n=30 and n=17, 
respectively). 
The bars that share a different letter, are different from each other (p<0.05). 
 
The ANCOVAS revealed no significant time by LOT-R interactions on any functional 
indicators. The average LOT-R score at baseline (pre-op) was 17.77±4.64, and there were no 
change (p<0.05) in the LOT-R scores between any of the four observations over time (pre-op, 
3wks, 6wks, and 12 wks post-op). Furthermore, there were no significant associations between the 
LOT-R scores (at baseline) and the functional measures (CS-PFP10 total, KSS function, WOMAC 
function, SF-36 physical function, or SF-36 physical composite score).  
4.4 Discussion 
The purpose of this study was to test the hypotheses that physical function will improve over 
time and that effect sizes would be stronger with KSS and CS-PFP10 when compared to WOMAC 
and SF-36. The characteristics of the current studys population, of which 75% were female, were 
consistent with the general OA population demographics62, 291. Furthermore, the majority of the 
study patients were either overweight or obese, with an average BMI of 33.69±6.25 (range 22.88 to 
47.93), which corresponds with the typical knee OA patient as obesity is a major contributor to the 
high prevalence of condition74.  Lastly, the age range of the study sample is similar to the age at  
  A       B                       B    A   B                B                 C 
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which knee OA is most likely to peak58, 74. 
The scores of physical function were as expected as measured by the KSS, WOMAC, and 
the SF-36. The mean CS-PFP10 score from the current study fell in between the mean CS-PFP 
scores for the independent (mean 46.3±16) and dependent (mean 25.7±10) congregate care 
facility residents in Cress and Meyers study in 2003280. The range of values in the current study 
(6.71-81.30) was also very similar to the range of CS-PFP10 values in Cress and Meyers study 
(7.0-82.3)280. It is reported though that majority of older adults over the age of 60 have some 
degree of OA. To our knowledge, there is only one study that has implemented the CS-PFP10 
test in TKA patient population282. 
The CS-PFP10 scores in the current study were lower than those reported in the one study 
that has utilized the CS-PFP10 in the TKA population282. Petrellas study design varied in 
comparison to the current study in at least the recruitment approach of the patients. We recruited 
all consecutive TKA candidates who qualified for the study (based on the inclusion and 
exclusion criteria) in a clinic setting with the help of the participating physicians. In Petrellas 
study, recruitment was conducted via mail outs, which may have resulted in different 
demographic and functional characteristics of the patients volunteering to participate. In our 
study, at baseline (pre-op), many patients had low level of physical function and well below the 
threshold of functional level of independence (as defined by Cress & Meyer280). Thus, these low 
functioning patients may have not been as likely to respond to a mail out compared to 
recruitment in clinic setting, because of the extra burden and effort it would have required them 
to go for functional testing.  
Furthermore, in the current study, functional testing was coordinated so that it was 
conducted the same day, time, and at the same location, than the participants doctors 
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appointment, thus further lessening the burden on the patient. Therefore, we speculate/suggest 
that there may have been a selection bias in Petrellas study to select out the least functional 
patients from their study sample. As a result of the approach to recruitment in the current study, 
we may have captured a more complete representation of the TKA candidates including the 
poorest functioning patients.  Furthermore, especially at 3 wks post, when the patients were at 
very low levels of function and were experiencing high levels of pain, swelling, and fatigue as a 
result of the TKA surgery, it would have been very difficult to get these patients to come in if it 
wasnt for the doctors appointment they had to come.  
The results from this study are similar to studies that have utilized the same outcome 
instruments in end stage OA patients/TKA candidates. The WOMAC Scores in this study were 
similar to those obtained in a large study (n = 862) of OA patients by Lingard et al. in 2001 and 
2004 with baseline WOMAC Physical Function Scores of 46.4±18.5 and 42.3±19, respectively. 
Lingard et al.s study did not, however, report any follow-up observations until 12 months after 
TKA.  Furthermore, almost identical WOMAC Total Scores of 56.6 were reported by Coleman 
et al. in comparison to the mean WOMAC Total Scores in our study (56.4) in 2005292. In 
addition, Lingard et al. reported SF-36 Physical Function scores very similar to ours 
(20.28±18.20) in 2001 and 2004220, 252. Finally, the baseline KSS scores in our study sample 
were similar to those of reported by Bullens et al. and Lingard et al11, 252.  Furthermore, Konig et 
al. reported similar KSS Function and Knee Scores at pre-op and at12-weeks following TKA 
when compared to the current study302. Lastly, the optimism/pessimism expressed as LOT-R 
scores were similar to the normative LOT-R scored reported by Scheier et al300. 
Consistent with our hypothesis, the ANOVAS and follow-up pairwise comparisons  
demonstrate a functional improvement over the12 weeks following TKA. In general, while the 
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results of the ANOVAS suggest main effects of time, however, there appear to be some 
differences in the direction of changes and the magnitude of effect sizes according to the 
functional outcome. Furthermore, the absence of a time by Life Orientation score interaction 
suggests no significant influence of dispositional optimism on the effect of time for this group of 
TKA patients. Furthermore, the CS-PFP10 demonstrated a largest ES between the early post-op 
period (from 3 weeks to 6 weeks post-op; ES=1.03). Effect sizes are generally considered as 
"small, d = .2," "medium, d = .5," and "large, d = .8"290. Unexpectedly, however, we observed 
an initial decrease in physical function at 3wks post-op as defined by scores on the CS-PFP10 
test. This unique finding gives us some insight on physical function (or limitations) in the 
immediate post-operative period following TKA, which is not well documented. Thus, the 3, 6- 
and 12-week follow-up data suggest that the CS-PFP10 is sensitive in detecting change in 
function over time, even among small groups of patients.   
Interestingly, none of the other measures detected the decline in function at 3 weeks after 
TKA. The SF-36 PF and WOMAC demonstrated a consistent increase from baseline to 12-
weeks post surgery. The differences in perceived physical function and performance based 
physical function are interesting. From these findings, one might hypothesize that the objective 
instrument was more inclined to detect the the decrement in performance because it is 
measuring true function, whereas psychological factors may have affected the subjective 
instruments. Thus, this difference in results with different instruments may be explained by the 
fact that the patients expected their function to incline as a result of TKA, which affected their 
perception of physical function. This data may also be an indication of the CS-PFP10 being a 
more sensitive measure of function when compared to the other instruments. 
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Figure 4.11 Physical Function Scores in TKA Patients  
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We tested these hypotheses by including LOT-R as a covariate. While this measure of 
dispositional optimism did not interact with time, the interaction term approached significance 
for the WOMAC scores (p = 0.16). This paired with power < 0.50 makes it difficult to rule out 
the possibility that optimism was in fact influence at least the WOMAC scores. Therefore, the 
possibility that the improvement in WOMAC scores are reflecting psychological benefits more 
so than actual functional improvements is worth of further investigation. 
Finally, we hypothesized that the effect sizes to detect change in function, in particular from 
weeks 3 to 6 post op, would be strongest for the CS-PFP10 and the KSS. The results of the 
study support this hypothesis. However, the PCS scores across 28 patients for whom three 
observations were available are at least as impressive. Further, the ES for the CS-PFP10 from 
weeks 3 to 12 post op, are the largest (ES=1.76). This reflects the instruments sensitivity to the 
initial drop in functional scores (at 3-weeks post) followed by incline, which the other 
    Pre-op    3 wks post          6 wks post           12 weeks post
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instruments failed to observe. These data in general support the inclusion of objective measures 
of function in evaluating the efficacy of TKA.  
Limitations of this study include non-randomized study design and lack of multi-center data. 
As with any non-randomized study design, selection bias is always a risk.  We tried minimizing 
selection bias by enrolling all consecutive patients whom consented to participation and fit the 
inclusion criteria. Further limitations of this study include a small sample size and a relatively 
short follow-up (12 weeks) after surgery.  Another limitation in the current study was that we 
had no control over the type and compliance of the post-operative rehabilitation, and what kind 
of contribution this had on return to function. Future studies should include a long-term follow-
up visits, such as 1- and 2-year follow-up, and a greater sample size. Strengths of the study 
include that it utilized both self-report and performance based, as well as clinician report 
outcomes instruments. This allows as non-biased view of the patients physical functional 
performance as possible.  
Thus, it appears that the CS-PFP10 can detect small changes in physical function and 
therefore could be applied to studies where change in function is an important consideration. 
Such applications include comparing the functional outcomes of different surgical approaches, 
implants, or rehabilitation protocols. Other more subjective or generic measures might be 
limited by floor and ceiling effects, whereas the CS-PFP10 might be able to give us information 
not limited by these effects. The clinical relevance of these findings is applicable in outcomes 
instrument selection. It may be reasoned that the CS-PFP10 used together with the KSS would 
give clinicians and researchers sensitive and well rounded information and reflect both 
performance based physical function as well as perceived physical function along with the 
clinical measures gained from the Knee Score of KSS. However, more research is needed to 
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confirm this observation.      
Finally, the data reveal that CS-PFP10 is sensitive to detect change particularly following 
the initial three to six weeks post-TKA. Furthermore, the other clinical assessments utilized in 
this study did not appear to be measuring small changes in function. Thus, it would be critical 
that clinicians and scientists use objective, performance-based instruments, such as the CS-
PFP10, to examine function, if detecting small changes in function is important, especially 
during the first 3 weeks following surgery. Thus, future research should focus on examining 
group differences, the early post-op period, and investigating predictors of physical function. 
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CHAPTER 5 
GENERAL DISCUSSION 
 
The general objective of this dissertation was to investigate physical function in 
osteoarthritis (OA) and total knee replacement (TKA) patients. Two studies were conducted to 
achieve this objective: 
• First, a validation study was performed to evaluate the validity of the CS-PFP10 test 
in OA patients (chapter 3, study 1). 
•  The second study was a 12-week prospective study (Chapter 4, study 2) 
investigating the return of physical function in TKA patients. We also examined the 
sensitivity of the CS-PFP10 test to change in TKA patients.  
Thus, the purposes of this final chapter are to (a) review the main results of both studies, (b) 
highlight strengths and limitations of the dissertation, (c) discuss the possible implications of 
this research, and (d) discuss future research. 
5.1 Summary of the Dissertation Studies 
5.1.1 Study 1: Validation Study 
The primary purpose of Study 1 (Chapter 3) was to examine the convergent validity of the 
CS-PFP10 test in a sample of patients with knee OA awaiting TKA. The CS-PFP10 scores were 
compared to the WOMAC, KSS, and the SF-36 physical function scores. The hypothesis of this 
investigation was that correlation analysis would reveal at least moderate associations between 
the CS-PFP10 test scores and the WOMAC, KSS, and SF-36 scores in TKA candidates. 
The results of this study indicated moderate association associations between the CS-PFP10 
and WOMAC physical function (r=.598, p<.001), the KSS Physical Function (r=.513, p<.001), 
and KSS Knee Scores (r =.474, p <.001) 290. Further, weak associations were found between the 
CS-PFP10 and SF-36 Physical Function, Physical Composite Score, and WOMAC total score. 
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The findings from this study show that the CS-PFP10 is a valid tool for measuring physical 
function in OA/TKA patients.  
5.1.2 Study 2: Prospective Study 
 The main purpose of study 2 was to investigate the return of function in TKA patients 
following surgery.  Further, sensitivity of the CS-PFP10 to change in TKA patients was 
examined. The hypotheses of this investigation included that the CS-PFP10 would be sensitive 
to functional changes in TKA patients and that the magnitude of effect sizes during the initial 
recovery period following surgery (between 3 and 6 weeks post-op) would be greatest for the 
CS-PFP10 and the KSS. Additionally, examining the extent of functional improvements in TKA 
patients following surgery was exploratory and the investigation was merely conducted to 
provide a basis for future research. Finally, we hypothesized that improvements in CS-PFP10 in 
TKA patients would not be affected by dispositional optimism, but the subjective measures of 
physical function would be.  
Consistent with our hypotheses, the results demonstrated a functional incline over the time 
course of the study. The effect sizes of the follow-up data suggest that the CS-PFP10 is sensitive 
in detecting change in function over time, even in a small group of patients. We also found an 
unexpected yet interesting finding, which indicated an initial drop in physical function 
immediately after surgery (3 weeks post). Furthermore, the only instrument that was able to 
show this decline was the CS-PFP10 test. The SF-36 PF and WOMAC demonstrated a 
consistent improvement in function from baseline to 12-weeks post surgery. These findings 
indicate that there are differences in perceived physical function and performance-based 
physical function. While the patients performance based function actually declined, the self-
reported function improved. This data may also be an indication of the CS-PFP10 being a more 
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sensitive measure of function when compared to the other instruments. 
5.2 Strength and Limitations of the Dissertation 
Although this dissertation improves upon the limitations of previous research, which 
commonly have utilized only self-reported outcome instruments, some limitations are still 
present. First, one of the major limitations of the dissertation studies includes the difficulty of 
recruiting participants, thus yielding a small sample size. In comparison, if the same study was 
conducted at a multi-center trial, a larger sample size would be possible along with a greater 
geographic variation in the study sample. Therefore, the generalizability of this data may be 
limited and larger studies are necessary to draw any firm conclusions.  
Further, the lack of a randomized study design always presents a selection bias, which we 
tried to minimize by recruiting all consecutive TKA candidates, who fit the inclusion criteria, in 
a clinic setting with the assistance of the physicians. This brings us to one of the strengths of the 
dissertation studies including the support from the participating clinic and physicians. This, we 
believe, was a crucial factor in being able to recruit a sample of patients whose functional levels 
ranged from very low to high. It is important to include the lowest functioning patients in 
research studies, so that we have a better understanding of the disability levels of the severe OA 
patients/TKA candidates.  If the patients would have been recruited by other means (such as 
mail-outs), it is likely that the lowest functioning patients would have been selected out simply 
because of their inability to come for testing sessions.  
Another limitation of these studies included long patient visits (1.5 hours/observation) 
putting a burden on the patient, and might effect the long-term participation rate. Thus, this must 
be taken into consideration in planning future studies by limiting the number of instruments 
used.  Yet, a variety of instruments utilized, including subjective and objective, and perception- 
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and performance-based measures of physical function, can also represent strength of the studies. 
By utilizing a variety of instruments, we ensured a well-rounded data set that included all 
important aspects of patients recovery.    
5.3 Implications of the Research 
It has been demonstrated that the CS-PFP10 is sensitive to changes in physical function, 
even in small study samples. Therefore, the CS-PFP10 could be utilized in future studies in 
which change in function is an important factor to assess such as when comparing the functional 
outcomes of different surgical approaches, implants, or rehabilitation protocols. Other 
measurement tools that are more subjective or generic might not be able to detect these changes 
and be limited by floor and ceiling effects. The clinical application of this information is 
important, as it may help researchers and physicians in choosing the appropriate tool in 
measuring outcomes. It may be reasoned that the ideal outcome instrument combination in 
studies when sensitivity of the instrument is important would include the CS-PFP10 and the 
KSS. This would allow clinicians and researchers to sensitively collect comprehensive 
information that reflects performance-based and perceived physical function along with the 
clinical measures gained from the Knee Score of KSS. However, more research is needed to 
confirm this observation.      
5.4 Future Research 
Future research should include the use of objective, performance-based instruments, such as 
the CS-PFP10, to examine function, when designing studies in which detecting small changes in 
function is important, especially during the first 3 weeks following surgery. Moreover, future 
research should focus on examining if group differences in performance-based physical function 
in this population exist, and whether activity levels of the patient affect the rate of functional 
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recovery following TKA. Additionally, investigating the effects of exercise interventions 
implemented before the TKA or following the initial standard physical therapy regimen on the 
functional abilities of patients would be interesting. Especially now that we have some 
indication of an instrument, that sensitively detects changes in physical function in the early 
post-op period, researchers should focus on what factors make a difference in terms of function 
early on in the recovery. Finally, investigating predictors of physical function in the TKA 
population would be a worthwhile effort for investigators. 
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APPENDIX A: KNEE SOCIETY CLINICAL RATING SYSTEM 
 
Patient Name____________________________________________ 
Date of Birth________________Date of Surgery_______________ 
 
BILATERAL       UNILATERAL 
 
Patient Reporting 
 
Thank you for taking the time to help us better understand how your knee problem affects your 
daily life.  
 
Please circle the answer that best describes your knee: 
 
1. How much pain do you have when you are walking? 
 
• None 
• Mild or Occasional 
• Moderate 
• Severe 
  
2. How much pain does your knee cause when going up and down stairs? 
 
• None 
• Mild or Occasional 
• Moderate 
• Severe 
 
3. How much pain does your knee cause when you are at rest?  
 
• None 
• Mild  
• Moderate 
• Severe 
 
4. How does your knee affect your walking ability? 
  
• I can walk unlimited distances. 
• I can walk 10-20 blocks. 
• I can walk 5-10 blocks. 
• I can walk 1-5 blocks. 
• I can walk less than one block. 
• I cannot walk at all. 
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5. How do you go up stairs? 
 
• I go up stairs normally one foot in front of the other. 
• I use the hand rail for balance. 
• I use the hand rail to pull myself up. 
• I cannot climb stairs. 
 
6. How do you go down stairs? 
 
• I go down stairs normally one foot in front of the other. 
• I use the hand rail for balance. 
• I use the hand rail to support myself. 
• I cannot come down stairs. 
 
7. How do you get out of a chair? 
 
• I get out of a chair normally without support. 
• I use the arm rests for balance. 
• I use the arm rests to push myself. 
• I cannot get out of a chair. 
 
8. What type of support do you use when walking? 
 
• None 
• Cane 
• 2 Canes 
• Crutches 
• Walker 
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Clinical Assessment 
 
 RIGHT      LEFT 
9. Range of Motion     Range of Motion 
 
______ Degrees    ______ Degrees 
  
10. Extension Lag    Extension Lag 
 
______ Degrees    ______ Degrees 
 
  
11. Flexion Contracture   Flexion Contracture 
 
______ Degrees    ______ Degrees 
  
12. Medial/Lateral Stability   Medial/Lateral Stability 
 
• 0-5 mm     0-5 mm 
• 5-10 mm     5-10 mm 
• >10 mm     >10 mm 
 
13. Anterior/Posterior Stability  Anterior/Posterior Stability 
 
• 0-5 mm     0-5 mm 
• 5-10 mm     5-10 mm 
• >10 mm     >10 mm 
 
14. Alignment     Alignment 
 
• ______ Degrees    ______ Degrees 
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APPPENDIX B. LIFE ORIENTATION TEST REVISED 
LOT-R  
Please be as honest and accurate as you can throughout.  Try not to let your response to one 
statement influence your responses to other statements.  There are no "correct" or "incorrect" 
answers.  Answer according to your own feelings, rather than how you think "most people" 
would answer.  
1. In uncertain times, I usually expect the best.  
 A = I agree a lot  
 B = I agree a little  
 C = I neither agree nor disagree  
 D = I Disagree a little  
 E = I Disagree a lot  
2.  It's easy for me to relax. 
 A = I agree a lot  
 B = I agree a little  
 C = I neither agree nor disagree  
 D = I Disagree a little  
 E = I Disagree a lot  
3. If something can go wrong for me, it will.  
 A = I agree a lot  
 B = I agree a little  
 C = I neither agree nor disagree  
 D = I Disagree a little  
 E = I Disagree a lot  
4.  I'm always optimistic about my future.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot 
 
5.  I enjoy my friends a lot. 
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
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D = I Disagree a little  
E = I Disagree a lot 
 
6.  It's important for me to keep busy.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot 
 
7.  I hardly ever expect things to go my way.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot 
 
8.  I don't get upset too easily.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot  
 
9.  I rarely count on good things happening to me.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot 
 
10.  Overall, I expect more good things to happen to me than bad.  
A = I agree a lot  
B = I agree a little  
C = I neither agree nor disagree  
D = I Disagree a little  
E = I Disagree a lot 
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34
67
2
54
.5
9
75
.9
4
37
.4
2
51
.3
3
51
.3
3
53
.6
6
. 
05
-0
26
   
15
7.
5 
74
.5
 
30
.0
3
74
2
55
.6
8
81
.5
9
35
.2
51
.4
51
.4
54
.5
6
. 
05
-0
27
   
18
0.
34
 
81
.8
2 
25
.1
6
57
1
88
.6
2
83
.9
5
74
.7
7
74
.2
4
72
.5
81
.3
. 
05
-0
28
   
15
8.
75
 
10
3.
64
 
41
.1
2
69
2
12
.3
7
58
.0
2
8.
71
13
.5
9
12
.1
9
16
.1
6
. 
05
-0
29
   
16
5.
1 
76
.3
6 
28
.0
1
65
2
22
.3
6
69
.7
1
10
.5
16
.5
6
15
20
.0
5
. 
05
-0
30
   
17
0.
18
 
12
5.
91
 
43
.4
75
36
44
1
77
.3
69
.8
8
44
.1
6
50
.4
51
.1
5
58
.4
3
. 
05
-0
31
   
16
5.
1 
10
7.
27
 
39
.3
53
57
62
2
0
40
.5
9
0
10
.1
5
9.
02
9.
02
. 
05
-0
32
   
18
2.
88
 
11
5.
91
 
34
.6
56
8
61
1
75
.6
1
81
.7
54
.0
2
66
.3
2
66
.1
2
70
.0
7
. 
05
-0
33
   
15
4.
94
 
82
.2
7 
34
.2
70
02
71
2
9.
28
40
.3
9
8.
59
12
.1
9
10
.7
9
13
.3
. 
05
-0
34
   
16
5.
1 
87
.2
7 
32
.0
16
28
71
2
49
.8
9
81
.6
6
42
.1
1
58
.3
3
57
.6
2
58
.6
3
. 
06
-0
36
   
15
4.
94
 
79
.5
 
33
.1
16
16
54
2
13
.5
4
49
.0
9
9.
18
16
.8
3
17
.1
17
.9
7
. 
06
-0
39
   
16
2.
6 
81
.8
 
30
.9
39
42
59
2
8.
88
20
.9
5.
95
11
.7
9
12
.9
11
.8
. 
06
-0
40
   
16
5.
1 
69
.1
 
25
.3
50
35
69
2
43
.2
6
70
.8
2
39
.4
3
56
.3
5
56
.1
1
55
.3
. 
A
PP
EN
D
IX
 C
: R
A
W
 D
A
TA
 
  
  
15
7  
  P
at
ie
nt
 
ID
 
H
ei
gh
t 
(c
m
) 
W
t (
kg
) 
B
M
I
A
ge
G
en
de
r
U
B
S
1
U
B
F1
LB
S
1
B
A
LC
O
R
1
E
N
D
U
R
1
P
FP
To
ta
l
U
B
S
2 
06
-0
41
   
17
5.
26
 
86
.3
6 
28
.1
15
58
73
2
16
.8
2
61
.9
3
10
.0
5
19
.9
18
.0
1
20
.6
9
. 
B
-0
01
   
 
16
0 
72
.7
 
28
.4
71
2
47
.0
4
76
.2
5
26
.3
2
45
.0
3
43
.3
1
45
.4
4
28
.8
1 
B
-0
02
   
 
18
2.
9 
11
3.
6 
33
.9
6
74
1
55
.3
1
66
.2
38
.0
5
54
.3
6
52
.7
4
54
.5
6
32
.9
 
B
-0
03
   
 
16
5.
1 
10
0 
36
.6
9
57
2
18
.9
6
51
.9
15
.8
3
23
.1
8
21
.2
23
.7
16
.8
5 
B
-0
04
   
 
15
8.
8 
81
.8
 
32
.4
4
68
2
46
.5
2
78
.1
9
30
.8
5
51
.3
9
50
.8
1
50
.9
7
46
.9
2 
B
-0
05
   
 
16
0.
2 
92
.7
3 
36
.1
3
53
2
69
.5
6
82
.3
48
.6
8
61
.2
9
60
.0
1
64
.5
1
72
.3
 
B
-0
06
   
 
16
7.
6 
10
9.
1 
38
.8
4
74
2
18
.6
5
58
.0
7
14
.3
22
.3
6
21
.8
23
.6
7
25
.3
7 
B
-0
07
   
 
15
7.
5 
11
3.
2 
45
.6
3
47
2
32
.2
6
76
.9
6
17
.1
1
25
.8
9
24
.6
9
29
.4
2
31
.5
6 
B
-0
08
   
 
15
6 
11
0.
5 
45
.4
1
63
2
54
.8
4
73
.5
5
34
.6
6
48
.0
1
43
.3
1
49
.1
4
15
.1
3 
B
-0
09
   
 
16
7.
6 
84
.8
 
30
.1
9
69
2
11
.9
6
53
.0
3
6.
7
13
.6
8
13
.4
1
15
.2
7
5.
08
 
B
-0
10
   
 
17
0.
2 
67
.3
 
23
.2
3
78
2
34
.8
9
76
.6
25
.7
36
.6
5
36
.8
7
39
.0
4
8.
27
 
B
-0
11
   
 
17
3.
5 
10
2.
27
 
33
.9
8
58
2
51
.8
9
57
.3
5
30
.6
3
37
.4
36
.5
9
41
.3
1
30
.5
 
B
-0
12
   
 
16
7 
91
.3
6 
32
.7
5
77
2
11
.4
9
34
.4
2
8.
63
13
.6
4
12
.9
7
14
.2
6
30
.2
3 
B
-0
13
   
 
16
7.
5 
90
.9
1 
32
.5
8
56
1
37
.8
2
62
.5
2
25
.5
3
39
.4
8
38
.4
7
39
.8
4
35
.9
4 
B
-0
14
   
 
16
2.
5 
62
.7
3 
23
.9
4
61
2
33
.4
1
48
.7
2
22
.6
9
33
.5
3
35
.2
7
34
.8
1
29
.7
 
B
-0
15
   
 
15
5 
80
.9
1 
33
.7
1
77
2
10
.6
1
43
.1
1
9.
09
13
.9
5
12
.5
6
14
.7
8
29
.4
3 
B
-0
16
   
 
16
7.
64
 
74
.0
9 
26
.3
7
72
2
47
.9
6
64
.9
6
36
.1
5
42
.0
2
40
.1
4
45
.1
5
29
.1
7 
B
-0
17
   
 
18
0.
34
 
85
 
26
.1
5
74
1
41
.8
6
47
.1
4
27
.3
5
31
.5
1
32
.6
1
35
.4
3
42
.2
4 
B
-0
18
   
 
. 
. 
.
.
.
.
.
.
.
.
.
53
.7
3 
U
-0
01
   
 
17
5.
3 
10
2.
3 
33
.2
9
61
1
51
.3
1
44
.3
5
25
.7
8
26
.0
1
26
.6
4
32
.5
45
.8
8 
U
-0
02
   
 
16
2.
6 
90
.9
 
34
.3
8
69
2
33
.4
8
73
.3
8
19
.3
8
40
.1
6
40
.3
1
39
.3
6
35
.8
6 
U
-0
03
   
 
15
4.
9 
11
5 
47
.9
3
68
2
17
.7
7
69
.5
5
9.
17
14
.7
4
13
.3
7
18
.0
3
16
.0
1 
U
-0
04
   
 
16
1.
3 
81
.4
 
31
.2
9
67
2
42
.2
6
76
.6
6
40
.2
7
58
.1
5
58
.3
5
57
.0
4
27
.5
7 
U
-0
05
   
 
18
0 
10
2.
3 
32
.3
6
53
1
36
.9
9
72
.7
8
22
.2
7
35
.4
8
35
.2
3
37
.3
7
27
.3
 
U
-0
06
   
 
16
3.
8 
61
.4
 
22
.8
8
79
2
19
.5
5
41
.8
9
16
.3
4
24
.2
1
22
.8
2
24
.0
8
20
.0
7 
U
-0
07
   
 
17
0.
2 
11
9.
5 
41
.2
5
64
2
38
.9
6
49
.8
9
26
.3
3
36
.5
3
34
.5
37
.1
2
26
.7
7 
U
-0
08
   
 
16
8 
96
.8
2 
34
.3
3
77
2
30
.0
9
58
.0
1
23
.9
9
30
.2
5
30
.5
1
32
.7
2
18
.2
5 
U
-0
09
   
 
17
2 
10
4.
55
 
35
.3
2
41
2
53
.3
4
75
.4
4
40
.0
2
50
.4
49
.1
4
52
.9
8
26
.2
4 
U
-0
10
   
 
17
2 
12
0.
45
 
40
.8
3
70
2
47
.1
3
38
.6
6
28
.4
3
38
.1
1
34
.4
38
.3
9
25
.9
7 
U
-0
11
   
 
16
9 
84
.0
9 
29
.4
68
2
40
.3
6
58
.8
4
21
.5
4
30
.9
5
31
.3
1
34
.0
5
28
.0
3 
U
-0
12
   
 
17
5.
26
 
80
.4
5 
26
.2
1
72
1
24
.8
7
36
.5
2
10
.4
14
.0
9
15
.2
4
17
.4
9
24
.4
5 
U
-0
13
   
 
17
5.
25
 
93
.1
8 
30
.3
5
83
1
28
.5
9
40
.8
7
14
.4
3
26
.0
9
25
.6
3
26
.2
7
17
.6
8 
U
-0
14
   
 
15
3 
79
.5
5 
33
.9
9
75
2
29
.8
7
30
.4
5
13
.5
3
12
.7
8
13
.2
17
.4
1
24
.9
1 
P
at
 ID
 
U
B
F2
 
LB
S
2 
B
A
LC
O
R
2
E
N
D
U
R
2
P
FP
To
ta
l2
U
B
S
3
U
B
F3
LB
S
3
B
A
LC
O
R
3
E
N
D
U
R
3
P
FP
TO
T3
U
B
S
4 
06
-0
41
   
. 
. 
.
.
.
.
.
.
.
.
.
. 
B
-0
01
   
 
76
.9
8 
17
.6
8 
23
.8
6
23
.9
1
28
.2
3
41
.4
4
72
27
.5
5
45
.0
8
44
.6
1
45
.1
5
47
.0
1 
B
-0
02
   
 
59
.7
4 
20
.3
5 
27
.3
8
30
.4
1
33
.5
9
35
.3
9
37
.6
9
20
.7
4
35
.8
2
35
.8
1
34
.7
5
56
.7
9 
  
  
15
8  
  B
-0
03
   
 
55
.6
4 
9.
26
 
11
.9
8
11
.3
15
.4
7
48
.0
8
82
.6
5
39
.0
5
55
53
.5
9
55
.4
54
.3
3 
B
-0
04
   
 
79
.4
5 
37
.6
4 
54
.4
2
52
.4
9
54
.1
6
59
.4
8
93
.3
47
.6
8
61
.7
4
59
.8
9
63
.7
6
61
.6
6 
B
-0
05
   
 
77
.7
1 
39
.0
6 
47
.2
6
46
.1
53
.4
8
77
.8
4
82
.8
5
47
.1
6
53
.8
2
53
.0
5
60
.7
4
. 
B
-0
06
   
 
66
.4
2 
19
.1
3 
27
.2
8
26
.5
29
.2
9
38
.6
1
73
.0
8
29
.3
4
39
.1
1
38
.7
3
41
.5
1
. 
B
-0
07
   
 
59
.7
4 
19
.3
2 
27
.3
8
29
.0
1
31
.9
5
46
.6
1
63
.6
32
.5
9
38
.9
44
.8
3
46
.6
8
. 
B
-0
08
   
 
60
.4
 
5.
37
 
18
.2
7
16
.1
1
19
.7
6
45
.9
6
62
.5
5
32
.0
7
38
.9
44
.1
5
45
.9
8
54
.5
6 
B
-0
09
   
 
50
.9
8 
3.
24
 
9.
4
9.
01
10
.6
6
45
.3
2
61
.5
1
31
.5
5
38
.9
43
.4
8
45
.2
8
. 
B
-0
10
   
 
42
.7
4 
3.
88
 
20
.1
18
.0
9
16
.9
2
26
.1
4
63
.1
4
16
.4
2
27
.2
25
.6
28
.2
2
25
.2
1 
B
-0
11
   
 
59
.7
4 
18
.5
 
27
.3
8
27
.9
30
.6
4
43
.9
5
29
.2
7
32
.8
6
43
.1
6
43
.0
1
42
.7
6
43
.6
5 
B
-0
12
   
 
59
.7
4 
18
.3
 
27
.3
8
27
.6
2
30
.3
1
43
.3
9
58
.3
7
29
.9
9
38
.9
41
.4
6
43
.1
8
. 
B
-0
13
   
 
65
.7
5 
26
.9
2 
44
.0
8
43
.4
2
43
.1
5
49
.1
5
63
.5
7
33
.0
2
47
.5
47
.6
6
48
.6
3
. 
B
-0
14
   
 
59
.7
4 
17
.8
8 
27
.3
8
27
.0
6
29
.6
6
37
.9
9
39
.9
6
22
.6
1
40
.1
3
40
.8
9
38
.6
7
34
.9
8 
B
-0
15
   
 
59
.7
4 
17
.6
8 
27
.3
8
26
.7
8
29
.3
3
37
.6
7
20
.9
3
22
.2
7
29
.4
2
28
.6
1
29
.9
8
. 
B
-0
16
   
 
59
.7
4 
17
.4
7 
27
.3
8
26
.5
1
29
44
.7
9
34
.9
4
26
.8
3
30
.0
8
29
.1
7
33
.3
1
. 
B
-0
17
   
 
59
.7
4 
15
.5
6 
22
.1
6
21
.5
4
26
.4
3
40
.1
8
53
.1
4
27
.4
38
.9
38
.1
8
39
.6
9
. 
B
-0
18
   
 
64
.1
9 
30
.1
2 
44
.1
8
45
.4
8
46
.8
9
53
.7
58
.8
6
37
51
.5
51
.9
2
52
.4
8
. 
U
-0
01
   
 
76
.7
 
24
.7
5 
43
.2
6
43
.2
6
44
.4
64
.5
9
72
.2
6
47
.1
6
59
.1
5
59
.1
6
62
.6
5
. 
U
-0
02
   
 
88
.2
1 
23
.4
9 
39
.7
8
39
.3
5
41
.1
9
32
.5
1
70
.6
6
28
.8
8
45
.1
3
43
.2
44
.2
4
39
.1
2 
U
-0
03
   
 
53
.6
 
9.
11
 
13
.0
1
11
.9
15
.7
16
.9
1
65
.9
3
9.
01
12
.9
6
12
.5
9
16
.8
4
17
.7
4 
U
-0
04
   
 
59
.7
4 
16
.2
4 
27
.3
8
24
.8
3
27
.0
4
29
.0
1
31
.7
5
20
.7
32
.1
7
33
.3
4
31
.5
8
47
.4
6 
U
-0
05
   
 
59
.7
4 
16
.0
3 
27
.3
8
24
.5
6
26
.7
1
48
.2
3
47
.6
9
34
.5
1
51
.1
8
50
.2
3
49
.7
6
53
.5
3 
U
-0
06
   
 
54
.6
8 
16
.3
9 
28
.0
8
27
.5
8
27
.7
6
22
.2
52
.9
7
17
.2
6
27
.8
3
27
.3
27
.9
7
28
.1
 
U
-0
07
   
 
59
.7
4 
15
.6
2 
27
.3
8
24
26
.0
5
39
.3
3
31
.5
8
33
.6
5
47
.1
2
42
.5
1
43
.5
1
44
.1
1 
U
-0
08
   
 
48
.9
4 
12
.0
9 
15
.7
4
14
.6
9
18
.1
4
34
.3
9
43
.7
2
22
.7
4
38
.9
32
.0
5
33
.4
44
.3
3 
U
-0
09
   
 
59
.7
4 
15
.2
1 
27
.3
8
23
.4
4
25
.4
33
.7
5
42
.6
7
22
.2
2
38
.9
38
.1
8
32
.7
. 
U
-0
10
   
 
59
.7
4 
15
 
27
.3
8
23
.1
6
25
.0
7
40
.6
21
.7
27
.0
7
39
.5
2
36
.9
6
37
.3
5
50
.2
5 
U
-0
11
   
 
57
.1
3 
16
.7
9 
24
.0
7
22
.9
8
26
.3
4
39
.3
3
72
.7
4
22
.7
6
37
.8
1
37
.1
6
39
.1
3
46
.6
9 
U
-0
12
   
 
40
.8
 
15
.3
3 
23
.6
1
23
.4
1
24
.4
4
27
.1
9
48
.3
8
19
.5
2
24
.4
6
24
.7
9
27
.0
1
. 
U
-0
13
   
 
24
.6
 
8.
23
 
9.
71
9.
27
11
.9
2
21
.4
8
38
.1
8.
59
18
.4
3
17
.5
6
18
.7
9
37
.5
1 
U
-0
14
   
 
59
.7
4 
14
.1
8 
27
.3
8
22
.0
5
23
.7
6
30
.7
8
25
.5
2
14
.9
7
17
.1
6
17
.2
3
20
.1
9
. 
   
 
 
 
P
at
 ID
 
LB
S
4 
B
A
LC
O
R
4 
E
N
D
U
R
4
U
B
F4
P
FP
to
t4
W
O
M
pa
in
W
O
M
st
iff
W
O
M
pf
W
O
M
to
t
W
O
M
pa
in
2
W
O
st
iff
2
W
O
M
pf
2 
05
-0
01
   
. 
. 
.
.
.
70
62
.5
73
.5
68
.6
7
.
.
. 
05
-0
02
   
. 
. 
.
.
.
75
62
.5
89
.6
7
75
.7
2
.
.
. 
05
-0
03
   
. 
. 
.
.
.
70
62
.5
79
.3
8
70
.6
3
.
.
. 
05
-0
04
   
. 
. 
.
.
.
50
62
.5
63
.2
1
58
.5
7
.
.
. 
05
-0
05
   
. 
. 
.
.
.
80
75
77
.9
1
77
.6
4
.
.
. 
  
  
15
9  
  0
5-
00
7 
  
. 
. 
.
.
.
70
75
67
.6
2
70
.8
7
.
.
. 
05
-0
08
   
. 
. 
.
.
.
80
75
76
.4
4
77
.1
5
.
.
. 
05
-0
09
   
. 
. 
.
.
.
60
75
66
.1
5
67
.0
5
.
.
. 
05
-0
10
   
. 
. 
.
.
.
45
37
.5
29
.4
37
.3
.
.
. 
05
-0
11
   
. 
. 
.
.
.
70
50
54
.3
9
58
.1
3
.
.
. 
05
-0
12
   
. 
. 
.
.
.
65
50
36
.7
5
50
.5
8
.
.
. 
05
-0
13
   
. 
. 
.
.
.
50
75
70
.5
6
65
.1
9
.
.
. 
05
-0
14
   
. 
. 
.
.
.
35
25
26
.4
6
28
.8
2
.
.
. 
05
-0
15
   
. 
. 
.
.
.
85
75
77
.9
1
79
.3
.
.
. 
05
-0
16
   
. 
. 
.
.
.
70
75
70
.5
6
71
.8
5
.
.
. 
05
-0
17
   
. 
. 
.
.
.
65
62
.5
60
.2
7
62
.5
9
.
.
. 
05
-0
18
   
. 
. 
.
.
.
45
50
51
.4
5
48
.8
2
.
.
. 
05
-0
19
   
. 
. 
.
.
.
35
50
42
.6
3
42
.5
4
.
.
. 
05
-0
20
   
. 
. 
.
.
.
45
75
39
.6
9
53
.2
3
.
.
. 
05
-0
21
   
. 
. 
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